0001493152-24-012417.txt : 20240401 0001493152-24-012417.hdr.sgml : 20240401 20240401163112 ACCESSION NUMBER: 0001493152-24-012417 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iveda Solutions, Inc. CENTRAL INDEX KEY: 0001397183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 202222203 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41345 FILM NUMBER: 24809892 BUSINESS ADDRESS: STREET 1: 1744 S. VAL VISTA DRIVE STREET 2: STE. 213 CITY: MESA STATE: AZ ZIP: 85204 BUSINESS PHONE: 480 338-1576 MAIL ADDRESS: STREET 1: 1744 S. VAL VISTA DRIVE STREET 2: STE. 213 CITY: MESA STATE: AZ ZIP: 85204 FORMER COMPANY: FORMER CONFORMED NAME: Iveda Corp DATE OF NAME CHANGE: 20090916 FORMER COMPANY: FORMER CONFORMED NAME: Charmed Homes Inc. DATE OF NAME CHANGE: 20070420 10-K 1 form10-k.htm
false FY 0001397183 P3Y 0001397183 2023-01-01 2023-12-31 0001397183 2023-09-30 0001397183 2024-03-15 0001397183 2023-10-01 2023-12-31 0001397183 2023-12-31 0001397183 2022-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001397183 2022-01-01 2022-12-31 0001397183 IVDA:EquipmentSalesMember 2023-01-01 2023-12-31 0001397183 IVDA:EquipmentSalesMember 2022-01-01 2022-12-31 0001397183 IVDA:ServiceRevenueMember 2023-01-01 2023-12-31 0001397183 IVDA:ServiceRevenueMember 2022-01-01 2022-12-31 0001397183 IVDA:OtherRevenueMember 2023-01-01 2023-12-31 0001397183 IVDA:OtherRevenueMember 2022-01-01 2022-12-31 0001397183 us-gaap:CommonStockMember 2021-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001397183 2021-12-31 0001397183 us-gaap:CommonStockMember 2022-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001397183 us-gaap:RetainedEarningsMember 2022-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001397183 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001397183 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001397183 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001397183 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001397183 us-gaap:CommonStockMember 2023-12-31 0001397183 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001397183 us-gaap:RetainedEarningsMember 2023-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001397183 2022-01-01 2022-03-31 0001397183 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2023-01-01 2023-12-31 0001397183 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanCoMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:YouMingHueiCoLtdMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChiconyPowerTechnologyMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:TaiwanCoMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChiconyPowerTechnologyMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:OtherCustomersMember srt:MinimumMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:OtherCustomersMember srt:MinimumMember 2022-01-01 2022-12-31 0001397183 srt:MinimumMember 2023-12-31 0001397183 srt:MaximumMember 2023-12-31 0001397183 country:US 2023-01-01 2023-12-31 0001397183 country:US 2023-12-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2023-01-01 2023-12-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2022-12-31 0001397183 IVDA:HuaNamBankMember 2023-12-31 0001397183 IVDA:HuaNamBankMember 2022-12-31 0001397183 IVDA:ChangHwaBankMember 2023-12-31 0001397183 IVDA:ChangHwaBankMember 2022-12-31 0001397183 IVDA:ShanghaiBankOneMember 2023-12-31 0001397183 IVDA:ShanghaiBankOneMember 2022-12-31 0001397183 IVDA:ShanghaiBankMember srt:MinimumMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankMember srt:MaximumMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2023-01-01 2023-12-31 0001397183 IVDA:HuaNamBankMember 2023-01-01 2023-12-31 0001397183 IVDA:ChangHwaBankMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankOneMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankMember srt:MinimumMember 2023-12-31 0001397183 IVDA:ShanghaiBankMember srt:MaximumMember 2023-12-31 0001397183 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2011-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2012-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2023-12-31 0001397183 IVDA:TwoThousandTwentyPlanMember srt:MaximumMember 2020-12-15 0001397183 IVDA:TwoThousandTwentyPlanMember 2023-12-31 0001397183 IVDA:StockOptionPlanMember 2023-12-31 0001397183 IVDA:StockOptionPlanMember 2022-12-31 0001397183 srt:MinimumMember 2022-01-01 2022-12-31 0001397183 srt:MaximumMember 2022-01-01 2022-12-31 0001397183 us-gaap:WarrantMember 2023-12-31 0001397183 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001397183 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001397183 us-gaap:WarrantMember srt:MinimumMember 2022-01-01 2022-12-31 0001397183 us-gaap:WarrantMember srt:MaximumMember 2022-01-01 2022-12-31 0001397183 IVDA:UsBasedSegmentMember 2023-12-31 0001397183 us-gaap:DomesticCountryMember 2023-12-31 0001397183 us-gaap:DomesticCountryMember 2023-01-01 2023-12-31 0001397183 stpr:AZ 2023-12-31 0001397183 2021-01-01 2021-12-31 0001397183 2020-12-31 0001397183 2020-01-01 2020-12-31 0001397183 2019-12-31 0001397183 2019-01-01 2019-12-31 0001397183 2018-12-31 0001397183 2018-01-01 2018-12-31 0001397183 2017-12-31 0001397183 2017-01-01 2017-12-31 0001397183 2016-12-31 0001397183 2016-01-01 2016-12-31 0001397183 2015-12-31 0001397183 2015-01-01 2015-12-31 0001397183 2014-12-31 0001397183 2014-01-01 2014-12-31 0001397183 2013-12-31 0001397183 2013-01-01 2013-12-31 0001397183 2012-12-31 0001397183 2012-01-01 2012-12-31 0001397183 2011-12-31 0001397183 2011-01-01 2011-12-31 0001397183 2010-12-31 0001397183 2010-01-01 2010-12-31 0001397183 2009-12-31 0001397183 2009-01-01 2009-12-31 0001397183 2008-12-31 0001397183 2008-01-01 2008-12-31 0001397183 2007-12-31 0001397183 2007-01-01 2007-12-31 0001397183 2006-12-31 0001397183 2006-01-01 2006-12-31 0001397183 2005-12-31 0001397183 2005-01-01 2005-12-31 0001397183 IVDA:MegasysMember 2023-01-01 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:TWD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-K

 

☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the fiscal year ended December 31, 2023

 

or

 

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 001-41345

 

IVEDA SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-2222203

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

     

1744 S Val Vista, Suite 213

Mesa, Arizona

   85204
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number, including area code: (480) 307-8700

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.00001 per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Check one:

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☒ Smaller reporting company ☒
  (Do not check if a smaller reporting company) Emerging growth company ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold was approximately $9,500,000 as of the last business day of the registrant’s most recently completed fiscal quarter. For purposes of this computation, all officers, directors, and 10% beneficial owners of the registrant are deemed to be affiliates. Such determination should not be deemed to be an admission that such officers, directors, or 10% beneficial owners are, in fact, affiliates of the registrant.

 

As of March 15, 2024, there were outstanding 16,169,891 shares of the registrant’s common stock, par value $0.00001 per share.

 

 

 

 
 

 

IVEDA SOLUTIONS, INC.

 

TABLE OF CONTENTS

 

PART I 4
ITEM 1 – BUSINESS 4
ITEM 1A – RISK FACTORS 12
ITEM lB – UNRESOLVED STAFF COMMENTS 24
ITEM 1C – CYBERSECURITY 24
ITEM 2 – PROPERTIES 24
ITEM 3 – LEGAL PROCEEDINGS 24
ITEM 4 – MINE SAFETY DISCLOSURES 24
   
PART II 25
ITEM 5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 25
ITEM 6 – SELECTED FINANCIAL DATA 26
ITEM 7 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 26
ITEM 7A – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 32
ITEM 8 – FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 32
ITEM 9 – CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 32
ITEM 9A – CONTROLS AND PROCEDURES 32
ITEM 9B – OTHER INFORMATION 33
ITEM 9C – DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 33
   
PART III 34
ITEM 10 – DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 34
ITEM 11 – EXECUTIVE COMPENSATION 37
ITEM 12 – SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 40
ITEM 13 – CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 41
ITEM 14 – PRINCIPAL ACCOUNTANT FEES AND SERVICES 41
   
PART IV 42
ITEM 15 – EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 42
SIGNATURES 43
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1
EX-31.1  
EX-31.2  
EX-32.1  
EX-32.2  

 

2

 

 

Cautionary Note Regarding Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this Annual Report on Form 10-K, including statements regarding future events, our future financial performance, business strategy, and plans and objectives for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” or “will” or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including the risks outlined under “Risk Factors” or elsewhere in this Annual Report on Form 10-K, which may cause our or our industry’s actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time, and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.

 

You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this Annual Report on Form 10-K. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this Annual Report on Form 10-K to conform our statements to actual results or changed expectations.

 

3

 

 

PART I

 

ITEM 1 – BUSINESS

 

History

 

Iveda Solutions, Inc. (“Iveda”, or the “Company”) was incorporated in Nevada as Charmed Homes, Inc. in June 2006. On October 15, 2009, IntelaSight, d/b/a Iveda, a Washington corporation, became a wholly owned subsidiary of the Company. In December 2010, IntelaSight merged with and into the Company and the Company became the surviving company. Iveda offered the first cloud hosting of streaming and recorded video from security cameras for its customers and real-time remote surveillance service utilizing intervention specialists to watch our customers’ cameras in real time, 24/7.

 

In April 2011, Iveda completed the acquisition of the Taiwan-based company Sole-Vision Technologies (doing business as Iveda Taiwan).

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras which is a global standard for the interface of IP-based physical security products.

 

In 2014, we changed our business model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators, and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal customer base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

4

 

 

Iveda Taiwan, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan. The company depends on Iveda Taiwan as the majority of the company’s revenues have come from Iveda Taiwan since we acquired them in April 2011.

 

Overview

 

Iveda specializes in AI and digital transformation technologies with real-world applications that improve quality of life and safety worldwide.

 

Iveda, through its wholly-owned subsidiary IntelaSight, Inc. has been offering real-time IP video surveillance technologies to our customers since 2005, prior to its merger with the company. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations worldwide. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

In the last few years, the concept of a smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Technology / Products

 

Iveda offers AI intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

 

IvedaAI

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

AI Functions

 

  ● Object Search
  ● Face Search (No Database Required)
  ● Face Recognition (from a Database)
  ● License Plate Recognition (100+ Countries), includes make and model
  ● Intrusion Detection
  ● Weapon Detection
  ● Fire Detection
  ● People Counting
  ● Vehicle Counting
  ● Temperature Detection
  ● Public Health Analytics (Facemask Detection)
  ● QR and Barcode Detection

 

Key Features

 

  ● Live Camera View
  ● Live Tracking
  ● Abnormality Detection – Vehicle/Person wrong direction detection
  ● Vehicle/Person Loitering Detection
  ● Fall Detection
  ● Illegal Parking Detection
  ● Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

5

 

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA (supervisory control and data acquisition) software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.

 

IvedaSPS is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

6

 

 

Utilus is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:

 

  ● Government or large-scale city deployments
  ● Supporting and Improving City Services
  ● Reducing Emergency Response Times
  ● Crime& Hazard Protection
  ● Monitoring and Improving Air Quality
  ● Sound Detection
  ● Traffic Monitoring and Mobility as a Service
  ● Data Analytics and Monetization Opportunities

 

vumastAR is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:

 

  ● Quality and Maintenance Exams: vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.
  ● Factory and Line Work: Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting.
  ● Pharma: Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error.
  ● Supply Chain: Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes.
  ● Manufacturing: Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data
  ● Transportation: Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.
  ● Retail: Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.

 

vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.

 

IvedaXpress is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.

 

7

 

 

Iveda Smart UVC is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.

 

Iveda’s Smart Drones are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.

 

Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.

 

Key Features of Iveda’s Smart Drone:

 

Fully Autonomous

Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging

Easy operation and 24-7 flight mission

 

Intelligent Computing

Live video streaming - real-time object recognition and tracking

Onboard (edged) AI and data analysis

 

Safety Design

Multiply redundant and fail-safe systems

Weather resistant industrial grade systems (IP54)

Designed and made in Taiwan (MIT)

 

Skywatch

Planning and editing real-time/timed missions

User/Group permission control & flight data management

Failsafe alarm and FPV gimbal control

 

Insight

Automated orthorectified service of imagery (2D/3D)

AI technology for inspecting natural disaster, vehicle & pedestrian tracking, and energy facilities inspection.

Visualizing geographic data and analysis report

 

  ●

Propellers: 8 (multiply redundant)

  ●

Diagonal Footprint: 29.76″ / 756 mm

  ●

Weight: 14.1lbs / 6.4 Kg

  ● Hover time: 30 mins
  ● Wind tolerance: Beaufort scale – 6
  ●

IP rating: IP54

  ●

Camera sensor: Dual RGB, IR/thermal

  ● Network: 5G/4G LTE and 2.4G Wi-Fi

 

The Smart Utility Cabinet gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.

 

Vemo Body Camera streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android, and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.

 

8

 

  

IvedaCare, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.

 

Customers

 

Our business model in the US is to license our software to organizations already providing services to an existing customer base and facilitating hardware acquisition through third party partners. This business model provides dual revenue streams – one from surveillance camera and analytics hardware sales to the service providers and the other from software licensing fees.

 

Iveda Taiwan continues to service its enterprise and government clients on a per-project basis. Some of its customers include Chunghwa Telecom, the Taiwan Stock Exchange, New Taipei City Police Department, Chicony Power Technology Co, Ltd. and Taiwan Energy Systems.

 

Here is a sample list of our historical and present customers and partners:

 

 

Seasonality of Business

 

There is no significant seasonality in our business.

 

9

 

 

Research and Development

 

Our CTO is spearheading the continued development of Cerebro, our proprietary IoT platform, utilizing internal resources and outsourced software engineers.

 

Intellectual Property

 

We regard certain aspects of our internal operations, products, and documentation as proprietary and rely on a combination of copyright and trademark (federal and common) laws, trade secrets, software security measures, license agreements, and nondisclosure agreements to protect our proprietary information. We do not own any patents, but in November 2012 we licensed, through our subsidiary, Sole-Vision Technologies, Inc., the right to use U.S. Patent No. 8,719,442 (as well as its Taiwanese and Chinese counterparts) ITRI with respect to the development of cloud-video technologies. We also recognize common law trademarks for “Iveda Solutions” and “Iveda” and its logo. We have pending trademarks applications before the U.S. Patent and Trademark Office for these marks.

 

We cannot guarantee that our protections will be adequate or that our competitors will not independently develop technologies that are substantially equivalent or superior to our system. Nonetheless, we intend to vigorously defend our proprietary technologies, trademarks, and trade secrets. We have required and will continue to require existing and future members of management, employees, and consultants to sign non-disclosure and invention assignment agreements for work performed on our behalf.

 

We are currently developing Cerebro IoT platform. Cerebro is a federated software platform for smart city management. It consists of power management, traffic management, location-based asset tracking, security systems management and AI intelligent video search management. We may consider patent protection for Cerebro based on the unique features we are developing. We are using a combination of open source and proprietary code for all our source coding.

 

We do not believe that our proprietary rights infringe the intellectual property rights of third parties. However, we cannot guarantee that third parties will not assert infringement claims against us with respect to current or future technology or that any such assertion may not require us to enter into royalty arrangements or result in costly litigation. Furthermore, our proposed future products and services may not be proprietary and other companies may already be providing these products and services.

 

Environmental Issues

 

Our business currently does not implicate any environmental regulation.

 

Industry Overview

 

Iveda is in AI space providing critical intelligence to video surveillance systems and IoT space providing digital transformation solutions to cities around the world. Both industry segments are projected to grow significantly. According to International Data Corporation (IDC) Worldwide Artificial Intelligence Spending Guide, global spending on AI is forecast to double over the next four years from USD 50.1 billion in 2020 to more than USD 110 billion in 2024. Spending on AI systems will accelerate over the next several years as organizations deploy artificial intelligence as part of their digital transformation efforts and to remain competitive in the digital economy.

 

According to Fortune Business Insights, the global IoT market size was USD 308.97 billion in 2020, exhibiting a growth of 23.1% in 2020 compared to the average year-on-year growth during 2017-2019. The market is projected to grow from USD 381.30 billion in 2021 to USD 1,854.76 billion in 2028.

 

Corporate Information

 

Our principal executive office is located at 1744 S. Val Vista Drive, Ste. 213, Mesa, Arizona 85204. The telephone number of our principal executive offices is (480) 307-8700. Our registered agent is CT Corporation System and their office is located at 701 S Carson Street, Suite 200, Carson City, NV, 89701. Information contained on our website on that can be accessed through our website is not incorporated by reference in this prospectus.

 

10

 

 

Government Regulation

 

The security and surveillance industry and consumer data privacy are subject to government regulation. Future changes in laws or regulations could require us to change the way we operate, which could increase costs or otherwise disrupt operations. In addition, failure to comply with any applicable laws or regulations could result in substantial fines or revocation of any required operating permits and licenses. If laws and regulations change or we fail to comply in the future, our business, financial condition, and results of operations could be materially and adversely affected.

 

Employees

 

As of December 31, 2023, we had 7 full-time employees in the United States and 25 full-time employees in Taiwan. Our future success will depend, in part, on our ability to attract, retain, and motivate highly qualified security, sales, marketing, technical, and management personnel. From time to time, we employ independent consultants or contractors to support our development, marketing, sales and support, and administrative needs. Our employees are not represented by any collective bargaining unit.

 

Insurance

 

We maintain insurance, including comprehensive general liability coverage, in amounts and types of coverage that we believe are customary in our industry. Special coverage is sometimes added in response to unique customer requirements. We also maintain compliance with applicable state workers’ compensation laws. A certificate of insurance, which meets individual contract specifications, is made available to every customer.

 

Our History

 

We were incorporated in Nevada in June 2006 under the name Charmed Homes, Inc. and engaged in the construction and marketing of custom homes in Alberta, Canada. As a result of the unfavorable housing market and a lack of available funding, we ceased operations in 2008. On October 15, 2009, we completed a reverse merger with IntelaSight, Inc. doing business as Iveda Solutions, a Washington corporation (“IntelaSight”), pursuant to which IntelaSight became a wholly owned subsidiary of our company. Thereafter, we changed our name to Iveda Corporation. After the reverse merger, all of our operations were conducted under IntelaSight until December 31, 2010, at which time IntelaSight merged with and into our company, with our company surviving. At that time, we changed our name to Iveda Solutions, Inc. On April 30, 2011, we completed our acquisition of Iveda Taiwan, which was incorporated in the Republic of China (Taiwan) on July 5, 1999.

 

Our common stock is listed on NASDAQ under the symbol “IVDA.”

 

Available Information

 

Our principal executive offices are located at 1744 Val Vista, Suite 213, Mesa, Arizona 85204 and our telephone number is (480) 307-8700. Iveda Taiwan’s headquarters is located at 2F,-15, No. 14, Lane 609, Sec. 5, Chongxin Rd., Sanchong Dist., New Taipei City 241, Taiwan (R.O.C.). We have two website addresses: www.iveda.com and www.mega-sys.com. The information contained on our websites does not constitute a part of this Annual Report on Form 10-K.

 

We electronically file our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to these reports and other information with the Securities and Exchange Commission (the “SEC”). Through our website, we make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.

 

The public can also obtain copies of any materials we file with, or furnish to, the SEC by visiting the SEC’s Public Reference Room at 100 F Street NE, Washington, DC 20549 on official business days during the hours of 10:00 a.m. to 3:00 p.m. or by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

 

11

 

 

ITEM 1A – RISK FACTORS

 

An investment in our common stock involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks described below, together with all of the other information set forth in this prospectus, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be materially and adversely affected, which could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. The risks described below and in the documents referenced above are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business. You should only consider investing in our securities if you can bear the risk of loss of your entire investment.

 

Risks Related to Our Company and Business

 

We Have Incurred Significant Net Losses Since Our Inception And May Not Be Able To Achieve Or Maintain Profitability On An Annual Basis In The Future.

 

We have incurred significant net losses since our inception. For the years ended December 31, 2023 and 2022, we incurred net losses of approximately $3.2 million and $3.3 million, respectively, and had accumulated losses of approximately $47 million through December 31, 2023. We cannot predict if we will achieve or maintain annual profitability in the near future or at all. The expected growth due to the recent change in our revenue model may not be sustainable or may decrease, and we may not generate sufficient revenue to achieve or maintain annual profitability. Our ability to achieve and maintain annual profitability depends on a number of factors, including our ability to attract and service customers on a profitable basis and the growth of the video surveillance industry. If we are unable to achieve or maintain annual profitability, we may not be able to execute our business plan, our prospects may be harmed, and our stock price could be materially and adversely affected.

 

12

 

 

We Depend On Certain Key Personnel.

 

Our future success is dependent on the efforts of key management personnel, particularly David Ly, our Chairman and Chief Executive Officer, Robert J. Brilon, our Chief Financial Officer, and Gregory Omi, our Chief Technology Officer, each of whom is employed by us at will. Mr. Ly’s relationships within our industry are vital to our continued operations, and if Mr. Ly were no longer actively involved with us, we would likely be unable to continue our operations. The loss of one or more of our other key employees could also have a material adverse effect on our business, financial condition, and results of operations.

 

We also believe that our future success will be largely dependent on our ability to attract and retain highly qualified management, sales, and marketing personnel. We cannot assure investors that we will be able to attract and retain such personnel and our inability to retain such personnel or to train them rapidly enough to meet our expanding needs could cause a decrease in the overall quality and efficiency of our staff, which could have a material adverse effect on our business, financial condition, and results of operations.

 

Demand For Our Products May Be Lower Than We Anticipate.

 

We have limited resources to undertake reseller distribution activities. We cannot predict with certainty the potential customer demand for our intelligent video search, smart utility, smart sensors, gateways and trackers, and IoT platforms (Products) or the degree to which we will meet that demand. If demand for our Products does not develop to the extent or as quickly as expected, we might not be able to generate enough revenue to become profitable.

 

We are currently targeting the sale of our Products to telecommunications companies and technology and systems integrators. Our strategy to target those organizations is based upon their interest and a number of assumptions, some or all of which could prove to be incorrect.

 

Even if markets for our Products develop, we could achieve a smaller share of those markets than we currently anticipate. Achieving market share will require substantial investment in technical, marketing, project management, and engineering functions to support the deployment of our Products. We cannot assure investors that our efforts will result in the attainment of sufficient market share to become profitable.

 

We Believe Industry Trends Support Our Open Source Systems, But If Trends Reverse We May Experience Decreased Demand.

 

The security and surveillance industry is characterized by rapid changes in technology and customer demands. We believe that the existing market preference for open source systems (systems capable of integrating a wide range of products and services through community and private-based cooperation, such as the Internet, Linux, and certain cameras used in our business) is strong and will continue for the foreseeable future. We cannot assure investors that customer demand for our products and the market’s preference for open source systems will continue. A lack of customer demand or a decline in the preference of open source systems could have a material adverse effect on our business, financial condition, and results of operations.

 

13

 

 

A Relatively Small Number Of Key Customers Account For A Significant Portion Of Our Revenue.

 

Historically, a significant portion of our revenue has come from a limited number of key customers. Revenue from two customers out of 65 total customers represented approximately 48% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with 25%, 2) Chicony Power Technology Co Ltd with 23%, (both Taiwan companies). Revenue from two customers out of 42 total customers represented approximately 52% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with 21%, 2) Chicony Power Technology Co Ltd with 31%, (both Taiwan companies). Total number of customers were 65 and 42, for the years ended December 31, 2023 and 2022, respectively. 50% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. Our accounts receivables are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we generally do not require collateral in exchange for our products and services provided on credit.

 

Our licensing business, in particular, may be susceptible to concentration of revenue, if through our licensing customers’ large consumer bases of end users. The loss of a key service provider customer, the delay, reduction, or cancellation of a significant order, or difficulty collecting on our accounts receivable from our service provider customers could have a material adverse effect on our business, financial condition, and results of operations.

 

Payment terms for our U.S.-based segment require prepayment for our Products before they are shipped. For our U.S.-based segment, accounts receivable that are more than 120 days past due are considered delinquent. Payment terms for our Taiwan-based segment vary based on our agreements with our customers. Generally, we receive payment for our Products and services within one year of commencing the project, except that we retain 5% of the total payment amount and release such amount one year after the completion of the project. Iveda Taiwan provides an allowance for doubtful accounts for any receivables that will not be paid within one year, which excludes such retained amounts. We have set up no doubtful accounts receivable allowances for our Taiwan-based and U.S.-based segments, respectively, as of the years ended December 31, 2023 and 2022. We deem our accounts receivable to be collectible based on certain factors, including the nature of the customer contracts and past experience with similar customers.

 

We Rely On Iveda Taiwan, Our Taiwan Subsidiary, For A Significant Portion Of Our Revenue.

 

We rely on Iveda Taiwan, our Taiwan subsidiary, for a significant portion of our revenue. For the years ended December 31, 2023 and 2022, Iveda Taiwan’s operations accounted for 87% and 79% of our total revenue, respectively. If Iveda Taiwan experiences a decline in customer demand for its services, an increase in supplier pricing, currency fluctuations, or general economic or governmental instability, our business, financial condition, and results of operations may be materially and adversely affected.

 

Rapid Growth May Strain Our Resources.

 

As we continue the commercialization of our Products, we expect to experience significant and rapid growth in the scope and complexity of our business, which may place a significant strain on our senior management team and our financial and other resources. Such growth, if experienced, may expose us to greater costs and other risks associated with growth and expansion. We may be required to hire a broad range of additional employees, including engineers, project managers, and other support personnel, among others, in order to successfully advance our operations. We may also be required to expand and enhance our technology to accommodate customized customer solutions. We may be unsuccessful in these efforts or we may be unable to project accurately the rate or timing of these increases.

 

14

 

 

The nature of our distribution channel business does not require us to increase our leased space. Our licensing partners may host our platforms in their own data centers or public cloud such as Amazon or Google. Our ability to manage our rapid growth effectively will require us to continue to improve our operations, to improve our financial and management information systems, and to train, motivate, and manage our employees.

 

This growth may place a strain on our management and operational resources. The failure to develop and implement effective systems, or to hire and retain sufficient personnel for the performance of all of the functions necessary to effectively service and manage our business, or the failure to manage growth effectively, could have a materially adverse effect on our business, financial condition, and results of operations. In addition, difficulties in effectively managing the budgeting, forecasting, and other process control issues presented by such a rapid expansion could harm our business, financial condition, and results of operations.

 

We Depend On Third Party Manufacturers and Suppliers For The Products We Sell.

 

We have relationships with a number of third-party manufacturers and suppliers that provide all of the hardware components of our Products. We have direct relationships with camera manufacturers in Taiwan for camera systems. Risks associated with our dependence upon third-party manufacturers include the following: (i) reduced control over delivery schedules; (ii) lack of control over quality assurance; (iii) poor manufacturing yields and high costs; (iv) potential lack of adequate capacity during periods of excess demand; and (v) potential misappropriation of our intellectual property. Although we depend on third-party manufacturers and suppliers for the Products we sell, risks are minimized because we do not depend exclusively on any one manufacturer or supplier. We utilize an open platform, which means that in order to deliver our services, we do not discriminate based on camera brand or manufacturer and our services can be used with a wide array of products.

 

We do not know if we will be able to maintain third-party manufacturing and supply contracts on favorable terms, if at all, or if our current or future third-party manufacturers and suppliers will meet our requirements for quality, quantity, or timeliness. Our success depends in part on whether our manufacturers are able to fill the orders we place with them in a timely manner. If our manufacturers fail to satisfactorily perform their contractual obligations or fill purchase orders we place with them, we may be required to pursue replacement manufacturer relationships.

 

While we believe we would be able to find replacement sources for all of our third-party manufacturers and suppliers, if we are unable to find replacements on a timely basis, or at all, we may be forced to either temporarily or permanently discontinue the sale of certain products and associated services, which could expose us to legal liability, loss of reputation, and risk of loss or reduced profit. We believe that our present suppliers offer products that are superior to comparable products available from other suppliers. In addition, we have development partner relationships with many of our present suppliers, which provide us with greater control over future enhancements to the products we sell. Our business, financial condition, results of operation, and reputation could be adversely impacted if we are unable to provide quality products to our customers in a timely manner.

 

We could also be adversely affected by an increase in our manufacturers’ prices for our product components or a significant decline in our manufacturers’ financial condition. Our manufacturers’ prices may increase as a result of internal price determinations, fluctuations in the prices of raw materials, natural disasters, raw material shortages, or other events beyond our control. If our relationship with any one of our manufacturers is terminated and we cannot successfully establish a relationship with an alternative manufacturer that offers similar services at similar prices, our costs could increase, adversely affecting our operations.

 

We Operate In A Highly Competitive Industry And Our Failure To Compete Effectively May Adversely Affect Our Ability To Generate Revenue.

 

We believe that our products offer more functions and are priced better than our competitors. However, some companies may be developing a similar product, including companies that may have significantly greater financial, technical, and marketing resources, larger distribution networks, and that generate greater revenue and have greater name recognition than we do. Those companies may develop products that are superior to those that we offer. Such competition may potentially affect our chances of achieving profitability.

 

15

 

 

Some of our competitors may conduct more extensive promotional activities and may offer lower prices to customers than we can, which could allow them to gain greater market share or prevent us from increasing our market share. In the future, we may need to decrease our prices to remain competitive. Our competitors may be able to respond more quickly to new or changing opportunities, technologies, and customer requirements. To be successful, we must carry out our business plan, establish and strengthen our brand awareness through marketing, effectively differentiate our services from those of our potential competitors, and build our network of service providers, while maintaining a superior platform and level of service, which we believe will ultimately differentiate our Products from those of our competitors. We may have to substantially increase marketing and development activities to compete effectively.

 

If Our Information Security Measures Are Breached And Unauthorized Access Is Obtained, Existing And Potential Service Providers May Not Perceive Our Software And Services As Being Secure And May Terminate Their Licensing Agreements Or Fail To Order Additional Products And Services.

 

Our software involves the monitoring of cameras that may be recording sensitive areas of end users’ facilities and the storage of sensitive data obtained from such cameras. Our software utilizes data and other security measures that are comparable to those used by financial institutions. However, because we no longer host the platform at our own data centers, information security risks associated with data centers are borne by the service providers. If we or any of our service providers or their end-users experience any breach of security in our software, we may be required to expend significant capital and resources to help restore our service providers’ systems. Furthermore, because techniques used to obtain unauthorized access to information systems change frequently and generally are not recognized until launched against a target, we may not be able to anticipate those techniques or to implement adequate preventative measures. Given the nature of our business and the business of the service providers we serve, if unauthorized parties gain access to our or our service providers’ information systems or such information is used in an unauthorized manner, misdirected, lost, or stolen during transmission, any theft or misuse of such information could result in, among other things, unfavorable publicity, governmental inquiry and oversight, difficulty in marketing our software, allegations by our service providers that we have not performed our contractual obligations, termination of services by existing customers, litigation by affected parties, and possible financial obligations for damages related to the theft or misuse of such information, any of which could have a material adverse effect on our business, financial condition, and results of operations.

 

Our Property And Business Interruption Insurance Coverage Is Limited And May Not Compensate Us Fully For Losses That May Occur As A Result Of A Disruption To Our Business.

 

Our property and business interruption insurance coverage is limited and is subject to deductibles and coverage limits. In the event that we experience a disruption to our business, our insurance coverage may not compensate us fully for losses that may occur. Any damage or failure that causes interruptions to our business could have a material adverse effect on our business, financial condition, and results of operations.

 

The Timing Of Our Revenue Can Vary Depending On How Long Customers Take To Evaluate Our Platform.

 

It is difficult to forecast the timing of revenue because the development period for a customized system or solution may be lengthy. In addition, our larger customers may need a significant amount of time to evaluate our products before purchasing them, and our governmental customers are subject to budgetary and other bureaucratic processes that may affect the timing of payment. The period between initial customer contact and a purchase by a customer varies greatly depending on the customer and historically has taken several months. During the evaluation period, customers may defer or reduce proposed orders of products or systems for various reasons, including (i) changes in budgets and purchasing priorities, (ii) decreased market adoption expectations, (iii) a reduced need to upgrade existing systems, (iv) introduction of products by competitors, and (v) general market and economic conditions.

 

We Are Subject To Certain Risks Inherent In Managing And Operating Businesses In Taiwan.

 

We have significant international operations in Taiwan that involve matters central to our business, including those relating to e-commerce, privacy and data protection, live streaming services, intellectual property, computer security, anti-money laundering, anti-corruption and anti-bribery, currency control regulations, data protection, privacy, consumer protection, competition, telecommunications and product liability. There are risks inherent in operating and selling products and services internationally, including the following: different regulatory environments and reimbursement systems; difficulties in enforcing agreements and collecting receivables through certain foreign legal systems; foreign customers who may have longer payment cycles than customers in the United States; fluctuations in foreign currency exchange rates; tax rates in certain foreign countries that may exceed those in the United States and foreign earnings that may be subject to withholding requirements; the imposition of tariffs, exchange controls, or other trade restrictions; general economic and political conditions in countries where we operate or where our customers reside; government control of capital transactions, including the borrowing of funds for operations or the expatriation of cash; potential adverse tax consequences; security concerns and potential business interruption risks associated with political or social unrest in foreign countries where our facilities or assets are located; difficulties associated with managing a large organization spread throughout various countries; difficulties in enforcing intellectual property rights and weaker intellectual property rights protection in some countries; required compliance with a variety of foreign laws and regulations; and differing customer preferences. The factors described above may have a material adverse effect on our business, financial condition, and results of operations.

 

16

 

 

Because the majority of the Company’s revenues come from our Iveda Taiwan subsidiary, which is located in Taiwan, the Company is subject to the risks of doing business in Taiwan, including periodic foreign economic downturns and political instability, which may adversely affect the Company’s revenue and cost of doing business in Taiwan.

 

Sole-Vision Technologies (doing business as Iveda Taiwan) is the Company’s wholly-owned subsidiary and generates the majority of the Company’s revenues. Iveda Taiwan’ primary place of business is in Taiwan, Republic of China, and the Company has certain key employees in Taiwan. Foreign economic downturns may affect our results of operations in the future. Additionally, other facts relating to the operation of the Company’s business outside of the U.S. may have a material adverse effect on the Company’s business, financial condition and results of operations, including:

 

  ● international economic and political changes;
  ● the imposition of governmental controls or changes in government regulations, including tax laws, regulations, trade policies, and treaties;
  ● changes in, or impositions of, legislative or regulatory requirements regarding the pharmaceutical industry;
  ● compliance with U.S. and international laws involving international operations, including the Foreign Corrupt Practices Act and export control laws;
  ● restrictions on transfers of funds and assets between jurisdictions;
  ● disruption to supply chains, impacting access to raw materials, labor, or finished products from third-party manufacturers;
  ● uncertainty in financial markets, leading to currency fluctuations, changes in interest rates, and stock market volatility;
  ● risk of elevated security concerns, including cyber threats, protests, or civil unrest; and
  ● China- Taiwan geo-political instability.

 

As the Company continues to operate its business in Taiwan, our success will depend in part, on our ability to anticipate and effectively manage these risks. The impact of any one or more of these factors could materially adversely affect our business, financial condition and results of operations.

 

Recent Geopolitical issues, conflicts and other global events could adversely affect our results of operations and financial condition.

 

Because a substantial portion of our business is conducted outside of the United States, our business is subject to global political issues and conflicts. Such political issues and conflicts could have a material adverse effect on our results of operations and financial condition if they escalate in areas in which we do business. In addition, changes in and adverse actions by governments in foreign markets in which we do business could have a material adverse effect on our results of operations and financial condition. For example, the recent and continuing conflict arising from the invasion of Ukraine by Russia could adversely impact macroeconomic conditions, give rise to regional instability and result in heightened economic tariffs, sanctions and import-export restrictions from the U.S. and the international community in a manner that adversely affects us, including to the extent that any such actions cause material business interruptions, restrict our ability to conduct business with certain suppliers or vendors, utilize the banking system, or repatriate cash.

 

We face risks associated with increased political uncertainty.

 

The recent invasion of Ukraine by Russia and the sanctions, bans and other measures taken by governments, organizations and companies against Russia and certain Russian citizens in response thereto has increased the political uncertainty in Europe and has strained the relations between Russia and a significant number of governments, including the U.S. The duration and outcome of this conflict, any retaliatory actions taken by Russia and the impact on regional or global economies is unknown, but could have a material adverse effect on our business, financial condition and results of our operations.

 

17

 

 

In the U.S., the change in the U.S. government to the Biden administration has resulted in uncertainty regarding potential changes in regulations, fiscal policy, social programs, domestic and foreign relations and international trade policies. In addition, potential changes in relationships among the U.S. and China and other countries including Taiwan could have significant impacts on global trade and regional economic conditions, among other things. In addition, changes in the relationships between the U.S. and its neighbors, such as Mexico, could have significant, potentially negative, impacts on commerce. Further, anti-American sentiment could harm the reputation and success of U.S. companies doing business abroad.

 

Our ability to respond to these developments or comply with any resulting new legal or regulatory requirements, including those involving economic and trade sanctions, could reduce our sales, increase our costs of doing business, reduce our financial flexibility and otherwise have a material adverse effect on our business, financial condition and results of our operations.

 

Our supply chain may be disrupted by changes in U.S. trade policy.

 

We rely on domestic and foreign suppliers to provide us with products in a timely manner and at favorable prices. We have experienced, and expect to continue to experience, increased international transit times. A disruption in the flow of our imported products or a material increase in the cost of those goods or transportation without any offsetting price increases may significantly decrease our profits. U.S. tariffs or other actions against foreign nations including China and any responses by such nations including China, could impair our ability to meet customer demand and could result in lost sales or an increase in our cost of products This would have a material adverse impact on our business and results of operations.

 

Our business activities may be subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, and similar anti-bribery and anti-corruption laws of other countries in which we operate, as well as U.S. and certain foreign export controls, trade sanctions, and import laws and regulations. Compliance with these legal requirements could limit our ability to compete in foreign markets and subject us to liability if we violate them.

 

If we further expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate. The FCPA generally prohibits companies and their employees and third party intermediaries from offering, promising, giving or authorizing the provision of anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action or otherwise obtain or retain business. The FCPA also requires public companies to make and keep books and records that accurately and fairly reflect the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls. Our business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments. Additionally, in many other countries, hospitals owned and operated by the government, and doctors and other hospital employees would be considered foreign officials under the FCPA. Recently the Securities and Exchange Commission (SEC) and Department of Justice (DOJ) have increased their FCPA enforcement activities with respect to biotechnology and pharmaceutical companies. There is no certainty that all of our employees, agents or contractors, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or our employees, disgorgement, and other sanctions and remedial measures, and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our products in one or more countries and could materially damage our reputation, our brand, our international activities, our ability to attract and retain employees and our business, prospects, operating results and financial condition.

 

In addition, our products and technology may be subject to U.S. and foreign export controls, trade sanctions and import laws and regulations. Governmental regulation of the import or export of our products and technology, or our failure to obtain any required import or export authorization for our products, when applicable, could harm our international sales and adversely affect our revenue. Compliance with applicable regulatory requirements regarding the export of our products may create delays in the introduction of our products in international markets or, in some cases, prevent the export of our products to some countries altogether. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products and services to countries, governments, and persons targeted by U.S. sanctions. If we fail to comply with export and import regulations and such economic sanctions, penalties could be imposed, including fines and/or denial of certain export privileges. Moreover, any new export or import restrictions, new legislation or shifting approaches in the enforcement or scope of existing regulations, or in the countries, persons, or products targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export our products to existing or potential customers with international operations. Any decreased use of our products or limitation on our ability to export or sell access to our products would likely adversely affect our business.

 

We Rely On Service Providers To Distribute Our Products To Customers.

 

We rely on service providers such as telecommunications companies, security integrators and other technology integrators to purchase and distribute our Products to their customers. We plan to continue this method of our internal sales activity for the foreseeable future to service large service providers and government accounts. While we believe we will be able to find alternate service providers if our relationship with any of our larger service providers is terminated and we are not successful in establishing a relationship with an alternative service provider that offers similar services at similar prices, our business could decline.

 

We have acquired, and may in the future acquire, assets, businesses and technologies as part of our business strategy. If we acquire companies or technologies in the future, they could prove difficult to integrate, disrupt our business, dilute stockholder value, and adversely affect our operating results and the value of our common stock.

 

As part of our business strategy, we may acquire, enter into joint ventures with, or make investments in complementary or synergistic companies, services, and technologies in the future. Acquisitions and investments involve numerous risks, including, without limitation:

 

  ● difficulties in identifying and acquiring products, technologies, proprietary rights or businesses that will help our business;
  ● difficulties in integrating operations, technologies, services, and personnel;
  ● diversion of financial and managerial resources from existing operations;
  ● the risk of entering new development activities and markets in which we have little to no experience;
  ● risks related to the assumption of known and unknown liabilities;
  ● risks related to our ability to raise sufficient capital to fund additional operating activities; and
  ● the issuance of our securities as partial or full payment for any acquisitions and investments could result in material dilution to our existing stockholders.

 

If we fail to integrate any acquired business into our operations, or if we fail to properly evaluate acquisitions or investments, we may not achieve the anticipated benefits of any such acquisitions, we may incur costs in excess of what we anticipate, and management resources and attention may be diverted from other necessary or valuable activities.

 

Any acquisitions we make could disrupt our business and seriously harm our financial condition.

 

We have in the past made (and may, from time to time, consider) acquisitions of complementary companies, products or technologies. Acquisitions involve numerous risks, including difficulties in the assimilation of the acquired businesses, the diversion of our management’s attention from other business concerns and potential adverse effects on existing business relationships. In addition, any acquisitions could involve the incurrence of substantial additional indebtedness. We cannot assure you that we will be able to successfully integrate any acquisitions that we pursue or that such acquisitions will perform as planned or prove to be beneficial to our operations and cash flow. Any such failure could seriously harm our business, financial condition and results of operations.

 

Our Ability To Use Our Net Operating Loss Carryforwards And Certain Other Tax Attributes May Be Limited, Which Could Potentially Result In Increased Tax Liabilities To Us In The Future.

 

In prior years, we have suffered losses, for tax and financial statement purposes that generated significant federal and state net operating loss carryforwards. As of December 31, 2023, we had approximately $35.0 million of federal and $5.0 million of state net operating loss carryforwards, which we believe could offset otherwise taxable income in the United States and Arizona. Our federal net operating loss carryforwards begin to expire in 2025. Our state net operating loss carryforwards, which are applicable in California and Arizona, began to expire in 2014. Although these net operating loss carryforwards may be used against taxable income in future periods, we will not receive any tax benefits from the losses we incurred unless, and only to the extent that, we have taxable income during the period prior to their expiration. In addition, our ability to use the net operating loss carryforwards would be severely limited in the event we complete a transaction that results in an ownership change under Section 382 of the Internal Revenue Code of 1986, as amended.

 

18

 

 

Risks Related to Our Intellectual Property

 

We Could Incur Substantial Costs Defending Against Claims That Our Products Infringe On The Proprietary Rights Of Others.

 

We do not own any patents. While we do not believe that our products infringe on the proprietary rights of any third parties, the intellectual property rights that we do have may not be sufficient to prevent infringement claims against us or claims that we have violated the intellectual property rights of third parties. We were named as a defendant in two patent-related lawsuits, both of which have been settled.

 

Competitors may have filed patent applications for or may have been issued patents and may obtain additional patents or other proprietary rights relating to products or processes that compete with or are related to our products and services. The scope and viability of these patents and other proprietary rights, the extent to which we may be required to obtain licenses under these patents or under other proprietary rights, and the cost and availability of licenses are unknown, but these factors may limit our ability to market our products and services.

 

While we do not believe that our products infringe on the proprietary rights of any third parties, third parties may claim infringement by us with respect to any patents or other proprietary rights that they hold, and we cannot assure investors that we would prevail in any such proceeding as the intellectual property status of our current and future competitors’ products and services is uncertain. Any infringement claim against us, whether meritorious or not, could be time-consuming, result in costly litigation or arbitration and diversion of technical and management personnel, or require us to develop non-infringing technology or to enter into royalty or licensing agreements.

 

We may not be successful in developing or otherwise acquiring rights to non-infringing technologies. Royalty or licensing agreements, if required, may not be available on terms acceptable to us, or at all, and could significantly harm our business and operating results. A successful claim of infringement against us or our failure or inability to license the infringed or similar technology could require us to pay substantial damages and could harm our business because we would not be able to continue operating our products without incurring significant additional expense.

 

In addition, to the extent we have agreed to or will agree to indemnify customers or other third parties against infringement of the intellectual property rights of others, a claim of infringement could require us to incur substantial time, effort, and expense to indemnify these customers and third parties and could disrupt or terminate their ability to use, market, or sell our products. Furthermore, our suppliers may not provide us with indemnification in the event that their products are found to infringe upon the intellectual property rights of any third parties, and if they do not, we would be forced to bear any resulting expense.

 

We Depend On Our Intellectual Property.

 

Our success and ability to compete depends in part on our proprietary Cerebro Smart IoT Platform and IvedaAI intelligent video search technology. We rely on a combination of copyright and trademark (federal and common) laws, trade secrets, software security measures, license agreements, and nondisclosure agreements to protect our proprietary information. We licensed, through our subsidiary, Sole-Vision Technologies, Inc., the right to use U.S. Patent No. 8,719,442 (as well as its Taiwanese and Chinese counterparts) from Industrial Technology Research Institute (ITRI) with respect to the development of cloud-video technologies. If any of our competitors copy or otherwise gain access to our proprietary technology or develop similar technologies independently, we may not be able to compete as effectively. We consider our proprietary platform invaluable to our ability to continue to develop and maintain the goodwill and recognition associated with our brand. We do not currently own any patents. The measures we take to protect our technologies and other intellectual property rights, which presently are based upon trade secrets, may not be adequate to prevent their unauthorized use.

 

If we are unable to protect our intellectual property, our competitors could use our intellectual property to market products, services, and technologies similar to ours, which could reduce demand for our Products, services, and technologies. We may be unable to prevent unauthorized parties from attempting to copy or otherwise obtaining and using our products or technology. Policing unauthorized use of our technology is difficult, and we may not be able to prevent misappropriation of our technology, particularly in foreign countries where the laws may not protect our intellectual property as fully as those in the United States. Others may circumvent the trade secrets, trademarks, and copyrights that we currently or in the future may own. We do not have patent protection with respect to our software or systems, although we are considering seeking such protection.

 

19

 

 

We seek to protect our proprietary intellectual property, which includes intellectual property that may only be protectable as a trade secret, in part by confidentiality agreements with our employees, consultants, and business partners. These agreements afford only limited protection and may not provide us with adequate remedies for any breach or prevent other persons or institutions from asserting rights to intellectual property arising out of these relationships. See “Business – Intellectual Property.”

 

We Could Incur Substantial Costs Defending Our Intellectual Property From Infringement By Others.

 

Unauthorized parties may attempt to copy aspects of our proprietary software or to obtain and use our other proprietary information. Litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets, and to determine the validity and scope of the proprietary rights of others. We may not have the financial resources to prosecute any infringement claims that we may have. Any litigation could result in substantial costs and diversion of resources with no assurance of success.

 

Risk Related to Ownership of Our Securities

 

We May Not Be Able To Access The Equity Or Credit Markets.

 

We face the risk that we may not be able to access various capital sources, including investors, lenders, or suppliers. Failure to access the equity or credit markets from any of these sources could have a material adverse effect on our business, financial condition, results of operations, and future prospects.

 

Future Sales Of Our Common Stock In The Public Market By Our Existing Stockholders, Or The Perception That Such Sales Might Occur, Could Depress The Market Price Of Our Common Stock.

 

The market price of our common stock could decline as a result of the sales of a large number of shares of our common stock in the market by the selling stockholders, and even the perception that these sales could occur may depress the market price of our common stock.

 

Future Sales And Issuances Of Our Common Stock Or Rights To Purchase Common Stock By Us, Including Pursuant To Acquisitions, Investments, Financings or Our Equity Incentive Plans, Could Result In Additional Dilution Of Percentage Ownership Of Our Stockholders And Could Cause Our Stock Price To Fall.

 

We intend to issue additional securities pursuant to our equity incentive plans and may issue equity or convertible securities in the future in connection with acquisitions, investments and/or additional financings. To the extent we do so, our stockholders may experience substantial dilution. We may sell common stock, convertible securities, or other equity securities in one or more transactions at prices and in a manner we determine from time to time. If we sell common stock, convertible securities, or other equity securities in more than one transaction, investors may be materially diluted by subsequent sales and new investors could gain rights superior to our existing stockholders.

 

There Is A Limited Market For Our Common Stock.

 

Our common stock is listed on the Nasdaq Capital Markets under the symbol “IVDA”. No assurance can be given that an active trading market for our shares will be maintained. In the absence of an active trading market for our common stock, the ability of our stockholders to sell their shares could be limited.

 

Our Warrants are speculative in nature.

 

Our Warrants do not confer any rights of common stock ownership on its holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire common stock at a fixed price for a limited period of time. Commencing on the date of issuance, holders of the Warrants may exercise their rights to acquire the common stock and pay an exercise price of $4.25 per share, subject to certain adjustments, prior to the fifth anniversary of the date of issuance, after which date any unexercised Warrants will expire and have no further value.

 

Our Reporting Obligations As A Public Company Are Costly.

 

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), and the Securities Act. These rules, regulations and requirements are extensive. We may incur significant costs associated with our public company corporate governance and reporting requirements. This may divert management’s attention from other business concerns, which could have a material adverse effect on our business, financial condition and results of operations. We also expect that these applicable rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as executive officers.

 

Future Changes in Financial Accounting Standards or Practices May Cause Adverse Unexpected Financial Reporting Fluctuations and Affect Reported Results of Operations.

 

A change in accounting standards or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and varying interpretations of accounting pronouncements have occurred and may occur in the future. Changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct business.

 

20

 

 

If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial results or prevent fraud and our business may be harmed and our stock price may be adversely impacted.

 

Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and to effectively prevent fraud. Any inability to provide reliable financial reports or to prevent fraud could harm our business. The Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) requires management to evaluate and assess the effectiveness of our internal control over financial reporting. In order to continue to comply with the requirements of the Sarbanes-Oxley Act, we are required to continuously evaluate and, where appropriate, enhance our policies, procedures and internal controls. We have in the past failed, and may in the future fail, to maintain the adequacy of our internal controls over financial reporting. Such failure could subject us to litigation or regulatory scrutiny and investors could lose confidence in the accuracy and completeness of our financial reports. We cannot provide any assurance that in the future we will be able to fully comply with the requirements of the Sarbanes-Oxley Act or that management will conclude that our internal control over financial reporting is effective. If we fail to fully comply with the requirements of the Sarbanes-Oxley Act, our business may be harmed and our stock price may decline. For example, our assessment, testing and evaluation of the design and operating effectiveness of our internal control over financial reporting resulted in our conclusion that as of December 31, 2023 our internal control over financial reporting was not effective, due to the Company not having adequate controls related to change management within the technology that support the Company’s financial reporting function.

 

Our financial controls and procedures may not be sufficient to ensure timely and reliable reporting of financial information, which, as a public company, could materially harm our stock price.

 

We require significant financial resources to maintain our public reporting status. We cannot assure you we will be able to maintain adequate resources to ensure that we will not have any future material weakness in our system of internal controls. The effectiveness of our controls and procedures may in the future be limited by a variety of factors including:

 

  ● faulty human judgment and simple errors, omissions or mistakes;
  ● fraudulent action of an individual or collusion of two or more people;
  ● inappropriate management override of procedures; and
  ● the possibility that any enhancements to controls and procedures may still not be adequate to assure timely and accurate financial information.

 

Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Despite these controls, because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Furthermore, smaller reporting companies like us face additional limitations. Smaller reporting companies employ fewer individuals and can find it difficult to employ resources for complicated transactions and effective risk management. Additionally, smaller reporting companies tend to utilize general accounting software packages that lack a rigorous set of software controls.

 

If we fail to have effective controls and procedures for financial reporting in place, we could be unable to provide timely and accurate financial information and be subject to investigation by the Securities and Exchange Commission and civil or criminal sanctions.

 

We Do Not Intend To Pay Dividends On Our Common Stock So Any Returns Will Be Limited To The Value Of Our Stock.

 

We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain any future earnings for the development, operation, and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will be limited to the value of their stock.

 

21

 

 

Our common stock is subject to price volatility unrelated to our operations.

 

The market price of our common stock could fluctuate substantially due to a variety of factors, including market perception of our ability to achieve our planned growth, quarterly operating results of other companies in the same industry, trading volume in our common stock, changes in general conditions in the economy and the financial markets or other developments affecting the Company’s competitors or the Company itself.

 

A decline in the price of our common stock could affect our ability to raise working capital and adversely impact our ability to continue operations.

 

A prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in our ability to raise capital. A decline in the price of our common stock could be especially detrimental to our liquidity, our operations and strategic plans. Such reductions may force us to reallocate funds from other planned uses and may have a significant negative effect on our business plan and operations, including our ability to develop new services and continue our current operations. If our common stock price declines, we can offer no assurance that we will be able to raise additional capital or generate funds from operations sufficient to meet our obligations. If we are unable to raise sufficient capital in the future, we may not be able to have the resources to continue our normal operations.

 

If we are not able to comply with the applicable continued listing requirements or standards of the Nasdaq Capital Market, Nasdaq could delist our securities.

 

We are listed on The Nasdaq Capital Market under the symbol “IVDA”. We also list the Warrants under the symbol “IVDAW.” We cannot assure you that our securities will continue to be, listed on The Nasdaq Capital Market in the future. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. We may not be able to comply with the applicable listing standards and Nasdaq could delist our securities as a result.

 

We cannot assure you that our common stock and/or Warrants, if delisted from The Nasdaq Capital Market, will be listed on another national securities exchange. If our common stock and/or Warrants are delisted by The Nasdaq Capital Market, they would likely trade on the OTCQB where an investor may find it more difficult to sell our securities or obtain accurate quotations as to the market value of our common stock and/or Warrants.

 

On September 28, 2023, the Company received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s Common Stock, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Price Requirement exists if the deficiency continues for a period of 30 consecutive trading days.

 

To regain compliance, the closing bid price of the Common Stock must be at least $1.00 per share for a minimum of 10 consecutive trading days prior to March 26, 2024, and the Company must otherwise satisfy The Nasdaq Capital Market’s requirements for listing. If the Company does not regain compliance by March 26, 2024, the Company may be eligible for an additional 180 calendar day compliance period if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company does not qualify for the second compliance period or fails to regain compliance during the second compliance period, then Nasdaq will notify the Company of its determination to delist the Company’s common stock, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.

 

The Company intends to monitor the closing bid price of the Common Stock and consider its available options to resolve the noncompliance with the Minimum Bid Price Requirement. There can be no assurance that the Company will be able to regain compliance with The Nasdaq Capital Market’s continued listing requirements or that Nasdaq will grant the Company a further extension of time to regain compliance, if applicable.

 

Techniques employed by short sellers may drive down the market price of the common stock.

 

Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale.

 

As it is in the short seller’s interest for the price of the security to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its prospects to create negative market momentum and generate profits for themselves after selling a security short. These short attacks have, in the past, led to selling of shares in the market.

 

It is not clear what effect such negative publicity could have on us. If we were to become the subject of any unfavorable allegations, whether such allegations are proven to be true or untrue, we could have to expend significant resources to investigate such allegations and/or defend ourselves.

 

While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which we can proceed against the relevant short seller by principles of freedom of speech, applicable state law or issues of commercial confidentiality. Such a situation could be costly and time-consuming, and could distract our management from growing our business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact our business, and any investment in the common stock could be greatly reduced or even rendered worthless.

 

22

 

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the market price for the common stock and trading volume could decline.

 

The trading market for the common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts who covers us downgrades the common stock or publishes inaccurate or unfavorable research about our business, the market price for the common stock would likely decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for the common stock to decline.

 

Our articles of incorporation contain anti-takeover provisions that could materially adversely affect the rights of holders of our common stock.

 

We have adopted an amended and restated memorandum and articles of incorporation that contain provisions to limit the ability of others to acquire control of our company or cause us to engage in change-of-control transactions. These provisions could deprive our shareholders of an opportunity to sell their shares at a premium over prevailing market prices by discouraging third parties from seeking to obtain control of our company in a tender offer or similar transaction.

 

Our board of directors has the authority, subject to any resolution of the shareholders to the contrary, to issue preferred shares in one or more series and to fix their designations, powers, preferences, privileges, and relative participating, optional or special rights and the qualifications, limitations or restrictions, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences, any or all of which may be greater than the rights associated with our common stock. Preferred shares could be issued quickly with terms calculated to delay or prevent a change in control of our company or make removal of management more difficult. If our board of directors decides to issue preferred shares, the price of our common stock may fall and the voting and other rights of the holders of our common stock may be materially adversely affected.

 

23

 

 

ITEM lB – UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 1C. CYBERSECURITY.

 

Cybersecurity Risk Management and Strategy

 

We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm to employees or customers and violation of data privacy or security laws.

 

We do not presently have any general processes for assessing, identifying, and managing material risks from cybersecurity threats. As we expand our business operations, we plan to develop processes that will allow for the identification and assessment of cybersecurity risk that will be integrated into an overall risk management system, which will be managed by senior management and overseen by the Board of Directors. As part of this development, we plan to identify and address cybersecurity risks related to our business, privacy and compliance issues through a multi-faceted approach that is expected to include third party assessments, internal information technology (IT) audit, IT security, governance, risk and compliance reviews. In connection with these planned approaches, and to defend, detect and respond to cybersecurity incidents, we, among other things, will consider: conducting proactive privacy and cybersecurity reviews of systems and applications, audits of applicable data policies, performing penetration testing using external third-party tools and techniques to test security controls, conducting employee training, monitoring emerging laws and regulations related to data protection and information security, and implementing appropriate changes.

 

As part of the above planned processes, we may engage external auditors and consultants with expertise in cybersecurity to assess our internal cybersecurity programs and compliance with applicable practices and standards.

 

We plan to design our risk management program to also assesses third party risks, and we plan to perform third-party risk management to identify and mitigate risks from third parties, such as vendors, suppliers, and other business partners associated with our use of third-party service providers. In addition to new vendor onboarding, we plan to perform risk management during third-party cybersecurity compromise incidents to identify and mitigate risks to us from third-party incidents.

 

Cybersecurity Governance

 

We expect that cybersecurity will become an important part of our risk management processes and an area of focus for our Board of Directors and management. We expect that our Board of Directors will be responsible for the oversight of risks from cybersecurity threats. We expect our senior management will provide our Board of Directors updates on a quarterly basis regarding matters of cybersecurity. This is expected to include existing and new cybersecurity risks, status on how management is addressing and/or mitigating those risks, cybersecurity and data privacy incidents (if any) and status on key information security initiatives. We expect that our Board members will also engage in periodic conversations with management on cybersecurity-related news events and discuss any updates to our cybersecurity risk management and strategy programs.

 

Currently, our Chief Financial Officer is expected to lead our cybersecurity risk assessment and management processes and oversees their implementation and maintenance. Our Chief Financial Officer will be tasked with staying informed about, and monitoring the prevention, mitigation, detection and remediation of cybersecurity incidents through his management of, and participation in, the cybersecurity risk management and strategy processes we plan to develop and as described above, including the operation of an incident response plan, and report to the Board of Directors on any appropriate items.

 

ITEM 2 – PROPERTIES

 

We currently rent for our principal executive offices approximately 3,000 square feet until February 2025 for approximately $4,500 per month. We believe that our current office space is adequate for the foreseeable future.

 

Iveda Taiwan leases for its principal executive offices in Taiwan, comprised of three suites totaling approximately 4,567 square feet. Iveda Taiwan pays an aggregate of approximately $3,136 per month under the terms of the three leases, which expire on June 30, 2024, September 15, 2024 and September 11, 2024.

 

ITEM 3 – LEGAL PROCEEDINGS

 

From time to time we may become involved in various legal proceedings that arise in the ordinary course of business, including actions related to our intellectual property. Although the outcomes of these legal proceedings cannot be predicted with certainty, we are currently not aware of any such legal proceedings or claims that we believe, either individually or in the aggregate, will have a material adverse effect on our business, financial condition, or results of operations.

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.

 

24

 

 

PART II

 

ITEM 5 – MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our common stock is listed on The Nasdaq Capital Market under the symbol “IVDA” since April 1, 2022. Set forth in the table below is information with respect to the high and low bid quotations of our common stock for the periods indicated as reported by NASDAQ and the OTC Markets. The quotations represent inter-dealer prices without retail mark-ups, mark-downs, or commissions and may not necessarily represent actual transactions.

 

See the High and Low Bid data below:

 

Fiscal Year 2023  High Bid   Low Bid 
First Quarter  $2.91   $0.57 
Second Quarter  $1.90   $1.04 
Third Quarter  $1.15   $0.74 
Fourth Quarter  $0.95   $0.57 

 

Fiscal Year 2022   High Bid     Low Bid  
First Quarter   $ 18.00     $ 5.28  
Second Quarter   $ 4.87     $ 1.07  
Third Quarter   $ 0.80     $ 0.47  
Fourth Quarter   $ 1.00     $ 0.50  

 

As of December 31, 2023, we had 16,169,891 shares of our Common Stock, par value $0.00001, issued and outstanding. There were approximately 700 beneficial owners of our Common Stock.

 

There is limited trading activity in our securities, and there can be no assurance that a regular trading market for our common stock will be sustained.

 

Security Holders

 

As of December 31, 2023, we had 16,169,891 shares of our common stock outstanding held by 103 shareholders of record, 0 shares of our Series A Preferred Stock outstanding and 0 shares of our series B Preferred Stock.

 

Dividend Policy

 

We have never paid a cash dividend on our common stock. We currently intend to retain all earnings, if any, to finance the growth and development of our business. We do not anticipate paying any cash dividends in the foreseeable future.

 

Equity Compensation Plans

 

For equity compensation plans information refer to Item 12 of Part III of this Annual Report on Form 10-K.

 

25

 

 

Recent Sales of Unregistered Securities

 

Set forth below are the sales of all securities by the Company within the past three years which were not registered under the Securities Act. The Company believes that each of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act and/or Regulation S under the Securities Act.

 

Between January 1, 2020 and December 31, 2021 the Company issued and sold an aggregate of 835,757 shares of common stock to investors for aggregate proceeds of approximately $2,790,000 in gross proceeds.

 

Between January 1, 2020 and December 31, 2021 the Company issued 439,527 shares of common stock to convertible debt holders upon conversion of $1,294,580 in principal and interest.

 

Between January 1, 2022 and December 31, 2022 the Company issued 8,215 shares of common stock to warrant holders upon exercise of $23,000 in proceeds.

 

Between January 1, 2023 and December 31, 2023 the Company issued 157,252 shares of restricted common stock for services valued at $138,547.

 

All of the securities referred to, above, were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as provided in Rule 506(b) of Regulation D promulgated thereunder.

 

ITEM 6 – SELECTED FINANCIAL DATA

 

Not applicable.

 

ITEM 7 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent search technology that provide true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  ● Object Search
     
  ● Face Search (No Database Required)
     
  ● Face Recognition (from a Database)
     
  ● License Plate Recognition (100+ Countries), includes make and model
     
  ● Intrusion Detection
     
  ● Weapon Detection
     
  ● Fire Detection
     
  ● People Counting
     
  ● Vehicle Counting
     
  ● Temperature Detection
     
  ● Public Health Analytics (Facemask Detection,)
     
  ● QR and Barcode Detection

 

26

 

 

Key Features

 

  ● Live Camera View
     
  ● Live Tracking
     
  ● Abnormality Detection – Vehicle/Person wrong direction detection
     
  ● Vehicle/Person Loitering Detection
     
  ● Fall Detection
     
  ● Illegal Parking Detection
     
  ● Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, care watch and tracking devices.

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro manages all the components of our smart power technology including statistics on energy consumption. Cerebro is a software platform designed to integrate multiple unconnected energy, security and safety applications and devices and control them through one comprehensive user interface.

 

Cerebro’s roadmap includes dashboard for all of Iveda’s platforms for central management of all devices. Cerebro is system agnostic and will support cross-platform interoperability. The common unified user interface will allow remote control of platforms, sensors and subsystems throughout an entire environment. This integration and unification of all subsystems enable acquisition and analysis of all information on one central command center, allowing comprehensive, effective, and overall management and protection of a city.

 

Iveda’s Utilus smart pole technology is a smart power management and wireless mesh communications network deployed on new or existing light pole structures. The Utilus network uses WiFi, 4G and 5G small cell capabilities, and other wireless protocols to provide distributed video surveillance with AI video search technology and remote management of local devices such as trackers, water meters, electrical meters, valves, circuit breakers and sensors.

 

In the last few years, the smart city concept has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources has necessitated the transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

We license our platform and sell IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal customer base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

27

 

 

Iveda Taiwan, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

In April 2011, we completed our acquisition of Iveda Taiwan, a company founded in 1998 by a group of sales and research and development professionals from Taiwan Panasonic Company. Iveda Taiwan, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City initiatives in Taiwan and other neighboring countries. Iveda Taiwan combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers and managing our relationship with the Industrial Technology Research Institute (“ITRI”) in Taiwan. Iveda Taiwan also houses the application engineering team that supports Sentir implementation for our service provider customers in Asia. The Company depends on Iveda Taiwan as the majority of the company’s revenues have come from Iveda Taiwan since we acquired them in April 2011. For the years ended December 31, 2023 and 2022, Iveda Taiwan’s operations accounted for 93% and 71% of our total revenue, respectively.

 

The acquisition of Iveda Taiwan provided the following benefits to our business:

 

  ● An established presence and credibility in Asia and access to the Asian market.
     
  ● Relationships in Asia for cost-effective research and development of new product offerings and securing the best pricing for end user devices.
     
  ● Sourcing of products directly using Iveda Taiwan’s product sourcing expertise to enhance our custom integration capabilities.
     
  ● Enhancements to the global distribution potential for our products and services.

 

In November 2012, we signed a cooperation agreement with ITRI, a research and development organization based in Taiwan. Together with ITRI, we have developed cloud-video services. Pursuant to the cooperation agreement, we licensed, through our subsidiary, Sole-Vision Technologies, Inc., the right to use U.S. Patent No. 8,719,442 (as well as its Taiwanese and Chinese counterparts) with respect to the development of cloud-video technologies.

 

In June and August 2014, in collaboration with our local partner in the Philippines, we shipped our ZEE cloud plug-and-play cameras for delivery to the Philippine Long Distance Telephone Company (“PLDT”) for distribution to its customers with a cloud video surveillance service offering, utilizing our Sentir platform.

 

Critical Accounting Policies and Estimates

 

Management’s Discussion and Analysis of Financial Conditions and Results of Operations is based upon our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. A description of our critical accounting policies and related judgments and estimates that affect the preparation of our financial statements is set forth in our audited consolidated financial statements for the year ended December 31, 2023. Such policies are unchanged.

 

New Accounting Standards

 

There were no new standards recently issued which would have an impact on our operations or disclosures.

 

28

 

 

Results of Operations for the Year Ended December 31, 2023 Compared with the Year Ended December 31, 2022

 

Net Revenue

 

We recorded net consolidated revenue of $6.5 million for the year ended December 31, 2023, compared with $4.5 million for the year ended December 31, 2022, an increase of $2.0 million, or 45%. For the year ended December 31, 2023, our recurring service revenue was $0.44 million, or 7% of net revenue, and our equipment sales and installation revenue was $6.0 million, or 93% of net revenue. In fiscal 2022, our recurring service revenue was $0.31 million, or 7% of consolidated net revenue, and our equipment sales and installation revenue was $4.2 million, or 93% of net revenue. The increase in total revenue in 2023 compared with the same period in fiscal 2022 is attributable primarily to increased equipment sales from Iveda Taiwan as a result of additional long-term contracts awarded and started during 2023.

 

Cost of Revenue

 

Total cost of revenue was $5.4 million (84% of revenue; gross margin of 16%) for the year ended December 31, 2023, compared with $3.5 million (78% of revenue; 22% gross margin) for the year ended December 31, 2022, an increase of ($1.1 million), or (55%). The increase in cost of revenue was primarily driven by increased Iveda Taiwan revenue. The decrease in overall gross margin was also primarily attributed to increased equipment sales proportion within Iveda Taiwan revenue as a result of additional long-term contracts awarded and started during 2023.

 

Operating Expenses

 

Operating expenses were $4.5 million for the year ended December 31, 2023, compared with $4.3 million for the year ended December 31, 2022, an increase of $0.2 million, or 4%. This net increase in operating expenses in 2023 compared with 2022 is due primarily related to a ramp up in personnel in sales and technical support personnel as well as research and development expenses for Cerebro IoT Platform and IvedaAI. Additional professional expenses have been incurred during this period with an effort to increase investor relations and marketing.

 

Loss from Operations

 

Loss from operations increased to $3.4 million for the year ended December 31, 2023, compared with $3.3 million for the year ended December 31, 2022, an increase of $0.1 million, or 2%. A majority of the increase in loss from operations was primarily due to increased operating expenses.

 

Other Income (Expense)-Net

 

Other income (expense)-net was $96,527 other income for the year ended December 31, 2023, compared with ($13,004) other expense for the year ended December 31, 2022, a positive change of $109,531. The majority of the other income in 2023 is interest income from cash balances.

 

Non-Controlled Portion of Joint Venture

 

Non-Controlled Portion of the Philippines Joint Venture net loss was $97,605 for the year ended December 31, 2023.

 

Net Loss

 

Net loss was $3.2 million for the year ended December 31, 2023, compared with $3.3 million for the year ended December 31, 2022. The decrease of $0.1 million, or 3%, in net loss was caused primarily by a decrease in operating expenses related to a ramp up in sales and technical support personnel as well as research and development expenses for Cerebro IoT Platform and IvedaAI. Additional professional expenses have been incurred during this period with an effort to increase investor relations and marketing.

 

Liquidity and Capital Resources

 

As of December 31, 2023, we had cash and cash equivalents of $2.9 million in our U.S.-based segment and $1.8 million in our Taiwan-based segment, compared to $6.0 million in our U.S.-based segment and $1.3 million in our Taiwan-based segment as of December 31, 2022. This decrease in our cash and cash equivalents is primarily a result of the cash used in operating activities of $3.5 million and $0.9 million investment in software platform development (Cerebro) during the year ended December 31, 2023. There are no legal or economic factors that materially impact our ability to transfer funds between our U.S.-based and Taiwan-based segments.

 

Net cash used in operating activities during the year ended December 31, 2023 was $3.5 million compared to $5.4 million net cash used during the year ended December 31, 2022. Net cash used in operating activities for the year ended December 31, 2023 consisted primarily of the $3.2 million net loss including $0.3 million of non-cash charges (primarily stock option compensation and common stock issued for investor relations services), $0.2 million of Taiwan vendor deposits, prepaids and advances to suppliers and $0.5 million net payments for accounts payable and accrued operating expenses. Net cash used in operating activities for the year ended December 31, 2022 consisted primarily of the $3.3 million net loss including $0.4 million of non-cash charges (primarily stock option compensation and common stock issued for investor relations services), $0.8 million in accounts receivable, $0.2 million of inventory, $0.2 million of Taiwan vendor deposits, prepaids and advances to suppliers and $1.2 million net payments for accounts payable and accrued operating and interest expenses.

 

Net cash used in investing activities for the year ended December 31, 2023 was $0.9 million. Net cash used by investing activities during the year ended December 31, 2022 was $14,165.

 

29

 

 

Net cash provided by financing activities for the year ended December 31, 2023 was $0.9 million compared with $11.4 million provided during the year ended December 31, 2022. Net cash provided by financing activities in 2023 is primarily a result of the $1.3 million exercise of warrants to purchase Common Stock at $1.40 per share issued with the offering of August 2022. Net cash provided by financing activities in 2022 is primarily a result of the $11.5 million sale of Common Stock and Pre-Funded warrants during the year ended December 31, 2023.

 

We have experienced significant operating losses since our inception. At December 31, 2023, we had approximately $32 million in net operating loss carryforwards available for federal income tax purposes, which will begin to expire in 2025. We did not recognize any benefit from the federal net operating loss carryforwards in 2023 or 2022. We also had approximately $5.0 million in state net operating loss carryforwards, which expire after five years.

 

We have limited liquidity and have not yet established a stabilized source of revenue sufficient to cover operating costs, based on our current estimated burn rate. Accordingly, our continuation as a going concern is dependent upon our ability to generate greater revenue through increased sales and/or our ability to raise additional funds through the capital markets. No assurance can be given that we will be successful in future financing and revenue-generating efforts. Even if funding is available, we cannot assure investors that it will be available on terms that are favorable to our existing stockholders. Additional funding may be achieved through the issuance of equity or debt securities that could be significantly dilutive to the percentage ownership of our existing stockholders. In addition, these newly issued securities may have rights, preferences, or privileges senior to those of our existing stockholders. Accordingly, such a financing transaction could materially and adversely impact the price of our common stock.

 

Substantially all of our cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (“Central Deposit Insurance Corporation”) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.

 

Our accounts receivable are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we generally do not require collateral in exchange for our products and services provided on credit.

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Payment terms for our U.S.-based segment require prepayment for most products before they are shipped and monthly Sentir licensing fees, which are due in advance on the first day of each month. For our U.S.-based segment, accounts receivable that are more than 120 days past due are considered delinquent. Payment terms for our Taiwan-based segment vary based on our agreements with our customers. Generally, we receive payment for our products and services within one year of commencing the project, except that we retain 5% of the total payment amount and release such amount one year after the completion of the project. For our U.S.-based segment, we had no doubtful accounts receivable allowances for the years ended December 31, 2023 and 2022, respectively. For our Taiwan-based segment, we set up no doubtful accounts receivable allowances for the years ended December 31, 2023 and 2022, respectively. We deem our accounts receivable to be collectible based on certain factors, including the nature of the customer contracts and past experience with similar customers. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer, and we generally do not charge interest on past due receivables.

 

Effects of Inflation

 

For the periods for which financial information is presented, we do not believe that the current levels of inflation in the United States have had a significant impact on our operations. Likewise, we do not believe that the current levels of inflation in Taiwan have had a significant impact on the operations of Iveda Taiwan.

 

Off Balance Sheet Arrangements

 

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not have any undisclosed borrowings or debt, and we have not entered into any synthetic leases. We are, therefore, not materially exposed to any financing, liquidity, market, or credit risk that could arise if we had engaged in such relationships.

 

Application of Critical Accounting Policies

 

We have identified the policies below as critical to our business operations and the understanding of our results of operations. The impact on our business operations and any associated risks related to these policies are discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported or expected financial results.

 

In the ordinary course of business, we have made a number of estimates and assumptions relating to the reporting of results of operations and financial condition in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”). We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The results form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe that the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require our most difficult, subjective, and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

 

30

 

 

The material estimates for our company are that of the stock-based compensation recorded for options and warrants issued and the income tax valuation allowance recorded for deferred tax assets. The fair values of options and warrants are determined using the Black-Scholes option pricing model. We have no historical data on the accuracy of these estimates. The estimated sensitivity to change is related to the various variables of the Black-Scholes option pricing model stated below. The specific quantitative variables are included in the notes to the financial statements. The estimated fair value of options and warrants is recognized as expense on the straight-line basis over the options’ and warrants’ vesting periods. The fair value of each option and warrant granted is estimated on the date of grant using the Black-Scholes option pricing model with the expected life, dividend yield, expected volatility, and risk-free interest rate weighted-average assumptions used for options and warrants granted. Expected volatility for 2014 and 2013 was estimated using the Dow Jones U.S. Industry indexes sector classification methodology for industries similar to that in which we operate. The risk-free rate for periods within the contractual life of the option and warrant is based on the U.S. Treasury yield curve in effect at the grant date. The expected life of options and warrants is based on the average of three public companies offering services similar to ours.

 

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment primarily consisting of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value.

 

Revenue and Expense Recognition

 

We recognize revenue when (1) persuasive evidence of an arrangement exists, (2) title transfer has occurred, (3) the price is fixed or readily determinable, and (4) collectability is reasonably assured. We recognize revenue in accordance with ASC 60, “Revenue Recognition.” Sales are recorded net of sales returns and discounts, which are estimated at the time of shipment based upon historical data. Revenue from monitoring services are recognized when the services are provided. Expenses are recognized as incurred.

 

Revenue from fixed-price equipment installation contracts are recognized on the percentage-of-completion method. The percentage completed is measured by the costs incurred to date as a percentage of estimated total costs for each contract. This method is used because we consider expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenue, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenue when their realization is reasonably assured. Claims are included in revenue when realization is probable and the amount can be reliably estimated.

 

The liability, “Billings in excess of costs and estimated earnings on uncompleted contracts,” represents billings in excess of revenue recognized.

 

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense for the years ended December 31, 2023 and 2022 includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, was estimated using the “minimum value method” as prescribed by the original provisions of ASC 718, “Accounting for Stock-Based Compensation” and therefore, no compensation expense was recognized for these awards in accordance with ASC 718. We recognized $104,600 and $120,581 of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.

 

31

 

 

ITEM 7A – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Item 10(f) of Regulation S-K and are not required to provide the information otherwise required under this item.

 

ITEM 8 – FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Reference is made to our consolidated financial statements, the notes thereto, and the report thereon, commencing on page F-1 of this Annual Report on Form 10-K, which consolidated financial statements, notes, and report are incorporated herein by reference.

 

ITEM 9 – CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A – CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer, as of December 31, 2023, concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act was recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.

 

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of our internal control over financial reporting as of December 31, 2023 as required by Rule 13a-15(c) under the Exchange Act. We utilized the criteria and framework established by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission in Internal Control – Integrated Framework (2013) in performing this assessment. Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of December 31, 2023.

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.

 

This Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Our management’s report was not subject to attestation by our independent registered public accounting firm pursuant to rules of the SEC that permit us to provide only management’s report in this Annual Report on Form 10-K.

 

Changes in Internal Control over Financial Reporting

 

In December 2013, we hired Robert J. Brilon, as Chief Financial Officer who has experience in SEC reporting and disclosures. We have plans for hiring additional financial personnel and implementing additional controls and processes involving both of our financial personnel in order to ensure all transactions are accounted for and disclosed in an accurate and timely manner. There have not been any other changes in our internal control over financial reporting identified by management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

32

 

 

Limitations on the Effectiveness of Controls

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors, and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management or Board override of the control.

 

The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Identified Material Weakness

 

As of December 31, 2023, we need to hire additional employees at Iveda Taiwan that are knowledgeable in SEC accounting and reporting. Increased staffing at the subsidiary level will provide daily oversight of Iveda Taiwan’s operations and minimize the likelihood of any material error in reporting the subsidiary’s results. Action plans are in place to address this staffing need during 2023.

 

Management’s Remediation Initiatives

 

As our resources allow, we plan to add financial personnel at the subsidiary level to properly provide accurate and timely financial reporting.

 

Segregation of Duties

 

As of December 31, 2023, we had two employees knowledgeable in SEC accounting and reporting. Our management has put in place policies and procedures designed, to the extent possible, to segregate the duties of initiating transactions, maintaining custody over assets, and recording transactions. Due to our size and limited resources, segregation of all conflicting duties may not always be possible and may not be economically feasible.

 

ITEM 9B – OTHER INFORMATION

 

(a) None.

 

(b) Corporate Governance

During the period covered by this Annual Report on Form 10-K, there were no changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors.

(c) Insider Trading Arrangements and Policies

During the quarter ended December 31, 2023, no director or officer of the Company “adopted” or “terminated” a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408 of Regulation S-K.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable.

 

33

 

 

PART III

 

ITEM 10 – DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Executive Officers and Directors

 

Set forth below is information concerning our directors, director nominees, executive officers and other key employees.

 

Name   Age   Position
David Ly   48   Chief Executive Officer, Chairman of the Board of Directors and President
Robert J. Brilon   63   Chief Financial Officer, Treasurer and Corporate Secretary
Gregory Omi   62   Chief Technology Officer
Joseph Farnsworth   64   Director
Alejandro Franco   70   Director
Robert D. Gillen   69   Director

 

David Ly founded our company and has served as our Chief Executive Officer and Chairman of the Board of Directors since October 2009. Mr. Ly also served as our President from October 2009 to February 2014. Mr. Ly served in Business-to-Business Sales for T-Mobile USA, a wireless network and communications company, from August 2002 to September 2003. From September 2001 to July 2002, Mr. Ly served as Market Manager of Door To Door Storage, a moving and portable storage company. Mr. Ly served as an Applications Engineer at Metricom, Inc., the first micro cellular data network, from November 1998 to August 2001. Mr. Ly holds a Bachelor of Science Degree in Civil Engineering with a minor in International Business from San Francisco State University. We believe Mr. Ly’s position as our Chief Executive Officer, his extensive knowledge and understanding of the video surveillance and AI industries, and his business and engineering expertise and management skills provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors.

 

Robert J. Brilon has served as our Chief Financial Officer since December 2013. He was also our President from February 2014 to July 2018 and Treasurer from December 2013 to July 2018 and was appointed Treasurer again on December 15, 2021. Mr. Brilon served as our Executive Vice President of Business Development from December 2013 to February 2014 and as our interim Chief Financial Officer and Treasurer from December 2008 to August 2010. Mr. Brilon is a Board Director and independent contract CFO for Bitech Technologies Corporation from October 2021 to present. Mr. Brilon joined New Gen Management Services, Inc. in July 2017 as the CFO (subsequently becoming President and CFO of New Gen in July 2018). Mr. Brilon was the President, Chief Financial Officer, Corporate Secretary, and Director of both Vext Science, Inc and New Gen until he resigned in February 2020. Mr. Brilon served as Chief Financial Officer and Executive Vice President of Business Development of Brain State Technologies, a brainwave optimization software licensing and hardware company, from August 2010 to November 2013. From January 2010 to August 2010, Mr. Brilon served as Chief Financial Officer of MD Helicopters, a manufacturer of commercial and light military helicopters. Mr. Brilon also served as Chief Executive Officer, President, and Chief Financial Officer of InPlay Technologies (NASDAQ: NPLA), formerly, Duraswitch (NASDAQ: DSWT), a company that licensed patented electronic switch technology and manufactured digital pen technology, from November 1998 to June 2007. Mr. Brilon served as Chief Financial Officer of Gietz Master Builders from 1997 to 1998, Corporate Controller of Rental Service Corp. (NYSE: RRR) from 1995 to 1996, Chief Financial Officer and Vice President of Operations of DataHand Systems, Inc. from 1993 to 1995, and Chief Financial Officer of Go-Video (AMEX:VCR) from 1986 to 1993. Mr. Brilon is a certified public accountant and practiced with several leading accounting firms, including McGladrey Pullen, Ernst and Young and Deloitte and Touche. Mr. Brilon holds a Bachelor of Science degree in Business Administration from the University of Iowa.

 

34

 

 

Gregory Omi has served as our Chief Technology Officer since May 2021. Prior, Mr. Omi served as director of our company from October 2009 to November 2016. Mr. Omi served as a senior programmer for Zynga, an online and mobile social gaming company, from November 2009 to March 2014 and then again briefly in 2016 and 2019 as architect. Mr. Omi served as senior engineer at Tesla, an electric vehicle manufacturer, from October 2016 to October 2017. Prior to that, Mr. Omi served as a programmer for Monkey Gods, LLC, a video game developer, from January 2009 to November 2009. Mr. Omi also served as Senior Programmer for Flektor, Inc., a developer of online audio and video editing tools, from October 2006 to January 2009. From October 1996 to June 2006, Mr. Omi served as a Senior Programmer for Naughty Dog, a computer game developer. Prior to that, Mr. Omi served in programming roles for 3DO from 1992 to 1996, TekMagic in 1992, Epyx from 1986 to 1992, Atari in 1991, Nexa from 1982 to 1983 and 1985 to 1986, and HES in 1983. Mr. Omi attended DeVry Institute in Phoenix, Arizona from 1979 to 1980 where he studied industrial electronics engineering.

 

Joseph Farnsworth has served as a director of our company since January 2010. Mr. Farnsworth has served as President and as a director of Farnsworth Realty & Management Co., an Arizona-based privately held real estate company, and as a director of Farnsworth Development, a closely held real estate developer, since 1995. Mr. Farnsworth has also served as a director of The Farnsworth Companies since 2008. Mr. Farnsworth has also served as a director of Venture West Aviation since 2022. From 1990 to 1995, Mr. Farnsworth served as President of Alfred’s International, with operations in China and Korea. Prior to that, Mr. Farnsworth served as President of Farnsworth International, a real estate investment company based in Taipei, Taiwan from 1987 to 1991. Mr. Farnsworth holds a Bachelor of Science degree in Real Estate Finance from Brigham Young University and is a licensed real estate broker in Arizona. We believe Mr. Farnsworth’s experience leading companies with operations in Asia and his business and management skills provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors.

 

Alejandro Franco has served as a director of our company since November 2011. Mr. Franco has also served as a consultant to our company since 2011, advising on business development and strategic partnership opportunities in Mexico. Mr. Franco is the founder and has served as President of Amextel, a telecommunications company in Mexico, since June 2003. Mr. Franco founded the Mexican American Business Council, a non-profit organization facilitating border relationships to increase business, support trade growth and investments, and has been the CEO since June 2015. Mr. Franco also founded and served as President of Bela Corp., a cloud technology and services company, from 1988 to 2000. Prior to that, Mr. Franco founded and served as President of TVM, Inc., a television and technology company in Mexico, from 1985 to 1988. Mr. Franco attended UNAM University, Mexico where he studied Economics. Mr. Franco also attended IBERO University, Mexico, where he studied Industrial Design. Mr. Franco holds a Master degree in Theology from the Oblate School of Theology in San Antonio, Texas. We believe Mr. Franco’s experience leading businesses with operations in Asia and Mexico, his experience as a consultant for our company, his extensive knowledge and understanding of the telecommunications and cloud technology industries, and his business and management skills provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors.

 

Robert D. Gillen has served as a director of our company since November 2011. Mr. Gillen founded and has served as President of the Law Offices of Robert D. Gillen, Ltd., a law firm located in Scottsdale, Arizona and Naperville, Illinois, which specializes in advising small- and medium-size businesses on domestic and international tax planning, since 1979. Mr. Gillen retired in October 2014. Mr. Gillen holds a Bachelor of Science degree in Business Administration from the University of Illinois and a J.D. from the Illinois Institute of Technology – Chicago Kent College of Law. Mr. Gillen also has extensive experience educating, CPAs, attorneys, and other financial and business professionals about asset protection and tax planning. We believe Mr. Gillen’s experience advising, clients operating the cellular industry, his experience leading a business involved in the lease and sale of cellular sites, his experience navigating international business and legal issues, and his prior board experience provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors.

 

35

 

 

Family Relationships

 

There are no family relationships among any of our directors, director nominees or executive officers.

 

Terms of Directors and Executive Officers

 

The number of directors of the Company shall be not less than one nor more than thirteen. Each of our directors holds office until the next annual meeting of shareholders and until his or her successor shall have been elected and qualified, until his or her resignation, or until his or her office is otherwise vacated in accordance with our articles of incorporation.

 

Our officers are elected by and serve at the discretion of the board of directors.

 

Board of Directors and Board Committees

 

Our board of directors consists of four directors, three of whom are independent as such term is defined by the Nasdaq Capital Market. We have determined that Joseph Farnsworth, Alejandro Franco and Robert D. Gillen satisfy the “independence” requirements under NASDAQ Rule 5605.

 

Board Committees

 

We have established three committees under the board of directors: an audit committee, a compensation committee and a nomination and corporate governance committee, and adopted a charter for each of the three committees. Copies of our committee charters are posted on our corporate investor relations website.

 

Each committee’s members and functions are described below.

 

Audit Committee. Our audit committee consists of Joseph Farnsworth, Alejandro Franco and Robert D. Gillen. Mr. Farnsworth is the chair of our audit committee. The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee is responsible for, among other things:

 

  ● appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;
     
  ● reviewing with the independent auditors any audit problems or difficulties and management’s response;
     
  ● discussing the annual audited financial statements with management and the independent auditors;
     
  ● reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures;
     
  ● reviewing and approving all proposed related party transactions;
     
  ● meeting separately and periodically with management and the independent auditors; and
     
  ● monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.

 

Compensation Committee. Our compensation committee consists of Joseph Farnsworth, Alejandro Franco and Robert D. Gillen. Mr. Farnsworth is the chair of our compensation committee. The compensation committee will be responsible for, among other things:

 

  ● reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers;
     
  ● reviewing and recommending to the shareholders for determination with respect to the compensation of our directors;
     
  ● reviewing periodically and approving any incentive compensation or equity plans, programs or similar arrangements; and
     
  ● selecting compensation consultant, legal counsel or other adviser only after taking into consideration all factors relevant to that person’s independence from management.

 

36

 

 

Nominations and Corporate Governance Committee. Our Nominations and Corporate Governance committee consists of Joseph Farnsworth, Alejandro Franco and Robert D. Gillen. Mr. Gillen is the chair of our Nominations and Corporate Governance committee. The nominating and corporate governance committee is responsible for, among other things, (i) determining the qualifications, qualities and skills required to be a director of the Company and evaluating, selecting and approving nominees to serve as directors, (ii) periodically reviewing, assessing and making recommendations for changes to the Board of Directors and its committees and (iii) overseeing the process for evaluation of the Board of Directors. Pursuant to the nominating and corporate governance committee charter, the nominating and corporate governance committee has the authority to delegate all or a portion of its duties and responsibilities to a subcommittee of the nominating and corporate governance committee. In addition, the nominating and corporate governance committee has unrestricted access to and assistance from our officers, employees and independent auditors and the authority to employ experts, consultants and professionals to assist with performance of their duties. The nominating and corporate governance committee is also responsible for establishing procedures regarding director nominees put forward by stockholders. The committee is also responsible for establishing procedures for shareholder communications with the Board of Directors.

 

Involvement in Certain Legal Proceedings

 

None of our directors or officers has been convicted in a criminal proceeding, excluding traffic violations or similar misdemeanors, nor has any been a party to any judicial or administrative proceeding during the past five years that resulted in a judgment, decree or final order enjoining the person from future violations of, or prohibiting activities subject to, federal or state securities laws, or a finding of any violation of federal or state securities laws, except for matters that were dismissed without sanction or settlement. Except as set forth in our discussion below in “Related Party Transactions,” our directors and officers have not been involved in any transactions with us or any of our affiliates or associates which are required to be disclosed pursuant to the rules and regulations of the SEC.

 

Code of Business Conduct and Ethics

 

We have adopted a code of business conduct and ethics which is applicable to all of our directors, executive officers and employees. A copy of the code of business conduct and ethics is posted on our corporate investor relations website as required for our listing on the Nasdaq Capital Market.

 

ITEM 11 – EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

We believe that it is important to design a compensation program that supports our business strategy. As a result, our compensation program emphasizes performance-based compensation and is designed to support our business goals, promote short- and long-term growth, and attract, retain, and motivate key talent. Our compensation program is comprised of three components: base salary, bonus awards, and long-term performance incentives.

 

We believe that our executive officers and other key employees should have a portion of their potential annual compensation tied to our profitability and our other goals. Additionally, we seek to align the ability to earn long-term incentives directly with the interests of our stockholders through the use of equity-based incentives. We strive to ensure compensation is competitive with companies similar to us; however, we acknowledge that base salaries are currently below market.

 

The following table sets forth certain information with respect to compensation for the years ended December 31, 2023 and 2022, earned by or paid to our chief executive officer and principal executive officer, our principal financial officer, and our other most highly compensated executive officers whose total compensation exceeded US $100,000 (the “named executive officers”).

 

Name and Principal Position  Year   Salary (1)   Warrants Awards (2)   Option
Awards (3)		   All Other Compensation (4)   Total 
David Ly  2023   $190,000        $23,859   $11,968   $225,827 
Chairman and Chief Executive Officer  2022   $190,000             $13,725   $11,968   $215,693 
Sid Sung  2023   $150,000        $2,130        $152,130 
Former President (6)  2022   $150,000        $2,825        $152,825 
Robert J. Brilon  2023   $180,000        $20,450        $200,450 
Chief Financial Officer, Treasurer and Corporate Secretary  2022   $180,000        $11,350        $191,350 
Luz A. Berg Former Chief Operating Officer  2023   $-        $-        $- 
Chief Marketing Officer and Corporate Secretary (5)  2022   $165,000        $141,000        $306,000 
Gregory Omi  2023    -        $2,130        $2,130 
Chief Technology Officer  2022             $2,825        $2,825 

 

(1) The amounts in this column reflect the amounts earned during the fiscal year, whether or not actually paid during such year.
   
(2) The amounts in this column reflect the aggregate probable grant date fair value of warrants awards to our named executive officers during the fiscal year calculated in accordance with FASB ASC Topic 718, Stock Compensation. The amounts reported in this column do not correspond to the actual economic value that may be received by our named executive officers from their option awards.
   
(3) The amounts in this column reflect the aggregate probable grant date fair value of option awards to our named executive officers during the fiscal year calculated in accordance with FASB ASC Topic 718, Stock Compensation. The amounts reported in this column do not correspond to the actual economic value that may be received by our named executive officers from their option awards.
   
(4) The amounts in this column reflect the amount of perquisites related to a vehicle allowance.
   
(5)

Resigned effective December 31, 2022.

 

(6)

Resigned effective December 31, 2023.

 

37

 

 

Outstanding Equity Awards as of December 31, 2023

 

The following table provides information regarding outstanding equity awards held by our named executive officers as of December 31, 2023.

 

Outstanding Equity Awards at Fiscal Year Ended December 31, 2023

 

Name and Principal Position  Grant Date  Number of Securities Underlying Unexercised Options/Warrants (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)   Option Exercise Price ($)   Option Expiration Date
David Ly                          
Chairman and  12/31/2013   6,250(1)   -    -   $14.00   12/31/2023
Chief Executive Officer  12/31/2014   6,250(1)   -    -   $9.20   12/31/2024
   2/25/2015   12,500(1)   -    -   $6.16   2/25/2025
   12/11/2015   25,000(1)   -    -   $5.76   12/11/2025
   12/15/2020   87,500(1)   -    -   $2.96   12/15/2030
   12/30/2021   18,750(1)   -    -   $16.24   12/31/2031
   6/15/2022   12,500(1)   -    -   $1.42   6/15/2032
   10/3/2022   5,000(1)   -    -   $0.75   10/3/2032
   12/1/2022   15,000(1)   -    -   $0.54   12/1/2032
   11/3/2023   70,000(2)   -    -   $0.68   11/3/2033
Robert J. Brilon                          
Chief Financial Officer,  12/1/2013   37,500(1)   -    -   $8.00   12/1/2023
Treasurer and Corporate Secretary  12/8/2014   12,500(1)   -    -   $8.00   12/8/2024
   5/2/2014   12,500(1)   -    -   $8.00   5/2/2024
   12/31/2014   6,250(1)   -    -   $9.20   12/31/2024
   12/30/2021   12,500(1)   -    -   $16.24   12/31/2031
   6/15/2022   10,000(1)   -    -   $1.42   6/15/2032
   10/3/2022   5,000(1)   -    -   $0.75   10/3/2032
   12/1/2022   12,500(1)   -    -   $0.54   12/1/2032
   11/3/2023   60,000(2)   -    -   $0.68   11/3/2033
Luz Berg                         
Former Chief Operating Officer,  12/31/2013   3,125(1)   -    -   $14.00   12/31/2023
Chief Marketing Officer  12/31/2014   3,125(1)   -    -   $9.20   12/31/2024
and Corporate Secretary (resigned effective 12/31/2022)  12/11/2015   3,125(1)   -    -   $5.76   12/11/2025
   12/15/2020   87,500(1)   -    -   $2.96   12/15/2030
   12/30/2021   12,500(1)   -    -   $16.24   12/30/2031
   6/15/2022   10,000(1)   -    -   $1.42   6/15/2032
   10/3/2022   5,000(1)   -    -   $0.75   10/3/2032
Sid Sung                          
President (resigned effective 12/31/2023)  12/20/2019   12,500(1)   -    -   $2.24   12/20/2029
   12/15/2020   12,500(1)   -    -   $2.96   12/15/2030
   12/30/2021   12,500(1)   -    -   $16.24   12/30/2031
   10/3/2022   5,000(1)   -    -   $0.75   10/3/2032
   12/1/2022   6,250(1)   -    -   $0.54   12/1/2032
   11/3/2023   6,250(2)   -    -   $0.68   11/3/2033

 

(1) The options became fully vested on the date of grant.
   
(2) The options became fully vested on December 31, 2023.

 

Equity Compensation Plans

 

On October 15, 2009, we adopted the 2009 Stock Option Plan (the “2009 Option Plan”), with an aggregate number of 187,500 shares of common stock issuable under the plan. The purpose of the 2009 Option Plan was to assume options that were already issued in the 2006 and 2008 Option plans under Iveda Corporation after the merger with Charmed Homes.

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 125,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 1,625,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of December 31, 2023, 359,125 options were outstanding under the 2010 Option Plan.

 

On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan has a maximum of 1,250,000 shares authorized with similar terms and conditions to the 2010 Option Plan. As of December 31, 2023, 941,875 options were outstanding under the 2020 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792)

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

38

 

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2023, we had approximately $62,066 unrecognized stock- based compensation.

 

We have periodically issued warrants to purchase shares of our common stock as equity compensation to officers, directors, employees, and consultants. As of December 31, 2023, warrants to purchase 394,822 shares of our common stock were outstanding, which were issued for services or incentive for the purchase of convertible debentures or common stock subscription. Terms of these warrants are comparable to the terms of the outstanding options.

 

Director Compensation

 

Non-employee directors receive stock-based compensation for their service on our Board of Directors and are reimbursed for their cost of attending meetings. For the year ended December 31, 2023, Joseph Farnsworth, Alejandro Franco and Robert Gillen received 50,000 options to purchase shares of our common stock as compensation for services during the year ended December 31, 2023. For the year ended December 31, 2022, Joseph Farnsworth received 15,000 options and Alejandro Franco and Robert Gillen received 11,250 options to purchase shares of our common stock as compensation for services during the year ended December 31, 2022. We do not pay additional compensation to our directors for their service, either as Chair or as a member, on the Audit Committee, Compensation Committee, or Nominations and Corporate Governance Committee.

 

Name  Fees Earned or paid in Cash $   Stock Awards
$		   2023 Options Awards
$		   Non-Equity Incentive Plan Compensation   Nonqualified Deferred Compensation Earnings
$		   All Other Compensation
$		   Total
$		 
Joseph Farnsworth        -            -   $17,042(1)         -         -         -   $17,042 
Alejandro Franco   -    -   $17,042(2)   -    -    -   $17,042 
Robert Gillen   -    -   $17,042(3)   -    -    -   $17,042 

 

(1) As of December 31, 2023, Mr. Farnsworth had outstanding options to purchase 168,125 shares of our common stock.

(2) As of December 31, 2023, Mr. Franco had outstanding options to purchase 123,750 shares of our common stock.

(3) As of December 31, 2023, Mr. Gillen had outstanding options to purchase 128,750 shares of our common stock.

 

Incentive-Based Compensation Recovery Policy

 

The Company adopted an Incentive-Based Compensation Recovery Policy in order to comply with Nasdaq Listing Rules and Rule 10D-1 under the Exchange Act. In the event the Company is required to prepare an accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, subject to the terms of the policy, the Company must recover reasonably promptly from its current and former executive officers the amount of any erroneously awarded incentive based compensation received on or after October 2, 2023 and during the three years preceding the date that the Company is required to prepare such accounting restatement.

 

39

 

 

ITEM 12 – SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table and accompanying footnotes set forth as of December 31, 2023, certain information regarding the beneficial ownership of shares of our common stock by: (i) each person who is known by us to own beneficially more than 5% of such stock; (ii) each member of our Board of Directors, and each of our named executive officers and (iii) all of our directors and executive officers as a group. Except as otherwise indicated, all Common Stock is owned directly, and the beneficial owners listed in the table below possess sole voting and investment power with respect to the stock indicated, and the address for each beneficial owner is c/o Iveda Solutions, Inc., 1744 S. Val Vista Drive, Suite 213, Mesa, Arizona 85204.

 

Name of Beneficial Owner  Common Shares   % of Common Shares 
Directors and Officers          
David Ly (1)   746,898    4.6%
Robert J. Brilon (2)   330,499    2.0%
Gregory Omi (3)   187,982    1.2%
Joseph Farnsworth (4)   275,067    1.7%
Alejandro Franco (5)   155,000    1.0%
Robert D. Gillen (6)   291,393    1.8%
All Directors and Officers   1,755,588    11.5%

 

(1) Includes options to purchase 258,750 shares of common stock, which are exercisable within 60 days of December 31, 2023.
(2) Includes options to purchase 168,750 shares of common stock, which are exercisable within 60 days of December 31, 2023.
(3) Includes options to purchase 75,000 shares of common stock, which are exercisable within 60 days of December 31, 2023.
(4) Consists of (a) options to purchase 168,125 shares of common stock, which are exercisable within 60 days of December 31, 2023, (b) 19,925 shares of common stock held by Farnsworth Realty, an entity owned by Mr. Farnsworth and (c) 87,018 shares of common stock.
(5) Consists of (a) options to purchase 123,750 shares of common stock, which are exercisable within 60 days of December 31, 2023, and (b) 31,250 shares of common stock held by Amextel S.A. De C.V. an entity owned by Mr. Franco.
(6) Consists (a) options to purchase 128,750 shares of common stock, which are exercisable within 60 days of December 31, 2023, and (b) 162,643 shares of common stock.

 

40

 

 

Shares Authorized for Issuance Under Equity Compensation Plans

 

The following table shows the number of securities to be issued upon exercise of outstanding options under equity compensation plans approved by our stockholders and under equity compensation plans not approved by our stockholders as of December 31, 2023.

 

   Number of securities to be issued upon exercise of outstanding options, warrants and rights   Weighted-average exercise price of outstanding options, warrants and rights   Number of securities remaining available for future issuance under equity compensation plans 
Equity compensation plans approved by stockholders (1)   359,125   $6.96    - 
Equity compensation plans approved by stockholders (2)   941,875   $3.56    308,125 
Equity compensation plans not approved by stockholders (3)   5,053,896   $2.84    - 
Total   6,354,896   $3.18    308,125 

 

  (1) Consists of our 2010 and 2012 Option Plan.
  (2) Consists of our 2020 Option Plan
  (3) Warrants issued not under a plan

 

ITEM 13 – CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

Transactions with Related Persons, Promoters and Certain Control Persons

 

Other than equity and other compensation, termination, change in control and other similar arrangements, which are described under “Executive and Director Compensation.”, since January 1, 2020 there are no transactions to which we were a party in which (i) the amount involved exceeded or will exceed the lesser of $120,000 of one percent (1%) of our average total assets at year-end for the last two completed fiscal years and (ii) any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of, or person sharing the household with, any of the foregoing persons, had or will have a direct or indirect material interest.

 

Director Independence

 

Our Board of Directors has undertaken a review of its composition, the composition of its committees, and the independence of each director. Our Board of Directors has determined, after considering all of the relevant facts and circumstances, that Messrs. Farnsworth, Franco, Gillen, and Omi do not have a relationship with us that would interfere with their exercise of independent judgment in carrying out their responsibilities as a director and that each of these directors is “independent” as that term is defined under the applicable rules and regulations of the SEC. In making this determination, our Board of Directors considered the current and prior relationships that each non-employee director has with our company and all other facts and circumstances our Board of Directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. Our Board of Directors did not consider any relationship or transaction between our company and the independent directors not already disclosed in this Annual Report on Form 10-K in making this determination. Mr. Ly is an employee director.

 

The Audit Committee currently consists of Messrs. Farnsworth (Chairman), Franco and Gillen, each of whom is an independent director of our company. The Compensation Committee currently consists of Messrs. Farnsworth (Chairman), Franco and Gillen, each of whom is an independent director of our company. The Nominations and Corporate Governance Committee currently consists of Messrs. Gillen (Chairman), Farnsworth, and Franco, each of whom is an independent director of our company.

 

ITEM 14 – PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Fees Paid to Independent Registered Public Accounting Firm

 

In July 2021, with the approval of the Audit Committee of the Board of Directors, we appointed BF Borgers CPA PC (“BFB”) as our principal accounting firm. BFB has served as the principal audit firm for Iveda 2020 and 2019 Financial Statements, and 2021 Financial Statements since July 2021.

 

We paid or accrued $137,500 and $119,000, during the year ended December 31, 2023 and 2022, respectively.

 

Audit Committee Pre-Approval Policies

 

As part of its responsibility for oversight of the independent registered public accountants, the Audit Committee has established a pre-approval policy for engaging audit and permitted non-audit services provided by our independent registered public accountants, BFB. In accordance with this policy, each type of audit, audit-related, tax and other permitted service to be provided by the independent auditors is specifically described and each such service, together with a fee level or budgeted amount for such service, is pre-approved by the Audit Committee. The Audit Committee has delegated authority to its Chairman to pre-approve additional non-audit services (provided such services are not prohibited by applicable law) up to a pre-established aggregate dollar limit. All services pre-approved by the Chairman of the Audit Committee must be presented at the next Audit Committee meeting for review and ratification. All of the services provided by BFB described above were approved by the Audit Committee pursuant to our Audit Committee’s pre-approval policy.

 

Our principal accountants, BFB, did not engage any other persons or firms other than their respective full-time, permanent employees.

 

41

 

 

PART IV

 

ITEM 15 – EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

  (a) Financial Statements and Financial Statement Schedules

 

1. Consolidated Financial Statements are listed in the Index to Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K.
   
2. Other schedules are omitted because they are not applicable, not required, or because required information is included in the Consolidated Financial Statements or notes thereto.

 

  (b) Exhibits

 

Exhibit Number   Description of Exhibit
     
2.1   Agreement and Plan of Merger, dated March 21, 2011, by and among Iveda Solutions, Inc., a Nevada corporation, Sole-Vision Technologies, Inc. (doing business as MEGAsys), a corporation organized under the laws of the Republic of China, and the shareholders of MEGAsys (Incorporated by reference to the Form 10-K/A filed on 2/9/2012)
3.1   Articles of Incorporation of Charmed Homes Inc. (Incorporated by reference to the Form SB-2 filed on 4/27/2007)
3.2   Bylaws of Iveda Solutions, Inc. (Incorporated by reference to the Form 10-K filed on 3/31/2014)
3.3   Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on September 9, 2009 (Incorporated by reference to the Form 8-K filed on 10/21/2009)
3.4   Articles of Merger filed with the Secretary of State of Nevada on December 28, 2010, and dated effective December 31, 2010 (Incorporated by reference to the Form 8-K filed on January 4, 2010)
3.5   Certificate of Amendment to Articles of Incorporation filed with the Secretary of State of Nevada on December 9, 2014 containing the rights and preferences of the Series A Preferred Stock (Incorporated by reference to the Form 8-K filed on December 15, 2014)
3.6   Certificate of Amendment of Articles of Incorporation filed with the Secretary of State of Nevada on January 15, 2015, containing the Designation of the Preferences, Rights and Limitations of the Series B Preferred Stock (Incorporated by reference to the Form 8-K filed on January 23, 2015)
4.1   Specimen Stock Certificate (Incorporated by reference to the Form SB-2 filed on 4/27/2007)
4.2   Form of Stock Option Agreement under the IntelaSight, Inc. 2008 Stock Option Plan (Incorporated by reference to the Form S-4/A1 filed on 7/10/2009)
4.3   Form of Common Stock Purchase Warrant issued by IntelaSight, Inc. (Incorporated by reference to the Form S-4/A1 filed on 7/10/2009)
4.4   2009 Stock Option Plan, dated October 15, 2009 (Incorporated by reference to the Form 8-K filed on 10/21/2009)
4.5   Form of Common Stock Purchase Warrant issued by Iveda Corporation in conjunction with the Merger (Incorporated by reference to the Form 8-K filed on 10/21/2009)
4.6   2010 Stock Option Plan, dated January 18, 2010 (Incorporated by reference to the Form S-8 filed on 2/4/2010)
4.7   Form of Notice of Grant of Stock Option under the Iveda Solutions, Inc. 2010 Stock Option Plan, as amended (Incorporated by reference to Form S-8 filed on 6/24/2011)
4.8   Form of Stock Option Agreement under the Iveda Solutions, Inc. 2010 Stock Option Plan, as amended (Incorporated by reference to Form S-8 filed on 6/24/2011)
4.9   Form of Stock Option Exercise Notice under the Iveda Solutions, Inc. 2010 Stock Option Plan, as amended (Incorporated by reference to Form S-8 filed on 6/24/2011)

 

42

 

 

4.10   Form of Tranche A Warrant (Incorporated by reference to the Form 8-K filed on 1/28/2015)
4.11   Form of Tranche B Warrant (Incorporated by reference to the Form 8-K filed on 1/28/2015)
4.12   Registration Rights Agreement dated January 16, 2015 (Incorporated by reference to the Form 8-K filed on 1/28/2015)
4.13   2020 Stock Option Plan, dated January 18, 2020 (filed with amended Form 10-12g filed on 10/25/2021)
4.14   Form of Warrant to purchase common stock to officers, directors, employees, and consultants (Incorporated by reference to the Form S-1 filed on 12/30/2021)
4.15   Form of Convertible Debenture(Incorporated by reference to the Form S-1 filed on 12/30/2021)
4.16   Form of Warrant(Incorporated by reference to the Form S-1 filed on 12/30/2021)
10.1   Application Development Service Agreement dated July 14, 2006 by and between Axis Communications AB and IntelaSight, Inc. (Incorporated by reference to the Form S-4/A2 filed on 8/2/2009)
10.2   Partner Agreement dated January 30, 2007 by and between Milestone Systems, Inc. and IntelaSight, Inc. (Incorporated by reference to the Form S-4/A1 filed on 7/10/2009)
10.3   Solution Partner Agreement dated March 13, 2008 by and between Milestone Systems A/S and IntelaSight, Inc. (Incorporated by reference to the Form S-4/A1 filed on 7/10/2009)
10.4   Channel Partner Program Membership Agreement – Gold Solution Partner Level – dated June 23, 2009 by and between Axis Communications Inc. and IntelaSight, Inc. (Incorporated by reference to the Form S-4/A1 filed on 7/10/2009)
10.5   Stock Purchase Agreement, dated October 15, 2009, by and among Iveda Corporation, IntelaSight, Inc., Ian Quinn and Kevin Liggins (Incorporated by reference to the Form 8-K filed on 10/21/2009)
10.6   Subscription Agreement, dated July 26, 2010 (Incorporated by reference to Form 10-Q filed on November 12, 2010)
10.7   Line of Credit Promissory Note, dated September 15, 2010 (Incorporated by reference to Form 10-Q filed on November 12, 2010)
10.8   Agreement for Service, dated October 20, 2010 (Incorporated by reference to Form 10-Q filed on November 12, 2010)
10.9   Consulting Agreement, dated October 25, 2010 (Incorporated by reference to Form 10-Q filed on November 12, 2010)
10.10   Operating Level Agreement, dated October 25, 2010 (Incorporated by reference to Form 10-Q filed on November 12, 2010)
10.11   Side Letter, dated March 21, 2011, by and among Iveda Solutions, Inc., a Nevada corporation, Sole-Vision Technologies, Inc. (doing business as MEGAsys), a corporation organized under the laws of the Republic of China, and the shareholders of MEGAsys (Incorporated by reference to Form 10-K filed on 3/30/2011)
10.12   Non-Exclusive Strategic Collaboration Agreement between Iveda Solutions, Inc. and Telmex, U.S.A., LLC, dated October 28, 2011 (Incorporated by reference to Form 10-Q/A filed on 3/7/2012)
10.13   2010 Digital Video Remote Monitoring Recording System Procurement Contract between Sole-Vision Technology, Inc. and New Taipei City Police Department Purchasing Authority, dated January 9, 2012 (Incorporated by reference to Form 10-K filed on 3/30/2012)
10.14   Consulting Agreement between Iveda Solutions, Inc. and Amextel S.A. de C.V. dated November 2, 2011 (Incorporated by reference to Form 10-K/A filed on 5/11/2012)
10.15   Securities Purchase Agreement dated January 16, 2015 (Incorporated by reference to the Form 8-K filed on 1/28/2015)
10.17   Cooperation Agreement with Industrial Technology Research Institute dated November 2012 (Incorporated by reference to the Form S-1 filed on 12/30/2021)
10.18   Form of Subscription Agreement (Incorporated by reference to the Form S-1 filed on 12/30/2021)
14.1   Code of Conduct and Ethics (Incorporated by reference to the Form 10-K filed on 4/15/2010)
14.2   Code of Ethics for Chief Executive Officer and Senior Financial Officers (Incorporated by reference to the Form 10-K filed on 4/15/2010)
21   Subsidiaries of the Registrant (Incorporated by reference to Form 10-K filed on 3/30/2012)
31.1*   Certification of Principal Executive Officer pursuant to Exchange Act Rule 15d-14(a)
31.2*   Certification of Principal Financial Officer pursuant to Exchange Act Rule 15d-14(a)
32.1*   Certification of Principal Executive Officer Pursuant to Section 1350
32.2*   Certification of Principal Financial Officer Pursuant to Section 1350
97.1   Compensation Recovery Policy of Iveda Solutions, Inc.
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished herewith.
† Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

 

43

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: April 1, 2024 IVEDA SOLUTIONS, INC.
     
  By: /s/ David Ly
    David Ly
    Chief Executive Officer and Chairman

 

Date: April 1, 2024 IVEDA SOLUTIONS, INC.
   
  By: /s/ Robert J. Brilon
    Robert J. Brilon
    Chief Financial Officer, Treasurer and Secretary

 

Pursuant to the requirements of Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Capacity   Date
         
/s/ David Ly   Chief Executive Officer and Chairman   April 1, 2024
David Ly   (Principal Executive Officer)    
         
/s/ Robert J. Brilon   Chief Financial Officer, Treasurer and Secretary   April 1, 2024
Robert J. Brilon   (Principal Financial and Accounting Officer)    
         
/s/ Joseph Farnsworth   Director   April 1, 2024
Joseph Farnsworth        
         
/s/ Alejandro Franco   Director   April 1, 2024
Alejandro Franco        
         
/s/ Robert D. Gillen   Director   April 1, 2024
Robert D. Gillen        

 

44

 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID: 5041) F-2
   
CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2023 AND 2022 F-3
   
CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 F-4
   
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 F-5
   
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 F-6
   
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS F-8

 

F-1

 

 

Report of Independent Registered Public Accounting Firm

 

To the shareholders and the board of directors of Iveda Solutions, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Iveda Solutions, Inc. as of December 31, 2023 and 2022, the related statements of operations, stockholders’ equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

 

Critical Audit Matter

 

Critical audit matters are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments.

 

We determined that there are no critical audit matters.

 

/S/ BF Borgers CPA PC (PCOAB ID 5041)

We have served as the Company’s auditor since 2021

Lakewood, CO

April 1, 2024

 

F-2

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2023 AND 2022

 

   December 31, 2023   December 31, 2022 
         
ASSETS          
CURRENT ASSETS          
Cash and Cash Equivalents  $4,754,597   $7,312,095 
Restricted Cash   129,778    129,527 
Accounts Receivable, Net   281,049    1,222,690 
Inventory, Net   324,515    526,470 
Other Current Assets   435,580    371,990 
Total Current Assets   5,925,520    9,562,772 
PROPERTY AND EQUIPMENT, NET   891,187    32,911 
OTHER ASSETS          
Other Assets   444,723    267,387 
Total Other Assets   444,723    267,387 
Total Assets  $7,261,430   $9,863,070 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts and Other Payables  $1,110,087   $1,638,727 
Short Term Debt   348,771    398,409 
Current Portion of Long-Term Debt   -    65,408 
Total Current Liabilities   1,458,858    2,102,544 
LONG-TERM DEBT   -    190,776 
STOCKHOLDERS’ EQUITY          
Preferred Stock, $0.00001 par value; 100,000,000 shares authorized          
Series B Preferred Stock, $0.00001 par value; 500 shares authorized, no shares issued and outstanding as of December 31, 2023 and December 31, 2022.   -    - 
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 16,169,891 and 15,066,739 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively   162    150 
Additional Paid-In Capital   54,065,633    52,496,914 
Joint Venture Non-Controlled Equity Portion   (99,048)     
Accumulated Comprehensive Loss   (222,380)   (220,643)
Accumulated Deficit   (47,941,796)   (44,706,671)
Total Stockholders’ Equity   5,802,572    7,569,750 
Total Liabilities and Stockholders’ Equity  $7,261,430   $9,863,070 

 

See accompanying Notes to Consolidated Financial Statements.

 

F-3

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

YEARS ENDED DECEMBER 31, 2023 AND 2022

 

   2023   2022 
         
REVENUE          
Equipment Sales  $6,052,298   $4,159,398 
Service Revenue   443,567    308,881 
Other Revenue   -    - 
TOTAL REVENUE   6,495,865    4,468,279 
COST OF REVENUE   5,428,261    3,504,778 
GROSS PROFIT   1,067,604    963,501 
OPERATING EXPENSES          
General & Administrative   4,478,553    4,292,820 
Total Operating Expenses   4,478,553    4,292,820 
LOSS FROM OPERATIONS   (3,410,949)   (3,329,320)
OTHER INCOME (EXPENSE)          
Miscellaneous Income (Expense)   (28,099)   (17,078)
Interest Income   131,881    57,397 
Interest Expense   (7,254)   (53,323)
Total Other Income (Expense)   96,527    (13,004)
Joint Venture Non-Controlled Interest   97,605      
LOSS BEFORE INCOME TAXES   (3,216,817)   (3,342,324)
BENEFIT (PROVISION) FOR INCOME TAXES   (18,308)   (2,947)
NET LOSS  $(3,235,124)  $(3,345,270)
BASIC AND DILUTED LOSS PER SHARE  $(0.20)  $(0.26)
WEIGHTED AVERAGE SHARES   15,973,422    12,846,848 

 

See accompanying Notes to Consolidated Financial Statements.

 

F-4

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

 

   Common
Shares		   Common
Stock
Amount		   Preferred
Shares		   Additional
Paid-in-Capital		   Accumulated
Deficit		   Accumulated
Other
Comprehensive
Income (loss)		   Total
Stockholders’
Equity(Deficit)		 
                             
BALANCE AT December 31, 2021   9,668,369    97    --  $40,727,518   $(41,361,401)  $(143,493)  $(777,279)
Costs of Capital                  (1,613,470)             (1,163,918)
Stock Based Compensation             --   120,581              120,581 
Common Stock issued for conversion error   65    -         -              - 
Common Stock issued for services   215,000    1    --   219,899              219,900 
Warrants for Services                  5,555              5,555 
Exercise of options and warrants   8,215    -         23,000              23,000 
Common Stock Offering for Cash   1,885,000    19         8,011,231              8,011,250 
Common Stock and Pre-Funded Warrant Offering for Cash – August 2022   3,289,474    33         4,999,803              4,999,836 
Warrants sold in
Over allotment		                  2,797              2,797 
Net Loss        -     -        (3,345,270)        (3,345,270)
Comprehensive Loss                            (77,150)   (77,150)
8 for 1 conversion adjustment   616                               
BALANCE AT December 31, 2022   15,066,739   $150    --  $52,496,914   $(44,706,671)  $(220,643)  $7,569,750 
Exercise of warrants issued August 2022   945,900    10         1,322,875              1,322,885 
Common Stock issued for services   157,252    2    --   138,544              138,546 
Joint Venture Non-Controlled Equity Interest                                 (99,048)
Net Loss        -     -        (3,235,124)        (3,235,124)
Comprehensive Loss              -             (1,737)   (1,737)
BALANCE AT December 31, 2023   16,169,891   $162    -   $54,065,633   $(47,941,796)  $(222,380)  $5,802,572 

 

* All share amounts and per share amounts reflect a reverse stock split of the outstanding shares of our Common Stock at a ratio of 1-for-8 effected on March 31, 2022.

 

See accompanying Notes to Consolidated Financial Statements

 

F-5

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

DECEMBER 31, 2023 AND 2022

 

   2023   2022 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(3,235,124)  $(3,345,270)
Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities          
Depreciation and Amortization   19,753    17,801 
Interest Value of Convertible Debt Issued   -    - 
Stock Option Compensation   104,600    120,581 
Common Stock Warrants Issued for Services   2,700    5,555 
Common Stock Warrants Issued for Interest   -    - 
Common Stock issued for Services   138,546    219,900 
(Increase) Decrease in Operating Assets          
Accounts Receivable   930,803    (785,969)
Inventory   199,124    (214,898)
Other Current Assets   (66,995)   (168,122)
Other Assets   (175,592)   (19,919)
Increase (Decrease) in Accounts and Other Payables   (522,460)   (1,238,379 
Net Cash Used in Operating Activities   (2,604,645)   (5,408,720)
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of Property and Equipment   (878,205)   (14,165)
Net Cash Provided by (Used in) Investing Activities   (878,205)   (14,165)
CASH FLOWS FROM FINANCING ACTIVITIES          
Changes in Restricted Cash   (685)   (214)
Proceeds from (Payments on) Short-Term Notes Payable/Debt   (47,554)   358,888 
Proceeds from (Payments to) Due to Related Parties   -    (300,000)
Proceeds from (Payments to) Long-Term Debt   (251,498)   (164,093)
Joint Venture Non-Controlled Equity Portion   (99,048)   - 
Common Stock Issued, Net of (Cost of Capital)   1,322,885    11,511,741 
Net Cash Provided by Financing Activities   924,100    11,406,322 
EFFECT OF EXCHANGE RATE CHANGES ON CASH   1,252    (56,617)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   (2,557,499)   5,926,820 
Cash and Cash Equivalents- Beginning of Period   7,312,095    1,385,275 
CASH AND CASH EQUIVALENTS - END OF PERIOD  $4,754,596   $7,312,095 

 

See accompanying Notes to Consolidated Financial Statements.

 

F-6

 

 

IVEDA SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

FOR THE YEARS ENDING DECEMBER 31, 2023 AND 2022

 

   2023   2022 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Interest Paid  $9,793   $53,323 
Income Tax Paid  $28,779   $- 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          

 

See accompanying Notes to Consolidated Financial Statements.

 

F-7

 

 

IVEDA SOLUTIONS, INC.

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provides true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Iveda also offers smart utility, smart sensors, gateways and trackers. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI® intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  ● Object Search
  ● Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  ● License Plate Recognition (100+ Countries), includes make and model
  ● Intrusion Detection
  ● Weapon Detection
  ● Fire Detection
  ● People Counting
  ● Vehicle Counting
  ● Temperature Detection
  ● Public Health Analytics (Facemask Detection)
  ● QR and Barcode Detection

 

Key Features

 

  ● Live Camera View
  ● Live Tracking
  ● Abnormality Detection – Vehicle/Person wrong direction detection
  ● Vehicle/Person Loitering Detection
  ● Fall Detection
  ● Illegal Parking Detection
  ● Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.

 

F-8

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.

 

IvedaSPS is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Utilus is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:

 

  ● Government or large-scale city deployments
  ● Supporting and Improving City Services
  ● Reducing Emergency Response Times
  ● Crime& Hazard Protection
  ● Monitoring and Improving Air Quality
  ● Sound Detection
  ● Traffic Monitoring and Mobility as a Service
  ● Data Analytics and Monetization Opportunities

 

vumastAR is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:

 

  ● Quality and Maintenance Exams: vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.
  ● Factory and Line Work: Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting.
  ● Pharma: Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error.
  ● Supply Chain: Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes.
  ● Manufacturing: Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data
  ● Transportation: Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.
  ● Retail: Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.

 

vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.

 

IvedaXpress is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.

 

F-9

 

 

Iveda Smart UVC is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.

 

Iveda’s Smart Drones are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.

 

Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.

 

Key Features of Iveda’s Smart Drone:

 

Fully Autonomous

Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging

Easy operation and 24-7 flight mission

 

Intelligent Computing

Live video streaming - real-time object recognition and tracking

Onboard (edged) AI and data analysis

 

Safety Design

Multiply redundant and fail-safe systems

Weather resistant industrial grade systems (IP54)

Designed and made in Taiwan (MIT)

 

Skywatch

Planning and editing real-time/timed missions

User/Group permission control & flight data management

Failsafe alarm and FPV gimbal control

 

Insight

Automated orthorectified service of imagery (2D/3D)

AI technology for inspecting natural disaster, vehicle & pedestrian tracking, and energy facilities inspection.

Visualizing geographic data and analysis report

 

  ●

Propellers: 8 (multiply redundant)

  ●

Diagonal Footprint: 29.76″ / 756 mm

  ●

Weight: 14.1lbs / 6.4 Kg

  ●

Hover time: 30 mins

  ●

Wind tolerance: Beaufort scale – 6

  ●

IP rating: IP54

  ●

Camera sensor: Dual RGB, IR/thermal

  ● Network: 5G/4G LTE and 2.4G Wi-Fi

 

The Smart Utility Cabinet gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.

 

Vemo Body Camera streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.

 

IvedaCare, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we previously only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras, which are a global standard for the interface of IP-based physical security products.

 

F-10

 

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

MEGAsys, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. MEGAsys combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

F-11

 

 

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the years ended December 31, 2023 and 2022.

 

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

F-12

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  ● The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable and the amount can be reliably estimated.

 

  ● The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  ● Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

F-13

 

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. 50% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was 52% of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.

 

Revenue from two customers out of 65 total customers represented approximately 48% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with 25%, 2) Chicony Power Technology Co Ltd with 23%, (both Taiwan companies).

 

Revenue from two customers out of 42 total customers represented approximately 52% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with 21%, 2) Chicony Power Technology Co Ltd with 31%, (both Taiwan companies).

 

No other customers represented greater than 10% of total revenues in years ended December 31, 2023 and 2022.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of December 31, 2023 and 2022, respectively, an allowance for uncollectible accounts of $0 and $0 was deemed necessary for our U.S.-based segment.

 

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 

Other Current Assets

 

Other current assets represent cash paid in advance to vendors for service coverage extending into subsequent periods.

 

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 and $0, as of December 31, 2023 and 2022, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the years ended December 31, 2023 and 2022 was $19,753 and $17,801, respectively.

 

F-14

 

 

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2023, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2023.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2019 to 2022 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2019 to 2022 are open to examination by the Taiwan Ministry of Finance.

 

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

Accounts and Other Payables

 

SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
Accounts Payable  $179,949   $360,395 
Accrued Expenses   900,928    1,243,027 
Deferred Revenue and Customer Deposits   29,211    35,305 
Accounts and Other Payables  $1,110,087   $1,638,727 

 

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

F-15

 

 

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $104,600 and $120,581 of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2023 and December 31, 2022. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

 

   December 31, 2023 
   Net Revenue   Net Assets (Liabilities) 
United States  $852,136   $5,364,184 
Republic of China (Taiwan)  $5,648,982   $907,113 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

Reclassification

 

Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.

 

New Accounting Standards

 

No new relevant accounting standards

 

F-16

 

 

NOTE 2 RELATED PARTIES - None

 

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

 

The short-term debt balances were as follows:

 

   December 31, 2023   December 31, 2022 
         
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from HuaNam Bank at 3.44% interest rate per annum. Due in May 2024.   97,777    - 
Loan from ChangHwa Bank at 3% interest rate per annum. Due in November 2024.   162,962    - 
Loan Agreement with Shanghai Bank at 2.94% interest rate per annum due September 2023.   -    398,409 
Balance at end of period  $348,771   $398,409 

 

The Long-term debt balances were as follows:

SCHEDULE OF LONG-TERM DEBT

 

Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Current Portion of Long-term debt   -    (65,408)
Balance at end of period  $-    190,776 

 

F-17

 

 

NOTE 4 PREFERRED STOCK

 

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share, 1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

 

NOTE 5 EQUITY

 

Common Stock

 

We are authorized to issue up to 37,500,000 shares of common stock, par value $0.00001 per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

 

NOTE 6 STOCK OPTION PLAN AND WARRANTS

 

Stock Options

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 125,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 1,625,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of December 31, 2023 there were 359,125 options outstanding under the 2010 Option Plan.

 

On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan has a maximum of 1,250,000 shares authorized with similar terms and conditions to the 2010 Option Plan. As of December 31, 2023 there were 941,875 options outstanding under the 2020 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792)

 

F-18

 

 

As of December 31, 2023 and December 31, 2022, there were 1,301,000 and 1,014,438 options outstanding, respectively, under all the option plans.

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2023, we had approximately $93,887 unrecognized stock-based compensation.

 

Stock option transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   1,014,438   $5.61    893,438   $6.80 
Granted   233,125    0.68    233,125    2.26 
Exercised   -    -    -    - 
Forfeited or Cancelled   (10,938)   1.35    (112,125)   16.19 
Outstanding at End of Year   1,301,000    4.50    1,014,438    5.61 
Options Exercisable at Year-End   1,260,375    4.62    959,750    5.61 
Weighted-Average Fair Value of Options Granted During the Year  $0.34        $0.92      

 

Information with respect to stock options outstanding and exercisable at December 31, 2023 is as follows:

 

    Options Outstanding   Options Exercisable 
Range of
Exercise
Prices		   Number
Outstanding at
December 31,
2023		   Weighted-
Average
Remaining
Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.32 - $17.76     1,301,000    6.5   $4.50    1,260,375   $4.62 

 

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   1.00%

 

F-19

 

 

Warrant transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   6,233,660   $2.66    872,259   $3.04 
Granted   11,250    0.72    5,616,224    2.96 
Exercised   (945,900)   1.40    (8,214)   2.80 
Forfeited or Cancelled   (245,114)   3.34    (246,609)   2.80 
Outstanding at End of Year   5,053,896    2.84    6,233,660    2.66 
Warrant Exercisable at Year-End   5,053,896    2.84    6,233,660    2.66 
Weighted-Average Fair Value of Warrants Granted During the Year  $0.24        $0.72 - $2.53       

 

Information with respect to warrants outstanding and exercisable at December 31, 2023 is as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices		   Number
Outstanding
at
December 31,
2023		   Weighted-
Average Remaining Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable
at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.68 - $13.20    6,233,660    3.4   $2.84    6,233,660   $2.84 

 

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   1.5 yrs    1.5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   0.18 - 1.00%

 

F-20

 

 

NOTE 7 INCOME TAXES

 

U.S. Federal Corporate Income Tax

 

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2023   2022 
Tax Operating Loss Carryforward - USA  $14,800,000   $11,800,000 
Other   -    - 
Valuation Allowance - USA   (14,800,000)   (11,800,000)
Deferred Tax Assets, Net  $-   $- 

 

The valuation allowance increased approximately $1.0 million, primarily as a result of the increased net operating losses of our U.S.- based segment.

 

As of December 31, 2023, we had federal net operating loss carryforwards for income tax purposes of approximately $35 million which will begin to expire in 2025. We also have Arizona net operating loss carryforwards for income tax purposes of approximately $ 2.0 million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.

 

Year Ending  Net Operating   Year of
December 31,  Loss:   Expiration
2023  $3,000,000   2043
2022   3,000,000   2042
2021   1,000,000   2041
2020   590,000   2040
2019   260,000   2039
2018   160,000   2038
2017   140,000   2037
2016   1,640,000   2036
2015   3,400,000   2035
2014   5,230,000   2034
2013   5,600,000   2033
2012   2,850,000   2032
2011   2,427,000   2031
2010   1,799,000   2030
2009   1,750,000   2029
2008   1,308,000   2028
2007   429,000   2027
2006   476,000   2026
2005   414,000   2025

 

Taiwan (Republic of China) Corporate Tax

 

Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year.

 

According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.

 

F-21

 

 

NOTE 8 EARNINGS (LOSS) PER SHARE

 

The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”

 

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the years ended December 31, 2023 and 2022 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended December 31, 2023 and 2022.

 

If we did not have net losses in 2023 and 2022 we would have had an additional amount of dilutive securities convertible at less than the then fair market value of the common stock. These amounts would have been 90,000 and 90,000, respectively.

 

   December 31,
2023		   December 31,
2022		 
         
Basic EPS          
Net Loss  $(3,235,124)  $(3,345,270)
Weighted Average Shares   15,973,422    12,840,598 
Basic Loss Per Share  $(0.20)  $(0.26)

 

NOTE 9 CONTINGENT LIABILITIES—TAIWAN

 

Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Siemens, Shihlin Electric & Engineering Corporation, and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2023 is $320,237.

 

NOTE 10 SUBSEQUENT EVENTS

 

F-22

 EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

 

RULE 13a-14(a)/15d-14(a) (17 CFR 240.15d-14(a))

 

(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, David Ly, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Iveda Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ David Ly  
David Ly  
Chief Executive Officer  
   
Date: April 1, 2024  

 

 
 EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

 

RULE 15d-14(a) (17 CFR 240.15d-14(a))

 

(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)

 

I, Robert J. Brilon, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Iveda Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Robert J. Brilon  
Robert J. Brilon  
Chief Financial Officer, Treasurer and Corporate Secretary  
   
Date: April 1, 2024  

 

 
 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

PURSUANT TO 18 U.S.C. § 1350

 

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

In connection with the Annual Report on Form 10-K of Iveda Solutions, Inc. (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Ly, Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Iveda Solutions, Inc.

 

/s/ David Ly  
David Ly  
Chief Executive Officer  
   
Date: April 1, 2024  

 

This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Iveda Solutions, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report on Form 10-K), irrespective of any general incorporation language contained in such filing.

 

 
 EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

PURSUANT TO 18 U.S.C. § 1350

 

(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

In connection with the Annual Report on Form 10-K of Iveda Solutions, Inc. (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert J. Brilon, Chief Financial Officer and Treasurer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Iveda Solutions, Inc.

 

/s/ Robert J. Brilon  
Robert J. Brilon  
Chief Financial Officer, Treasurer and Corporate Secretary  
   
Date: April 1, 2024  

 

This certification accompanies the Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Iveda Solutions, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Annual Report on Form 10-K), irrespective of any general incorporation language contained in such filing.

 

 

 

 

 EX-97.1 6 ex97-1.htm

 

Exhibit 97.1

 

IVEDA SOLUTIONS, inc.

INCENTIVE-BASED COMPENSATION RECOVERY POLICY

 

Effective December 1, 2023 (“Effective Date”)

 

In accordance with Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Exchange Act Rule 10D-1, and Nasdaq Listing Rule 5608, (“Nasdaq Listing Rules”), the exchange upon which the shares of common stock and warrants to purchase common stock of Iveda Solutions, Inc. (the “Company”) are listed, the Company’s Board of Directors (the “Board”) has adopted this Incentive-Based Compensation Recovery Policy (the “Policy”). The purpose of this Policy is to recover the erroneously awarded Inventive-Based Compensation (defined below), if any, in the event that the Company is required to prepare an Accounting Restatement.

 

Capitalized terms used in the Policy are defined in Section A below. The application of the Policy to Executive Officers is not discretionary, except to the limited extent provided in Section G below, and applies without regard to whether an Executive Officer was at fault.

 

A. Definitions

 

“Accounting Restatement” means an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

 

“Accounting Restatement Determination Date” means the date that a Company is required to prepare an Accounting Restatement, which is the earlier of: (a) the date the Board, a committee of the Board, or one or more of the officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement; and (b) the date a court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement.

 

“Excess Compensation” means the amount of Incentive-Based Compensation Received that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received had such Incentive-Based Compensation been determined based on the restated amounts (this is referred to in the listings standards as “erroneously awarded incentive-based compensation”) and must be computed without regard to any taxes paid.

 

“Executive Officer” means each individual who is or was ever designated as an “officer” by the Board in accordance with Exchange Act Rule 16a-1(f).

 

1

 

 

“Financial Reporting Measures” means measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total shareholder return are also Financial Reporting Measures. A Financial Reporting Measure need not be presented within the financial statements or included in a filing with the Securities and Exchange Commission.

 

“Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure (for the avoidance of doubt, no compensation that is potentially subject to recovery under the Policy will be earned until the Company’s duty to recover under the Policy has lapsed) and excludes the following: salaries, bonuses paid solely at the discretion of the Committee or Board that are not paid from a bonus pool that is determined by satisfying a Financial Reporting Measure, bonuses paid solely upon satisfying one or more subjective standards and/or completion of a specified employment period, non-equity incentive plan awards earned solely upon satisfying one or more strategic measures or operational measures, and equity awards for which the grant is not contingent upon achieving any Financial Reporting Measure performance goal and vesting upfront, upon the signing of certain agreements, or is contingent solely upon completion of time requirement (e.g., time-based vesting equity awards) and/or attaining one or more non-Financial Reporting Measures.

 

“Received” means, with respect to any Incentive-based Compensation, actual or deemed receipt, and Incentive-Based Compensation is “Received” under the Policy in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period. For the avoidance of doubt, the Policy does not apply to Incentive-Based Compensation for which the Financial Reporting Measure is attained prior to October 2, 2023.

 

B. Persons Covered by the Policy

 

The Policy is binding and enforceable against all Executive Officers who received Incentive-Based Compensation covered by this Policy from the Company (See Section E below).

 

C. Administration of the Policy

 

The Compensation Committee of the Board (the “Committee”) has full-delegated authority to administer the Policy. The Committee is authorized to interpret and construe the Policy and to make all determinations necessary, appropriate, or advisable for the administration of the Policy. In addition, if determined in the discretion of the Board, the Policy may be administered by the independent members of the Board or another committee of the Board made up of independent members of the Board, in which case all references to the Committee will be deemed to refer to such independent members of the Board or such other Board committee. All determinations of the Committee will be final and binding and will be given the maximum deference permitted by law.

 

2

 

 

D. Accounting Restatements Requiring Application of the Policy

 

If the Company is required to prepare an Accounting Restatement, then the Committee must determine the Excess Compensation, if any, that must be recovered. The Company’s obligation to recover Excess Compensation is not dependent on if or when the restated financial statements are filed.

 

E. Compensation Covered by the Policy

 

The Policy applies to all Incentive-Based Compensation Received by an Executive Officer:

 

  (a) after beginning service as an Executive Officer;
     
  (b) who served as an Executive Officer at any time during the performance period for that Incentive-Based Compensation;
     
  (c) while the Company has a class of securities listed on the Exchange;
     
  (d) during the three completed fiscal years immediately preceding the Accounting Restatement Determination Date. In addition to these last three completed fiscal years, the Policy must apply to any transition period (that results from a change in the Company’s fiscal year) within or immediately following those three completed fiscal years. However, a transition period between the last day of the Company’s previous fiscal year end and the first day of the Company’s new fiscal year that comprises a period of nine to 12 months would be deemed a completed fiscal year; and
     
  (e) on or after October 2, 2023.

 

F. Excess Compensation Subject to Recovery of the Policy

 

To determine the amount of Excess Compensation for Incentive-Based Compensation based on stock price or total shareholder return, where it is not subject to mathematical recalculation directly from the information in an Accounting Restatement, the amount must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received and the Company must maintain documentation of the determination of that reasonable estimate and provide the documentation to the Exchange.

 

G. Repayment of Excess Compensation

 

The Company must recover Excess Compensation reasonably promptly and Executive Officers are required to repay Excess Compensation to the Company. Subject to applicable law, the Company may recover Excess Compensation by requiring the Executive Officer to repay such amount to the Company by direct payment to the Company or such other means or combination of means as the Committee determines to be appropriate (these determinations do not need to be identical as to each Executive Officer). These means may include:

 

  (a) requiring reimbursement of cash Incentive-Based Compensation previously paid;

 

3

 

 

  (b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;
     
  (c) offsetting the amount to be recovered from any unpaid or future compensation to be paid by the Company or any affiliate of the Company to the Executive Officer;
     
  (d) cancelling outstanding vested or unvested equity awards; and/or
     
  (e) taking any other remedial and recovery action permitted by law, as determined by the Committee.

 

The repayment of Excess Compensation must be made by an Executive Officer notwithstanding any Executive Officer’s belief (whether or not legitimate) that the Excess Compensation had been previously earned under applicable law and therefore is not subject to recovery.

 

In addition to its rights to recovery under the Policy, the Company or any affiliate of the Company may take any legal actions it determines appropriate to enforce an Executive Officer’s obligations to the Company or its affiliate or to discipline an Executive Officer, including (without limitation) termination of employment, institution of civil proceedings, reporting of misconduct to appropriate governmental authorities, reduction of future compensation opportunities, or change in role. The decision to take any actions described in the preceding sentence will not be subject to the approval of the Committee and can be made by the Board, any committee of the Board, or any duly authorized officer of the Company or of any applicable affiliate of the Company.

 

H. Limited Exceptions to the Policy

 

The Company must recover Excess Compensation in accordance with the Policy except to the limited extent that any of the conditions set forth below are met, and the Committee determines that recovery of the Excess Compensation would be impracticable:

 

  (a) The direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered. Before reaching this conclusion, the Company must make a reasonable attempt to recover the Excess Compensation, document the reasonable attempt(s) taken to so recover, and provide that documentation to the Exchange;
     
  (b) Recovery would violate home country law where that law was adopted prior to November 28, 2022. Before reaching this conclusion, the Company must obtain an opinion of home country counsel, acceptable to the Exchange, that recovery would result in such a violation, and must provide such opinion to the Exchange; or
     
  (c) Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) (Assignment and alienation) or 26 U.S.C. 411(a) (Minimum vesting standards) and regulations thereunder.

 

4

 

 

I. No Indemnification

 

The Company is prohibited from indemnifying any Executive Officer or former Executive Officer against the loss of Excess Compensation.

 

J. Relationship to Other Agreements

 

The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require an Executive Officer to agree to abide by the terms of this Policy. In the event of any inconsistency between the terms of the Policy and the terms of any employment agreement, equity award agreement, or similar agreement under which Incentive-Based Compensation has been granted, awarded, earned or paid to an Executive Officer, whether or not deferred, the terms of the Policy shall govern.

 

K. Other Important Information in the Policy

 

Notwithstanding the terms of any of the Company’s organizational documents (including, but not limited to, the Company’s bylaws), any corporate policy or any contract (including, but not limited to, any indemnification agreement), neither the Company nor any affiliate of the Company will indemnify or provide advancement for any Executive Officer against any loss of Excess Compensation, or any claims relating to the Company’s enforcement of its rights under the Policy. Neither the Company nor any affiliate of the Company will pay for or reimburse insurance premiums for an insurance policy that covers potential recovery obligations. In the event that pursuant to the Policy the Company is required to recover Excess Compensation from an Executive Officer who is no longer an employee, the Company will be entitled to seek recovery in order to comply with applicable law, regardless of the terms of any release of claims or separation agreement such individual may have signed. Neither the Company nor any affiliate of the Company will enter into any agreement that exempts any Incentive-Based Compensation that is granted, paid, or awarded to an Executive Officer from the application of the Policy or that waives the Company’s right to recovery of any Excess Compensation, and the Policy shall supersede any such agreement (whether entered into before, on, or after the adoption of the Policy).

 

The Committee or Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect final regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with Nasdaq Listing Rules.

 

If any provision of the Policy or the application of any such provision to any Executive Officer is adjudicated to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability will not affect any other provisions of the Policy or the application of such provision to another Executive Officer, and the invalid, illegal or unenforceable provisions will be deemed amended to the minimum extent necessary to render any such provision or application enforceable.

 

The Policy will terminate and no longer be enforceable when the Company ceases to be a listed issuer within the meaning of Section 10D of the Exchange Act or when the Exchange Act Rule 10D-1, and Nasdaq Listing Rule 5608 are no longer effective.

 

5

 

 GRAPHIC 7 form10-k001.jpg begin 644 form10-k001.jpg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end EX-101.SCH 8 ivda-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - SHORT-TERM AND LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - EQUITY link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - STOCK OPTION PLAN AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - EARNINGS (LOSS) PER SHARE link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - CONTINGENT LIABILITIES—TAIWAN link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - CONTINGENT LIABILITIES—TAIWAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ivda-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 ivda-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 ivda-20231231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series B Preferred Stock [Member] Product and Service [Axis] Equipment Sales [Member] Service Revenue [Member] Other Revenue [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Chunghwa Telecom [Member] Revenue Benchmark [Member] Taiwan Co [Member] Legal Entity [Axis] YOU MING HUEI CO. LTD [Member] Chicony Power Technology [Member] Other Customers [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Geographical [Axis] UNITED STATES Republic of China (Taiwan) [Member] Related Party, Type [Axis] Shanghai Bank [Member] Hua Nam Bank [Member] Chang Hwa Bank [Member] Shanghai Bank One [Member] Series A Preferred Stock [Member] Plan Name [Axis] 2010 Stock Option Plan [Member] 2020 Plan [Member] Stock Option Plan [Member] Award Type [Axis] Warrant [Member] Segments [Axis] U.S. - Based Segment [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] ARIZONA Megasys [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Document Financial Statement Error Correction [Flag] Auditor Name Auditor Firm ID Auditor Location Statement [Table] Statement [Line Items] ASSETS CURRENT ASSETS Cash and Cash Equivalents Restricted Cash Accounts Receivable, Net Inventory, Net Other Current Assets Total Current Assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Other Assets Total Other Assets Total Assets LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts and Other Payables Short Term Debt Current Portion of Long-Term Debt Total Current Liabilities LONG-TERM DEBT STOCKHOLDERS’ EQUITY Preferred Stock, value Common Stock, $0.00001 par value; 100,000,000 shares authorized; 16,169,891 and 15,066,739 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively Additional Paid-In Capital Joint Venture Non-Controlled Equity Portion Accumulated Comprehensive Loss Accumulated Deficit Total Stockholders’ Equity Total Liabilities and Stockholders’ Equity Preferred Stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding REVENUE TOTAL REVENUE COST OF REVENUE GROSS PROFIT OPERATING EXPENSES General & Administrative Total Operating Expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Miscellaneous Income (Expense) Interest Income Interest Expense Total Other Income (Expense) Joint Venture Non-Controlled Interest LOSS BEFORE INCOME TAXES BENEFIT (PROVISION) FOR INCOME TAXES NET LOSS BASIC LOSS PER SHARE DILUTED LOSS PER SHARE BASIC WEIGHTED AVERAGE SHARES DILUTED WEIGHTED AVERAGE SHARES Balance Balance, shares Costs of Capital Stock Based Compensation Common Stock issued for conversion error Common Stock issued for conversion error, shares Common Stock issued for services Common Stock issued for services, shares Warrants for Services Exercise of options and warrants Exercise of options and warrants, shares Common Stock Offering for Cash Common Stock Offering for Cash, shares Common Stock and Pre-Funded Warrant Offering for Cash – August 2022 Common Stock and Pre-Funded Warrant Offering for Cash - August 2022, shares Warrants sold in Over allotment Net Loss Comprehensive Loss 8 for 1 conversion adjustment 8 for 1 conversion adjustment, shares Exercise of warrants issued August 2022 Exercise of warrants issued August 2022, shares Joint Venture Non-Controlled Equity Interest Balance Balance, shares Statement of Stockholders' Equity [Abstract] Reverse stock split Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities Depreciation and Amortization Interest Value of Convertible Debt Issued Stock Option Compensation Common Stock Warrants Issued for Services Common Stock Warrants Issued for Interest Common Stock issued for Services (Increase) Decrease in Operating Assets Accounts Receivable Inventory Other Current Assets Other Assets Increase (Decrease) in Accounts and Other Payables Net Cash Used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of Property and Equipment Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Changes in Restricted Cash Proceeds from (Payments on) Short-Term Notes Payable/Debt Proceeds from (Payments to) Due to Related Parties Proceeds from (Payments to) Long-Term Debt Joint Venture Non-Controlled Equity Portion Common Stock Issued, Net of (Cost of Capital) Net Cash Provided by Financing Activities EFFECT OF EXCHANGE RATE CHANGES ON CASH NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents- Beginning of Period CASH AND CASH EQUIVALENTS - END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Interest Paid Income Tax Paid SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTIES Debt Disclosure [Abstract] SHORT-TERM AND LONG-TERM DEBT Equity [Abstract] PREFERRED STOCK EQUITY Share-Based Payment Arrangement [Abstract] STOCK OPTION PLAN AND WARRANTS Income Tax Disclosure [Abstract] INCOME TAXES Earnings Per Share [Abstract] EARNINGS (LOSS) PER SHARE Commitments and Contingencies Disclosure [Abstract] CONTINGENT LIABILITIES—TAIWAN Subsequent Events [Abstract] SUBSEQUENT EVENTS Nature of Operations Consolidation Impairment of Long-Lived Assets Basis of Accounting Use of Estimates Revenue and Expense Recognition Comprehensive Loss Concentrations Cash and Cash Equivalents Accounts Receivable Deposits – Current Other Current Assets Inventories Property and Equipment Deposits—Long-Term Income Taxes Restricted Cash Accounts and Other Payables Deferred Revenue Stock-Based Compensation Fair Value of Financial Instruments Segment Information Reclassification New Accounting Standards SCHEDULE OF ACCOUNTS AND OTHER PAYABLES SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS SCHEDULE OF SHORT-TERM DEBT SCHEDULE OF LONG-TERM DEBT SCHEDULE OF STOCK OPTION TRANSACTIONS SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL SCHEDULE OF WARRANT TRANSACTIONS SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SUMMARY OF OPERATING LOSS CARRYFORWARDS SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED Accounts Payable Accrued Expenses Deferred Revenue and Customer Deposits Accounts and Other Payables Net Revenue Net Assets (Liabilities) Schedule of Product Information [Table] Product Information [Line Items] Cash, FDIC Insured Amount Percentage of concentration risk Allowance for uncollectible accounts Inventory reserve Useful life Depreciation expense Stock option compensation Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Short term debt Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Interest rate Debt instrument, maturity date Loans Current portion of long term debt Long term debt Debt interest rate Debt instrument, maturity date, description Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock, par value Shares, Outstanding at Beginning of Year Weighted-Average Exercise Price, Outstanding at Beginning of Year Shares, Granted Weighted-Average Exercise Price, Granted Shares, Exercised Weighted-Average Exercise Price Exercised Shares, Forfeited or Canceled Weighted-Average Exercise Price, Forfeited or Canceled Shares, Outstanding at End of Year Weighted-Average Exercise Price, Outstanding at End of Year Shares, Options Exercisable at End of Year Weighted-Average Exercise Price, Options Exercisable at End of Year Weighted-Average Fair Value of Options Granted During the Period Range of Exercise, Lower Range Limit Range of Exercise, Upper Range Limit Options Outstanding, Number Outstanding Options Outstanding, Weighted- Average Remaining Contractual Life Options Outstanding, Weighted-Average Exercise Price Options Exercisable, Number Exercisable Options Exercisable, Weighted-Average Exercise Price Expected life Dividend yield Expected volatility Risk-Free interest rate Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Shares, Outstanding at Beginning of Year Weighted-Average Exercise Price, Outstanding at Beginning of Year Shares, Granted Weighted-Average Exercise Price, Granted Shares, Exercised Weighted-Average Exercise Price, Exercised Shares, Forfeited or Canceled Weighted-Average Exercise Price, Forfeited or Canceled Shares, Outstanding at End of Year Weighted-Average Exercise Price, Outstanding at End of Year Shares, Options Exercisable at End of Year Weighted-Average Exercise Price, Options Exercisable at End of Year Weighted-Average Fair Value of Options Granted During the Period Range of Exercise Prices Warrants Outstanding, Number Outstanding Warrants Outstanding, Weighted-Average Remaining Contractual Life Warrants Outstanding, Weighted-Average Exercise Price Warrants Exercisable, Number Exercisable Warrants Exercisable, Weighted-Average Exercise Price Expected Life Dividend Yield Expected Volatility Risk-Free Interest Rate Number of shares authorized under plan Options outstanding Unrecognized stock- based compensation Tax Operating Loss Carryforward - USA Other Valuation Allowance - USA Deferred Tax Assets, Net Net operating loss Year of Expiration Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Valuation allowance increased Net operating loss carryforwards Operating loss carryforwards, limitations on use Taiwan corporate tax rate Basic EPS Weighted Average Shares Basic Loss Per Share Dilutive securities convertible Financial exposure contingent future payments Nature Of Operations [Policy Text Block] Chunghwa Telecom [Member] Customer One [Member] Chicony Power Technology [Member] Other Customers [Member] Other Current Assets [Policy Text Block] Accounts And Other Payables [Policy Text Block] Republic of China (Taiwan) [Member]. Shanghai Bank [Member] Hua Nam Bank [Member] Shanghai Bank One [Member] Chang Hwa Bank [Member] Stock issued during period value stock warrants exercised. Stock Issued During Period Shares Stock Warrants Exercised. Stock issued during period value reverse stock splits. Adjustments to additional paid-in capital warrants sold in over allotment. Common stock and prefunded warrant offering Common stock and prefunded warrant offering shares 2010 Stock Option Plan [Member] Proceeds from repayments of changes in restricted cash. Stock Option Plan [Member] Non option equity instruments exercisable number. Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average ExercisePrice. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, Granted. Share based compensation arrangement by share based payment award non options exercised weighted average exercise price. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, forfeited. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average ExercisePrice. Summary Of Warrants Outstanding And Exercisable Information [Table Text Block] Schedule of Warrants Outstanding And Exercisable [Table Text Block] U.S. - Based Segment [Member] Year of Expiration. Taiwan corporate tax rate. Megasys [Member] 2020 Plan [Member] Equipment Sales [Member] Service Revenue [Member] Other Revenue [Member] Common stock warrants issued for services. Common stock warrants issued for interest. Common stock issued for services. YOU MING HUEI CO. LTD [Member] Non controlled interest in joint ventures. Weighted average shares outstanding basic. Taiwan Co [Member] Assets, Current Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment Assets Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Shares, Outstanding StockIssuedValueJointVenturePartnersNonControlledEquityInterest Interest on Convertible Debt, Net of Tax Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets Increase (Decrease) in Other Noncurrent Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Proceeds from (Payments for) Other Financing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Comprehensive Income, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Other Current Assets [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Accounts And Other Payables [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net EX-101.PRE 12 ivda-20231231_pre.xml XBRL PRESENTATION FILE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Mar. 15, 2024
Sep. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41345    
Entity Registrant Name IVEDA SOLUTIONS, INC.    
Entity Central Index Key 0001397183    
Entity Tax Identification Number 20-2222203    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 1744 S Val Vista    
Entity Address, Address Line Two Suite 213    
Entity Address, City or Town Mesa    
Entity Address, State or Province AZ    
Entity Address, Postal Zip Code 85204    
City Area Code (480)    
Local Phone Number 307-8700    
Title of 12(g) Security Common Stock, par value $0.00001 per share    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 9,500,000
Entity Common Stock, Shares Outstanding   16,169,891  
Document Financial Statement Error Correction [Flag] false    
Auditor Name BF Borgers CPA PC    
Auditor Firm ID 5041    
Auditor Location Lakewood, CO    

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash and Cash Equivalents $ 4,754,597 $ 7,312,095
Restricted Cash 129,778 129,527
Accounts Receivable, Net 281,049 1,222,690
Inventory, Net 324,515 526,470
Other Current Assets 435,580 371,990
Total Current Assets 5,925,520 9,562,772
PROPERTY AND EQUIPMENT, NET 891,187 32,911
OTHER ASSETS    
Other Assets 444,723 267,387
Total Other Assets 444,723 267,387
Total Assets 7,261,430 9,863,070
CURRENT LIABILITIES    
Accounts and Other Payables 1,110,087 1,638,727
Short Term Debt 348,771 398,409
Current Portion of Long-Term Debt 65,408
Total Current Liabilities 1,458,858 2,102,544
LONG-TERM DEBT 190,776
STOCKHOLDERS’ EQUITY    
Preferred Stock, value
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 16,169,891 and 15,066,739 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 162 150
Additional Paid-In Capital 54,065,633 52,496,914
Joint Venture Non-Controlled Equity Portion (99,048)  
Accumulated Comprehensive Loss (222,380) (220,643)
Accumulated Deficit (47,941,796) (44,706,671)
Total Stockholders’ Equity 5,802,572 7,569,750
Total Liabilities and Stockholders’ Equity 7,261,430 9,863,070
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred Stock, value
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Preferred Stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 100,000,000 100,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 16,169,891 15,066,739
Common stock, shares outstanding 16,169,891 15,066,739
Series B Preferred Stock [Member]    
Preferred Stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 500 500
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
REVENUE    
TOTAL REVENUE $ 6,495,865 $ 4,468,279
COST OF REVENUE 5,428,261 3,504,778
GROSS PROFIT 1,067,604 963,501
OPERATING EXPENSES    
General & Administrative 4,478,553 4,292,820
Total Operating Expenses 4,478,553 4,292,820
LOSS FROM OPERATIONS (3,410,949) (3,329,320)
OTHER INCOME (EXPENSE)    
Miscellaneous Income (Expense) (28,099) (17,078)
Interest Income 131,881 57,397
Interest Expense (7,254) (53,323)
Total Other Income (Expense) 96,527 (13,004)
Joint Venture Non-Controlled Interest 97,605  
LOSS BEFORE INCOME TAXES (3,216,817) (3,342,324)
BENEFIT (PROVISION) FOR INCOME TAXES (18,308) (2,947)
NET LOSS $ (3,235,124) $ (3,345,270)
BASIC LOSS PER SHARE $ (0.20) $ (0.26)
DILUTED LOSS PER SHARE $ (0.20) $ (0.26)
BASIC WEIGHTED AVERAGE SHARES 15,973,422 12,846,848
DILUTED WEIGHTED AVERAGE SHARES 15,973,422 12,846,848
Equipment Sales [Member]    
REVENUE    
TOTAL REVENUE $ 6,052,298 $ 4,159,398
Service Revenue [Member]    
REVENUE    
TOTAL REVENUE 443,567 308,881
Other Revenue [Member]    
REVENUE    
TOTAL REVENUE
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2021 $ 97 $ 40,727,518 $ (41,361,401) $ (143,493) $ (777,279)
Balance, shares at Dec. 31, 2021 9,668,369        
Costs of Capital     (1,613,470)     (1,163,918)
Stock Based Compensation   120,581     120,581
Common Stock issued for conversion error      
Common Stock issued for conversion error, shares 65          
Common Stock issued for services $ 1 219,899     219,900
Common Stock issued for services, shares 215,000          
Warrants for Services     5,555     5,555
Exercise of options and warrants   23,000     $ 23,000
Exercise of options and warrants, shares 8,215        
Common Stock Offering for Cash $ 19   8,011,231     $ 8,011,250
Common Stock Offering for Cash, shares 1,885,000          
Common Stock and Pre-Funded Warrant Offering for Cash – August 2022 $ 33   4,999,803     4,999,836
Common Stock and Pre-Funded Warrant Offering for Cash - August 2022, shares 3,289,474          
Warrants sold in Over allotment     2,797     2,797
Net Loss   (3,345,270)   (3,345,270)
Comprehensive Loss         (77,150) (77,150)
8 for 1 conversion adjustment, shares 616          
Balance at Dec. 31, 2022 $ 150 52,496,914 (44,706,671) (220,643) 7,569,750
Balance, shares at Dec. 31, 2022 15,066,739        
Common Stock issued for services $ 2 138,544     $ 138,546
Common Stock issued for services, shares 157,252          
Exercise of options and warrants, shares          
Net Loss   (3,235,124)   $ (3,235,124)
Comprehensive Loss       (1,737) (1,737)
Exercise of warrants issued August 2022 $ 10   1,322,875     1,322,885
Exercise of warrants issued August 2022, shares 945,900          
Joint Venture Non-Controlled Equity Interest           (99,048)
Balance at Dec. 31, 2023 $ 162   $ 54,065,633 $ (47,941,796) $ (222,380) $ 5,802,572
Balance, shares at Dec. 31, 2023 16,169,891        
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders' Equity (Parenthetical)
 3 Months Ended
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]  
Reverse stock split 1-for-8
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (3,235,124) $ (3,345,270)
Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities    
Depreciation and Amortization 19,753 17,801
Interest Value of Convertible Debt Issued
Stock Option Compensation 104,600 120,581
Common Stock Warrants Issued for Services 2,700 5,555
Common Stock Warrants Issued for Interest
Common Stock issued for Services 138,546 219,900
(Increase) Decrease in Operating Assets    
Accounts Receivable 930,803 (785,969)
Inventory 199,124 (214,898)
Other Current Assets (66,995) (168,122)
Other Assets (175,592) (19,919)
Increase (Decrease) in Accounts and Other Payables (522,460) (1,238,379)
Net Cash Used in Operating Activities (2,604,645) (5,408,720)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of Property and Equipment (878,205) (14,165)
Net Cash Provided by (Used in) Investing Activities (878,205) (14,165)
CASH FLOWS FROM FINANCING ACTIVITIES    
Changes in Restricted Cash (685) (214)
Proceeds from (Payments on) Short-Term Notes Payable/Debt (47,554) 358,888
Proceeds from (Payments to) Due to Related Parties (300,000)
Proceeds from (Payments to) Long-Term Debt (251,498) (164,093)
Joint Venture Non-Controlled Equity Portion (99,048)
Common Stock Issued, Net of (Cost of Capital) 1,322,885 11,511,741
Net Cash Provided by Financing Activities 924,100 11,406,322
EFFECT OF EXCHANGE RATE CHANGES ON CASH 1,252 (56,617)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,557,499) 5,926,820
Cash and Cash Equivalents- Beginning of Period 7,312,095 1,385,275
CASH AND CASH EQUIVALENTS - END OF PERIOD 4,754,596 7,312,095
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest Paid 9,793 53,323
Income Tax Paid $ 28,779
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure [Table]    
Net Income (Loss) Attributable to Parent $ (3,235,124) $ (3,345,270)
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2023
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provides true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Iveda also offers smart utility, smart sensors, gateways and trackers. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI® intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  ● Object Search
  ● Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  ● License Plate Recognition (100+ Countries), includes make and model
  ● Intrusion Detection
  ● Weapon Detection
  ● Fire Detection
  ● People Counting
  ● Vehicle Counting
  ● Temperature Detection
  ● Public Health Analytics (Facemask Detection)
  ● QR and Barcode Detection

 

Key Features

 

  ● Live Camera View
  ● Live Tracking
  ● Abnormality Detection – Vehicle/Person wrong direction detection
  ● Vehicle/Person Loitering Detection
  ● Fall Detection
  ● Illegal Parking Detection
  ● Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.

 

IvedaSPS is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Utilus is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:

 

  ● Government or large-scale city deployments
  ● Supporting and Improving City Services
  ● Reducing Emergency Response Times
  ● Crime& Hazard Protection
  ● Monitoring and Improving Air Quality
  ● Sound Detection
  ● Traffic Monitoring and Mobility as a Service
  ● Data Analytics and Monetization Opportunities

 

vumastAR is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:

 

  ● Quality and Maintenance Exams: vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.
  ● Factory and Line Work: Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting.
  ● Pharma: Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error.
  ● Supply Chain: Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes.
  ● Manufacturing: Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data
  ● Transportation: Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.
  ● Retail: Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.

 

vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.

 

IvedaXpress is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.

 

 

Iveda Smart UVC is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.

 

Iveda’s Smart Drones are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.

 

Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.

 

Key Features of Iveda’s Smart Drone:

 

Fully Autonomous

Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging

Easy operation and 24-7 flight mission

 

Intelligent Computing

Live video streaming - real-time object recognition and tracking

Onboard (edged) AI and data analysis

 

Safety Design

Multiply redundant and fail-safe systems

Weather resistant industrial grade systems (IP54)

Designed and made in Taiwan (MIT)

 

Skywatch

Planning and editing real-time/timed missions

User/Group permission control & flight data management

Failsafe alarm and FPV gimbal control

 

Insight

Automated orthorectified service of imagery (2D/3D)

AI technology for inspecting natural disaster, vehicle & pedestrian tracking, and energy facilities inspection.

Visualizing geographic data and analysis report

 

  ●

Propellers: 8 (multiply redundant)

  ●

Diagonal Footprint: 29.76″ / 756 mm

  ●

Weight: 14.1lbs / 6.4 Kg

  ●

Hover time: 30 mins

  ●

Wind tolerance: Beaufort scale – 6

  ●

IP rating: IP54

  ●

Camera sensor: Dual RGB, IR/thermal

  ● Network: 5G/4G LTE and 2.4G Wi-Fi

 

The Smart Utility Cabinet gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.

 

Vemo Body Camera streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.

 

IvedaCare, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we previously only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras, which are a global standard for the interface of IP-based physical security products.

 

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

MEGAsys, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. MEGAsys combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

 

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the years ended December 31, 2023 and 2022.

 

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  ● The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable and the amount can be reliably estimated.

 

  ● The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  ● Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. 50% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was 52% of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.

 

Revenue from two customers out of 65 total customers represented approximately 48% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with 25%, 2) Chicony Power Technology Co Ltd with 23%, (both Taiwan companies).

 

Revenue from two customers out of 42 total customers represented approximately 52% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with 21%, 2) Chicony Power Technology Co Ltd with 31%, (both Taiwan companies).

 

No other customers represented greater than 10% of total revenues in years ended December 31, 2023 and 2022.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of December 31, 2023 and 2022, respectively, an allowance for uncollectible accounts of $0 and $0 was deemed necessary for our U.S.-based segment.

 

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 

Other Current Assets

 

Other current assets represent cash paid in advance to vendors for service coverage extending into subsequent periods.

 

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 and $0, as of December 31, 2023 and 2022, respectively.

 

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the years ended December 31, 2023 and 2022 was $19,753 and $17,801, respectively.

 

 

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2023, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2023.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2019 to 2022 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2019 to 2022 are open to examination by the Taiwan Ministry of Finance.

 

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 

Accounts and Other Payables

 

SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
Accounts Payable  $179,949   $360,395 
Accrued Expenses   900,928    1,243,027 
Deferred Revenue and Customer Deposits   29,211    35,305 
Accounts and Other Payables  $1,110,087   $1,638,727 

 

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

 

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $104,600 and $120,581 of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.

 

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2023 and December 31, 2022. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

 

   December 31, 2023 
   Net Revenue   Net Assets (Liabilities) 
United States  $852,136   $5,364,184 
Republic of China (Taiwan)  $5,648,982   $907,113 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 

Reclassification

 

Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.

 

New Accounting Standards

 

No new relevant accounting standards

 

 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTIES
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTIES

NOTE 2 RELATED PARTIES - None

 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.1
SHORT-TERM AND LONG-TERM DEBT
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
SHORT-TERM AND LONG-TERM DEBT

NOTE 3 SHORT-TERM AND LONG-TERM DEBT

 

The short-term debt balances were as follows:

 

   December 31, 2023   December 31, 2022 
         
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from HuaNam Bank at 3.44% interest rate per annum. Due in May 2024.   97,777    - 
Loan from ChangHwa Bank at 3% interest rate per annum. Due in November 2024.   162,962    - 
Loan Agreement with Shanghai Bank at 2.94% interest rate per annum due September 2023.   -    398,409 
Balance at end of period  $348,771   $398,409 

 

The Long-term debt balances were as follows:

SCHEDULE OF LONG-TERM DEBT

 

Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Current Portion of Long-term debt   -    (65,408)
Balance at end of period  $-    190,776 

 

 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1
PREFERRED STOCK
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
PREFERRED STOCK

NOTE 4 PREFERRED STOCK

 

We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share, 1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.

 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1
EQUITY
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
EQUITY

NOTE 5 EQUITY

 

Common Stock

 

We are authorized to issue up to 37,500,000 shares of common stock, par value $0.00001 per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.

 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK OPTION PLAN AND WARRANTS
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK OPTION PLAN AND WARRANTS

NOTE 6 STOCK OPTION PLAN AND WARRANTS

 

Stock Options

 

On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 125,000 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 1,625,000 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of December 31, 2023 there were 359,125 options outstanding under the 2010 Option Plan.

 

On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan has a maximum of 1,250,000 shares authorized with similar terms and conditions to the 2010 Option Plan. As of December 31, 2023 there were 941,875 options outstanding under the 2020 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792)

 

 

As of December 31, 2023 and December 31, 2022, there were 1,301,000 and 1,014,438 options outstanding, respectively, under all the option plans.

 

Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.

 

We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2023, we had approximately $93,887 unrecognized stock-based compensation.

 

Stock option transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   1,014,438   $5.61    893,438   $6.80 
Granted   233,125    0.68    233,125    2.26 
Exercised   -    -    -    - 
Forfeited or Cancelled   (10,938)   1.35    (112,125)   16.19 
Outstanding at End of Year   1,301,000    4.50    1,014,438    5.61 
Options Exercisable at Year-End   1,260,375    4.62    959,750    5.61 
Weighted-Average Fair Value of Options Granted During the Year  $0.34        $0.92      

 

Information with respect to stock options outstanding and exercisable at December 31, 2023 is as follows:

 

    Options Outstanding   Options Exercisable 
Range of
Exercise
Prices		   Number
Outstanding at
December 31,
2023		   Weighted-
Average
Remaining
Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.32 - $17.76     1,301,000    6.5   $4.50    1,260,375   $4.62 

 

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   1.00%

 

 

Warrant transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   6,233,660   $2.66    872,259   $3.04 
Granted   11,250    0.72    5,616,224    2.96 
Exercised   (945,900)   1.40    (8,214)   2.80 
Forfeited or Cancelled   (245,114)   3.34    (246,609)   2.80 
Outstanding at End of Year   5,053,896    2.84    6,233,660    2.66 
Warrant Exercisable at Year-End   5,053,896    2.84    6,233,660    2.66 
Weighted-Average Fair Value of Warrants Granted During the Year  $0.24        $0.72 - $2.53       

 

Information with respect to warrants outstanding and exercisable at December 31, 2023 is as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices		   Number
Outstanding
at
December 31,
2023		   Weighted-
Average Remaining Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable
at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.68 - $13.20    6,233,660    3.4   $2.84    6,233,660   $2.84 

 

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   1.5 yrs    1.5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   0.18 - 1.00%

 

 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 7 INCOME TAXES

 

U.S. Federal Corporate Income Tax

 

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2023   2022 
Tax Operating Loss Carryforward - USA  $14,800,000   $11,800,000 
Other   -    - 
Valuation Allowance - USA   (14,800,000)   (11,800,000)
Deferred Tax Assets, Net  $-   $- 

 

The valuation allowance increased approximately $1.0 million, primarily as a result of the increased net operating losses of our U.S.- based segment.

 

As of December 31, 2023, we had federal net operating loss carryforwards for income tax purposes of approximately $35 million which will begin to expire in 2025. We also have Arizona net operating loss carryforwards for income tax purposes of approximately $ 2.0 million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.

 

Year Ending  Net Operating   Year of
December 31,  Loss:   Expiration
2023  $3,000,000   2043
2022   3,000,000   2042
2021   1,000,000   2041
2020   590,000   2040
2019   260,000   2039
2018   160,000   2038
2017   140,000   2037
2016   1,640,000   2036
2015   3,400,000   2035
2014   5,230,000   2034
2013   5,600,000   2033
2012   2,850,000   2032
2011   2,427,000   2031
2010   1,799,000   2030
2009   1,750,000   2029
2008   1,308,000   2028
2007   429,000   2027
2006   476,000   2026
2005   414,000   2025

 

Taiwan (Republic of China) Corporate Tax

 

Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year.

 

According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.

 

 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS (LOSS) PER SHARE
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE

NOTE 8 EARNINGS (LOSS) PER SHARE

 

The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”

 

Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the years ended December 31, 2023 and 2022 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended December 31, 2023 and 2022.

 

If we did not have net losses in 2023 and 2022 we would have had an additional amount of dilutive securities convertible at less than the then fair market value of the common stock. These amounts would have been 90,000 and 90,000, respectively.

 

   December 31,
2023		   December 31,
2022		 
         
Basic EPS          
Net Loss  $(3,235,124)  $(3,345,270)
Weighted Average Shares   15,973,422    12,840,598 
Basic Loss Per Share  $(0.20)  $(0.26)

 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.1
CONTINGENT LIABILITIES—TAIWAN
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
CONTINGENT LIABILITIES—TAIWAN

NOTE 9 CONTINGENT LIABILITIES—TAIWAN

 

Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Siemens, Shihlin Electric & Engineering Corporation, and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2023 is $320,237.

 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 10 SUBSEQUENT EVENTS
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Nature of Operations

Nature of Operations

 

Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provides true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Iveda also offers smart utility, smart sensors, gateways and trackers. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our IvedaAI® intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.

 

AI Functions

 

  ● Object Search
  ● Face Search (No Database Required)
  ●  Face Recognition (from a Database)
  ● License Plate Recognition (100+ Countries), includes make and model
  ● Intrusion Detection
  ● Weapon Detection
  ● Fire Detection
  ● People Counting
  ● Vehicle Counting
  ● Temperature Detection
  ● Public Health Analytics (Facemask Detection)
  ● QR and Barcode Detection

 

Key Features

 

  ● Live Camera View
  ● Live Tracking
  ● Abnormality Detection – Vehicle/Person wrong direction detection
  ● Vehicle/Person Loitering Detection
  ● Fall Detection
  ● Illegal Parking Detection
  ● Heatmap Generation

 

IvedaAI consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.

 

IvedaAI works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.

 

Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.

 

 

We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

Iveda’s Cerebro is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.

 

IvedaSPS is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.

 

In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.

 

Utilus is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:

 

  ● Government or large-scale city deployments
  ● Supporting and Improving City Services
  ● Reducing Emergency Response Times
  ● Crime& Hazard Protection
  ● Monitoring and Improving Air Quality
  ● Sound Detection
  ● Traffic Monitoring and Mobility as a Service
  ● Data Analytics and Monetization Opportunities

 

vumastAR is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:

 

  ● Quality and Maintenance Exams: vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.
  ● Factory and Line Work: Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting.
  ● Pharma: Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error.
  ● Supply Chain: Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes.
  ● Manufacturing: Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data
  ● Transportation: Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.
  ● Retail: Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.

 

vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.

 

IvedaXpress is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.

 

 

Iveda Smart UVC is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.

 

Iveda’s Smart Drones are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.

 

Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.

 

Key Features of Iveda’s Smart Drone:

 

Fully Autonomous

Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging

Easy operation and 24-7 flight mission

 

Intelligent Computing

Live video streaming - real-time object recognition and tracking

Onboard (edged) AI and data analysis

 

Safety Design

Multiply redundant and fail-safe systems

Weather resistant industrial grade systems (IP54)

Designed and made in Taiwan (MIT)

 

Skywatch

Planning and editing real-time/timed missions

User/Group permission control & flight data management

Failsafe alarm and FPV gimbal control

 

Insight

Automated orthorectified service of imagery (2D/3D)

AI technology for inspecting natural disaster, vehicle & pedestrian tracking, and energy facilities inspection.

Visualizing geographic data and analysis report

 

  ●

Propellers: 8 (multiply redundant)

  ●

Diagonal Footprint: 29.76″ / 756 mm

  ●

Weight: 14.1lbs / 6.4 Kg

  ●

Hover time: 30 mins

  ●

Wind tolerance: Beaufort scale – 6

  ●

IP rating: IP54

  ●

Camera sensor: Dual RGB, IR/thermal

  ● Network: 5G/4G LTE and 2.4G Wi-Fi

 

The Smart Utility Cabinet gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.

 

Vemo Body Camera streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.

 

IvedaCare, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.

 

Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we previously only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras, which are a global standard for the interface of IP-based physical security products.

 

 

In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.

 

MEGAsys, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. MEGAsys combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.

 
Consolidation

Consolidation

 

Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.

 

 
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the years ended December 31, 2023 and 2022.

 
Basis of Accounting

Basis of Accounting

 

Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

 
Revenue and Expense Recognition

Revenue and Expense Recognition

 

The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.

 

The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.

 

 

The Company sells its products and services primarily to municipalities and commercial customers in the following manner:

 

  ● The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.

 

Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.

 

Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable and the amount can be reliably estimated.

 

  ● The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.
     
  ● Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period.

 
Comprehensive Loss

Comprehensive Loss

 

Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.

 
Concentrations

Concentrations

 

Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.

 

Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.

 

 

Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. 50% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was 52% of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.

 

Revenue from two customers out of 65 total customers represented approximately 48% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with 25%, 2) Chicony Power Technology Co Ltd with 23%, (both Taiwan companies).

 

Revenue from two customers out of 42 total customers represented approximately 52% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with 21%, 2) Chicony Power Technology Co Ltd with 31%, (both Taiwan companies).

 

No other customers represented greater than 10% of total revenues in years ended December 31, 2023 and 2022.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 
Accounts Receivable

Accounts Receivable

 

We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of December 31, 2023 and 2022, respectively, an allowance for uncollectible accounts of $0 and $0 was deemed necessary for our U.S.-based segment.

 
Deposits – Current

Deposits – Current

 

Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.

 
Other Current Assets

Other Current Assets

 

Other current assets represent cash paid in advance to vendors for service coverage extending into subsequent periods.

 
Inventories

Inventories

 

We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $0 and $0, as of December 31, 2023 and 2022, respectively.

 
Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of three to seven years. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the years ended December 31, 2023 and 2022 was $19,753 and $17,801, respectively.

 

 
Deposits—Long-Term

Deposits—Long-Term

 

Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.

 
Income Taxes

Income Taxes

 

Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2023, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2023.

 

We are subject to U.S. federal income tax as well as state income tax.

 

Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2019 to 2022 are open to examination by federal, local, and state authorities.

 

Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2019 to 2022 are open to examination by the Taiwan Ministry of Finance.

 
Restricted Cash

Restricted Cash

 

Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.

 
Accounts and Other Payables

Accounts and Other Payables

 

SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
Accounts Payable  $179,949   $360,395 
Accrued Expenses   900,928    1,243,027 
Deferred Revenue and Customer Deposits   29,211    35,305 
Accounts and Other Payables  $1,110,087   $1,638,727 

 
Deferred Revenue

Deferred Revenue

 

Advance payments received from customers on future installation projects are recorded as deferred revenue.

 

 
Stock-Based Compensation

Stock-Based Compensation

 

On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $104,600 and $120,581 of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2023 and December 31, 2022. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.

 
Segment Information

Segment Information

 

We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:

 

   December 31, 2023 
   Net Revenue   Net Assets (Liabilities) 
United States  $852,136   $5,364,184 
Republic of China (Taiwan)  $5,648,982   $907,113 

 

Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.

 

We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.

 
Reclassification

Reclassification

 

Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.

 
New Accounting Standards

New Accounting Standards

 

No new relevant accounting standards
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

SCHEDULE OF ACCOUNTS AND OTHER PAYABLES

   December 31, 2023   December 31, 2022 
         
Accounts Payable  $179,949   $360,395 
Accrued Expenses   900,928    1,243,027 
Deferred Revenue and Customer Deposits   29,211    35,305 
Accounts and Other Payables  $1,110,087   $1,638,727 
SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS

   December 31, 2023 
   Net Revenue   Net Assets (Liabilities) 
United States  $852,136   $5,364,184 
Republic of China (Taiwan)  $5,648,982   $907,113 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.1
SHORT-TERM AND LONG-TERM DEBT (Tables)
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
SCHEDULE OF SHORT-TERM DEBT

The short-term debt balances were as follows:

 

   December 31, 2023   December 31, 2022 
         
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.   88,032    - 
Loan from HuaNam Bank at 3.44% interest rate per annum. Due in May 2024.   97,777    - 
Loan from ChangHwa Bank at 3% interest rate per annum. Due in November 2024.   162,962    - 
Loan Agreement with Shanghai Bank at 2.94% interest rate per annum due September 2023.   -    398,409 
Balance at end of period  $348,771   $398,409 
SCHEDULE OF LONG-TERM DEBT

The Long-term debt balances were as follows:

SCHEDULE OF LONG-TERM DEBT

 

Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026   -    256,184 
Current Portion of Long-term debt   -    (65,408)
Balance at end of period  $-    190,776 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK OPTION PLAN AND WARRANTS (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION TRANSACTIONS

Stock option transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   1,014,438   $5.61    893,438   $6.80 
Granted   233,125    0.68    233,125    2.26 
Exercised   -    -    -    - 
Forfeited or Cancelled   (10,938)   1.35    (112,125)   16.19 
Outstanding at End of Year   1,301,000    4.50    1,014,438    5.61 
Options Exercisable at Year-End   1,260,375    4.62    959,750    5.61 
Weighted-Average Fair Value of Options Granted During the Year  $0.34        $0.92      
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE

Information with respect to stock options outstanding and exercisable at December 31, 2023 is as follows:

 

    Options Outstanding   Options Exercisable 
Range of
Exercise
Prices		   Number
Outstanding at
December 31,
2023		   Weighted-
Average
Remaining
Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.32 - $17.76     1,301,000    6.5   $4.50    1,260,375   $4.62 
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL

The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   5 yrs    5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   1.00%
SCHEDULE OF WARRANT TRANSACTIONS

Warrant transactions during 2023 and 2022 were as follows:

 

   2023   2022 
   Shares   Weighted-
Average
Exercise
Price		   Shares   Weighted-
Average
Exercise
Price		 
                 
Outstanding at Beginning of Year   6,233,660   $2.66    872,259   $3.04 
Granted   11,250    0.72    5,616,224    2.96 
Exercised   (945,900)   1.40    (8,214)   2.80 
Forfeited or Cancelled   (245,114)   3.34    (246,609)   2.80 
Outstanding at End of Year   5,053,896    2.84    6,233,660    2.66 
Warrant Exercisable at Year-End   5,053,896    2.84    6,233,660    2.66 
Weighted-Average Fair Value of Warrants Granted During the Year  $0.24        $0.72 - $2.53       
SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION

Information with respect to warrants outstanding and exercisable at December 31, 2023 is as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Range of
Exercise
Prices		   Number
Outstanding
at
December 31,
2023		   Weighted-
Average Remaining Contractual
Life		   Weighted-
Average
Exercise
Price		   Number
Exercisable
at
December 31,
2023		   Weighted-
Average
Exercise
Price		 
$ 0.68 - $13.20    6,233,660    3.4   $2.84    6,233,660   $2.84 
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE

The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.

 

   2023   2022 
Expected Life   1.5 yrs    1.5 yrs 
Dividend Yield   0%   0%
Expected Volatility   90%   90%
Risk-Free Interest Rate   4.00%   0.18 - 1.00%
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:

 

   2023   2022 
Tax Operating Loss Carryforward - USA  $14,800,000   $11,800,000 
Other   -    - 
Valuation Allowance - USA   (14,800,000)   (11,800,000)
Deferred Tax Assets, Net  $-   $- 
SUMMARY OF OPERATING LOSS CARRYFORWARDS

Year Ending  Net Operating   Year of
December 31,  Loss:   Expiration
2023  $3,000,000   2043
2022   3,000,000   2042
2021   1,000,000   2041
2020   590,000   2040
2019   260,000   2039
2018   160,000   2038
2017   140,000   2037
2016   1,640,000   2036
2015   3,400,000   2035
2014   5,230,000   2034
2013   5,600,000   2033
2012   2,850,000   2032
2011   2,427,000   2031
2010   1,799,000   2030
2009   1,750,000   2029
2008   1,308,000   2028
2007   429,000   2027
2006   476,000   2026
2005   414,000   2025
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS (LOSS) PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED

   December 31,
2023		   December 31,
2022		 
         
Basic EPS          
Net Loss  $(3,235,124)  $(3,345,270)
Weighted Average Shares   15,973,422    12,840,598 
Basic Loss Per Share  $(0.20)  $(0.26)
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]    
Accounts Payable $ 179,949 $ 360,395
Accrued Expenses 900,928 1,243,027
Deferred Revenue and Customer Deposits 29,211 35,305
Accounts and Other Payables $ 1,110,087 $ 1,638,727
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
UNITED STATES  
Net Revenue $ 852,136
Net Assets (Liabilities) 5,364,184
Republic of China (Taiwan) [Member]  
Net Revenue 5,648,982
Net Assets (Liabilities) $ 907,113
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
TWD ($)
Product Information [Line Items]      
Cash, FDIC Insured Amount     $ 3
Allowance for uncollectible accounts $ 0 $ 0  
Inventory reserve 0 0  
Depreciation expense 19,753 17,801  
Stock option compensation $ 104,600 $ 120,581  
Minimum [Member]      
Product Information [Line Items]      
Useful life 3 years   3 years
Maximum [Member]      
Product Information [Line Items]      
Useful life 7 years   7 years
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Chunghwa Telecom [Member]      
Product Information [Line Items]      
Percentage of concentration risk 50.00% 52.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | YOU MING HUEI CO. LTD [Member]      
Product Information [Line Items]      
Percentage of concentration risk 25.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Chicony Power Technology [Member]      
Product Information [Line Items]      
Percentage of concentration risk 23.00% 31.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Chunghwa Telecom [Member]      
Product Information [Line Items]      
Percentage of concentration risk   21.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Taiwan Co [Member]      
Product Information [Line Items]      
Percentage of concentration risk 48.00% 52.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Other Customers [Member] | Minimum [Member]      
Product Information [Line Items]      
Percentage of concentration risk 10.00% 10.00%  
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF SHORT-TERM DEBT (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]    
Short term debt $ 348,771 $ 398,409
Shanghai Bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short term debt 88,032
Hua Nam Bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short term debt 97,777
Chang Hwa Bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short term debt 162,962
Shanghai Bank One [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Short term debt $ 398,409
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical)
 12 Months Ended
Dec. 31, 2023
Shanghai Bank [Member]  
Debt Instrument [Line Items]  
Debt instrument, maturity date Due in January 2024 and July 2024
Shanghai Bank [Member] | Minimum [Member]  
Debt Instrument [Line Items]  
Interest rate 1.00%
Debt instrument, maturity date February 2024
Shanghai Bank [Member] | Maximum [Member]  
Debt Instrument [Line Items]  
Interest rate 3.06%
Debt instrument, maturity date November 2026
Hua Nam Bank [Member]  
Debt Instrument [Line Items]  
Interest rate 3.44%
Debt instrument, maturity date Due in May 2024.
Chang Hwa Bank [Member]  
Debt Instrument [Line Items]  
Interest rate 3.00%
Debt instrument, maturity date Due in November 2024.
Shanghai Bank One [Member]  
Debt Instrument [Line Items]  
Interest rate 2.94%
Debt instrument, maturity date due September 2023.
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF LONG-TERM DEBT (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]    
Current portion of long term debt $ (65,408)
Long term debt 190,776
Shanghai Bank [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Loans $ 256,184
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) - Shanghai Bank [Member]
 12 Months Ended
Dec. 31, 2023
Debt Instrument [Line Items]  
Debt instrument, maturity date, description Due in January 2024 and July 2024
Minimum [Member]  
Debt Instrument [Line Items]  
Debt interest rate 1.50%
Debt instrument, maturity date, description February 2024
Maximum [Member]  
Debt Instrument [Line Items]  
Debt interest rate 2.97%
Debt instrument, maturity date, description November 2026
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.1
PREFERRED STOCK (Details Narrative) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]    
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, par value $ 0.00001 $ 0.00001
Series A Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 1,250,000  
Series B Preferred Stock [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 500 500
Preferred stock, par value $ 0.00001 $ 0.00001
Maximum [Member]    
Class of Stock [Line Items]    
Preferred stock, shares authorized 12,500,000  
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.1
EQUITY (Details Narrative) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Common stock, shares authorized 100,000,000 100,000,000
Common stock, par value $ 0.00001 $ 0.00001
Maximum [Member]    
Common stock, shares authorized 37,500,000  
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Shares, Outstanding at Beginning of Year 1,014,438 893,438
Weighted-Average Exercise Price, Outstanding at Beginning of Year $ 5.61 $ 6.80
Shares, Granted 233,125 233,125
Weighted-Average Exercise Price, Granted $ 0.68 $ 2.26
Shares, Exercised
Weighted-Average Exercise Price Exercised
Shares, Forfeited or Canceled (10,938) (112,125)
Weighted-Average Exercise Price, Forfeited or Canceled $ 1.35 $ 16.19
Shares, Outstanding at End of Year 1,301,000 1,014,438
Weighted-Average Exercise Price, Outstanding at End of Year $ 4.50 $ 5.61
Shares, Options Exercisable at End of Year 1,260,375 959,750
Weighted-Average Exercise Price, Options Exercisable at End of Year $ 4.62 $ 5.61
Weighted-Average Fair Value of Options Granted During the Period $ 0.34 $ 0.92
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details)
 12 Months Ended
Dec. 31, 2023
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Range of Exercise, Lower Range Limit $ 0.32
Range of Exercise, Upper Range Limit $ 17.76
Options Outstanding, Number Outstanding | shares 1,301,000
Options Outstanding, Weighted- Average Remaining Contractual Life 6 years 6 months
Options Outstanding, Weighted-Average Exercise Price $ 4.50
Options Exercisable, Number Exercisable | shares 1,260,375
Options Exercisable, Weighted-Average Exercise Price $ 4.62
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Expected life 5 years 5 years
Dividend yield 0.00% 0.00%
Expected volatility 90.00% 90.00%
Risk-Free interest rate 4.00% 1.00%
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WARRANT TRANSACTIONS (Details) - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares, Outstanding at Beginning of Year 6,233,660 872,259
Weighted-Average Exercise Price, Outstanding at Beginning of Year $ 2.66 $ 3.04
Shares, Granted 11,250 5,616,224
Weighted-Average Exercise Price, Granted $ 0.72 $ 2.96
Shares, Exercised (945,900) (8,214)
Weighted-Average Exercise Price, Exercised $ 1.40 $ 2.80
Shares, Forfeited or Canceled (245,114) (246,609)
Weighted-Average Exercise Price, Forfeited or Canceled $ 3.34 $ 2.80
Shares, Outstanding at End of Year 5,053,896 6,233,660
Weighted-Average Exercise Price, Outstanding at End of Year $ 2.84 $ 2.66
Shares, Options Exercisable at End of Year 5,053,896 6,233,660
Weighted-Average Exercise Price, Options Exercisable at End of Year $ 2.84 $ 2.66
Weighted-Average Fair Value of Options Granted During the Period $ 0.24  
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-Average Fair Value of Options Granted During the Period   0.72
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-Average Fair Value of Options Granted During the Period   $ 2.53
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) - $ / shares
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants Outstanding, Number Outstanding 5,053,896 6,233,660 872,259
Warrants Outstanding, Weighted-Average Exercise Price $ 2.84 $ 2.66 $ 3.04
Warrants Exercisable, Number Exercisable 5,053,896 6,233,660  
Warrants Exercisable, Weighted-Average Exercise Price $ 2.84 $ 2.66  
Warrant [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants Outstanding, Number Outstanding 6,233,660    
Warrants Outstanding, Weighted-Average Remaining Contractual Life 3 years 4 months 24 days    
Warrants Outstanding, Weighted-Average Exercise Price $ 2.84    
Warrants Exercisable, Number Exercisable 6,233,660    
Warrants Exercisable, Weighted-Average Exercise Price $ 2.84    
Minimum [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Range of Exercise Prices 0.68    
Maximum [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Range of Exercise Prices $ 13.20    
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected Life 5 years 5 years
Dividend Yield 0.00% 0.00%
Expected Volatility 90.00% 90.00%
Risk-Free Interest Rate 4.00% 1.00%
Warrant [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected Life 1 year 6 months 1 year 6 months
Dividend Yield 0.00% 0.00%
Expected Volatility 90.00% 90.00%
Risk-Free Interest Rate 4.00%  
Warrant [Member] | Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Risk-Free Interest Rate   0.18%
Warrant [Member] | Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Risk-Free Interest Rate   1.00%
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK OPTION PLAN AND WARRANTS (Details Narrative) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 15, 2020
Dec. 31, 2012
Dec. 31, 2011
Jan. 18, 2010
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Options outstanding 1,301,000 1,014,438 893,438        
Unrecognized stock- based compensation $ 93,887            
2010 Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized under plan         1,625,000 375,000 125,000
Options outstanding 359,125            
2020 Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Options outstanding 941,875            
2020 Plan [Member] | Maximum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized under plan       1,250,000      
Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Options outstanding 1,301,000 1,014,438          
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Tax Operating Loss Carryforward - USA $ 14,800,000 $ 11,800,000
Other
Valuation Allowance - USA (14,800,000) (11,800,000)
Deferred Tax Assets, Net
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Income Tax Disclosure [Abstract]                                      
Net operating loss $ 3,000,000 $ 3,000,000 $ 1,000,000 $ 590,000 $ 260,000 $ 160,000 $ 140,000 $ 1,640,000 $ 3,400,000 $ 5,230,000 $ 5,600,000 $ 2,850,000 $ 2,427,000 $ 1,799,000 $ 1,750,000 $ 1,308,000 $ 429,000 $ 476,000 $ 414,000
Year of Expiration 2043 2042 2041 2040 2039 2038 2037 2036 2035 2034 2033 2032 2031 2030 2029 2028 2027 2026 2025
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAXES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2006
Dec. 31, 2005
Operating Loss Carryforwards [Line Items]                                      
Net operating loss carryforwards $ 3,000,000 $ 3,000,000 $ 1,000,000 $ 590,000 $ 260,000 $ 160,000 $ 140,000 $ 1,640,000 $ 3,400,000 $ 5,230,000 $ 5,600,000 $ 2,850,000 $ 2,427,000 $ 1,799,000 $ 1,750,000 $ 1,308,000 $ 429,000 $ 476,000 $ 414,000
Taiwan corporate tax rate Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year                                    
ARIZONA                                      
Operating Loss Carryforwards [Line Items]                                      
Net operating loss carryforwards $ 2,000,000.0                                    
Domestic Tax Authority [Member]                                      
Operating Loss Carryforwards [Line Items]                                      
Net operating loss carryforwards $ 35,000,000                                    
Operating loss carryforwards, limitations on use which will begin to expire in 2025.                                    
U.S. - Based Segment [Member]                                      
Operating Loss Carryforwards [Line Items]                                      
Valuation allowance increased $ 1,000,000.0                                    
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Basic EPS    
Net Loss $ (3,235,124) $ (3,345,270)
Weighted Average Shares 15,973,422 12,840,598
Basic Loss Per Share $ (0.20) $ (0.26)
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS (LOSS) PER SHARE (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]    
Dilutive securities convertible $ 90,000 $ 90,000
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.1
CONTINGENT LIABILITIES—TAIWAN (Details Narrative)
 12 Months Ended
Dec. 31, 2023
USD ($)
Megasys [Member]  
Financial exposure contingent future payments $ 320,237
EXCEL 61 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
AH+^V>SNX"-6)T?;JQ*V <-)NKW.]&^DG MBA.6=!*11N"+[#9?DQ+NF2<)N@M!-WSL5B!W]+R[]+?:U?1'A%HB?TY-G,CTTN[$1IBY=\)ZVT M$\0GEA[+0/*1QIY8,:_7PHU/%W?JYN+KQ:=#/)OUUIF_JM.C43H\.*9/%%H<'Z;#TT,"X?;25S(]YW/::VK'7J;!CQT? MGJ:O3D?T^=7@A&*- W79-1 04E!I8K?]LZK#:V1KY=IF# RRLH6UI%%WGFM# M3JVP749":55,< YSXCEVAL4I=/]^DX7,G MP-5F:VOHX"AKK>59.L631U3W9+-SAACO6"C[6@:A_XCN1 M;$,?:3/;3!DYPFG.%5/OHG5GGC_%C*9EPB"'_OCGTM MG,!$.@=M_YF<@?5=$."I#<=@B(!O7A(I/>(JC1YRSBUJNC)1P[V'24W.5ZFZ M0PN^8]G["=LEI;T)0MN]MG>R^1>EU=E'L*%G?E/NJE?NVYU'J-:.ME=K;_2D MQ+WH[HAVK^?XB9+M)EUU+IJ:1(+EC%RXFJ'QK_@#/-S69@7"&,FFL9Z_]F84 MZINC[?7-3_JA]^1ZKR2>)97T'H+_5'-_ NF!OL^>:-+MF\Q^].\#\9W+Y]Q^ MSB_+/Q7DO_7_TM*9_/M"X7'Y9YH^\A$%W*,VI5<'>R<$!QKYEX_DC[9>\K\V M-*Y;VHK\<:Y)(1L\0+]/Z[IU?V _^]/_?;_4$L#!!0 ( ."#@5@?V#3\ M80, *H' 9 >&PO=V]R:W-H965TA_Z MDHSMF3/'/AY/_\3%%[D'4.2]R$LYL/9*'1X=1V9[**A\X $@';@15ZCZ.6]C<.GQB;Z)VL M.?^B!\EF8+F:$.20*8U \?<&$>2Y!D(:?U:85IU2!WZT+^C/9N^XES65$/'\ M-[91^X'5M<@&MO28JP4_O4"U'T,PX[DT7W*J?%V+9$>I>%$%(X."E><_?:_. MX4<"_"K -[S/B0S+)ZKHL"_XB0CMC6C:,%LUT4B.E5J45 E<91BGANGJ]35< M?":S9Y(FXVGRG$3A=$G"*)JMILMD.B;SV22)DC@E=TNZSD'>]QV%B76XDU5) M1N2>#YYY:7:2Q*7&]C\'37S7#V[@!?4Q M! 8O^ Y>F&7\6"I6[LBP!K^\I/7=G^]P;99LVW>0A^FT4O\M)K$6K5*J92$TRC M29Q>HWT3^#KM2[;&[6P-U 2*-8A:%_+/&;]1G;,D<_I5WR;R,_$Z/;O7[*$5 MM%T[Z+6TDSC"AL3O^/1(5*+GNG;/[Q+/]IN![?H=S+4%(=!G 6]0'H'0J3UZ5C2DYF%[GFN[W8ZQVT'7[O@= MK:;MM=M-A9P.*ZQ8 G?DFC/2JJ?*7:B MY;UQ:S>[=J_KH]US.RAP<%50Y\/[B?=G9[J$).:VG)_2>K9N1.'Y_?WF?NYB MKU3L6"E)#EL,=1\Z*(8X=X;S0/&#>8W77.%E->8>FRD([8#K6\[59: 3U.UY M^!=02P,$% @ X(.!6 *>2PB) P WP@ !D !X;"]W;W)K&ULE5;;DMI&$'WG*[KDK,NN MVYK8$J6-@0U]YJP8&Y]^G3WF6GUMD*^J!A1P_+ [PENU<$83"0+(5[,Y+=EWW(-(4PQT@:!T=\KWF":&B"B\?<. MTZI<&L/#\1[]MHB=8EDPA3XXF7\;"B7:XHQ+7/X/K^7 ON(X53/@2E\< #I&LF/I[IB/_(N(8(QL" MKPZ^ZP<7\((J\J# "\[B+32,$Q6E0N42X<_A0FE)*OGK5+0E5G@:R]R<:[5A M$?8MNAH*Y2M:@X\?O);[Y0+3L&(:7D(?S&ZFD_&WNPD\WL)!O4R%3E&]"':: MZCS&FHJ%U V-,B-54VH6+&4\0@5;I.PP!2N1TA56U[#G4_N13XVJA-D"954I M>+_BU^X$X["2(H-9S/@Z9@F,&'\!IL&[:@2VV[J"A!,35!HDTP@;,F>Z![MB?1;=?;[?:1W8TA,=VR-\N]V8-X+7-4VGHMO]YM54Z':XE(#Z&FMT'' M/\;BV]T0EH0TPXVN< (;&A!T._70[=9&93'-::3PQ,JD-!%+^ 6"L$-,/3,J M#\,%R38KR39_6K+';\HIQ5[$.J_8.\'7/R'8([T>DRGRJTY)I,CTD0@5>';3 MO:*D4K[;5V^:+%)_BPOY)J&/'SJ^YWTYJFO+6#9;=:\3_G^WA<]W3LZ!W^12 M&K$\T7TVC8^*_2Y3#?C4:E*I._#YDC(:X'5=TD;KI"*<@Z:3H5P7K55!)'*N MR_Y3K5;=>U@VK;?C9>N_9W*=4$)27)&I:[=)$+)LI^5$BTW1PA9"4T,LAC%] M@: T!VA_)83>3XR#ZIMF\"]02P,$% @ X(.!6.>/H.6V!0 FA$ !D M !X;"]W;W)K&ULO5AM;]LV$/ZN7W'PNB$%9%GO MMK+$@-_2&DWBP'::%<,^,!)M"Y$ECZ3C]-_O2,F*$MAJVFY#X(A'\1X>[YZ[ MDW2VR]@#7U$JX&F=I/R\L1)B<]IJ\7!%UX0;V8:F>&>1L341*+)EBV\8)9%2 M6BKH2< M:'7/-F1)9U3<;FX82JT2)8K7-.5QE@*CB_-&SSKM!W*]6O YICM>&8,\R7V6 M/4AA')TW3&D036@H) +!RR,=T"210&C&WP5FH]Q2*E;'>_0+=78\RSWA=) E M=W$D5N>-3@,BNB#;1$RSW4=:G,>3>&&62K\4%'H'%.P"P5;V9UOI*P<$D&Z9RS; 9.K$4T.U%&5-AH7IS(H,\'P;HQZ MHCN;3P:?8'(S'T^NX>:R=PV]ZR'<]:;3WO5\!B=S(P2B,:O01HH96EJ?;>U+Y=BSBDH0&.I8-MVDX-GE,>W5%X MSK&CKPBCS3Z&-((;\A69)J#'&$F75(W_[-USP9 V?QTZ?8[M'L:6J73*-R2D MYPW,%4[9(VUT?_O%\LW?:RQW2\O=.O3N;/!Q-+R]','D EX$<(Y1F_4&&;%:&FR-MGD3BXLD5DH :1F4Z)8NNV;NM/V4-NW(? "O8TH2K=T5>^1 M,JRL<$%B!I])LJ5R]SWTW@W#/(YB17/#WJ%#'%== AMJZ.J5=/5^C*Z3V_EL MCO5F?/U!E9W1'Z/I8#SK]2]'A]A;N\MA]H[3O&_A@;5=+%;81_@&&P*(#+AD M-F2%-[)JI-#!]*7CL?C0]3UE90&"F+^-YS6'+*-O;ZEJ3C:8+6-ME]AFV]X&-N"RJ[#+>$&3;[NG4A='3Y*W"'L9+RAXX&G#^#&. M*%+U2TR3"$SX5?Z>%W[.$B1^$HNO$,B;\I\VC?E#\X)1"F,T"+-!P%3ZQ35, MN<92EQH:M$L:M-],@^)IXIO=J1;Q<'[?$=FPA?83C>F8A?]N3_)UV6!\W\14 MLPW?AT[;UFTO0-$Q3+?L21;F)&:F:;1M\'3?0CW;18V@VI1. M?3 XR4;#NN M"2<=W;9Z?\=-/*CZG]P#&U,C)5XI23_TKWPL@C'OPO66KUB.'@EV_PY'^583T_VM@VNL&!M_?P-[BH:,M MS,+G$/S])VW,-*Q.32]K5=Z7UY0MU5>OG[]O/R_*O% M%6%8ZCDD=(&J6(/P(97E7P)R060;]?9]GPE\EU?#%24197(!WE]DF=@+3SS^)GQV$YWK_0WLT&T\)8FF>E5 M-]9N[^IU$V\P%>96;3&CD972J;!DZG7=;#6*91Z4)G7/<9KU5,BLVN_FV+/N M=]7.)C+#9PUFEZ9"_[S'1.U[5;=: %.YWE@&ZOWN5JQQAO9E^ZS)JI?O!?M#GCOELA &!RKY*I=VTZNVJ[#$E=@E=JKVG_&83RXP M5HG)_V%_\ W(.=X9J])C,"E(979XBK=C'3.)GQHLRLIE%)<;8_>AI,'B.8AW]%,_@P%XL$S<=NW1(U M.]3C(\W]@<9[A\;UX%%E=F,@RI:X_)6@3II*85XA[-Z[RCC$^!9\MP:>X_E7 M^/PR43_G\]]+-(M5BC 7;S"4)DZ4V6F$O\.%L9I:XY]+.1\8@\N,O%WNS%;$ MV*O2?C"H?V"U__MO;M/YXXK>H-0;7&/OSP:?H^'+.(+) PRCAV@ZC8:\3!#. M9M%\!N'3$,:C\'XT'LU'T>R2_*L37)8_QW2K-.W.RE*N5J@QB]' NT>,8.5 MS$062Y& L<(B[4T+L=#ZI\S6(%*URZP!D2W!;A L59KVBS2@5B",P>-8(L5" M)M)*//J27ZQQ*6UNTG&CA65"6B)3R>GI[-D+S;3"LB_-S3L/-87E\>_1TPH+ M RN5T-EC[J"H:>6_U;3"K'\/I*S?'R?1K.!U> M[+3_A;CRBD+S^<$EYMQ.!<]'U(K*$&.ZH$KRP<"K< ?1VU;JO*"'Y;H!GVN6 MU\US I]1[U?,8\P%]QQS&7.@T2D1AQ"W UZS0/P.(VUP3TB;D1:M>HFT&&D2 M=_.$-1EKD(:@G,]O,!9 H^;Y)18PYA/6//FQ?CIQ,M;C'!S*H>8[[0+C+)P6!%X1Z7$63A."5K- . >G 0'U MZ!%I7&JY^ME-E*)>Y_>M@9B/AL.E5*+EE1X>;K*3^^%[X%'HMV M14VF#W?LP;!JF]]K"V7IELQ?-_19@IH=:'REE"T,GJ#\T.G_"U!+ P04 M" #@@X%8)"?CGI4" "0!0 &0 'AL+W=OT@4H!T1:(4D79]F/9@DH-$36)JF])] M^]D)I$RB/.V%^.R[G__GXZZ_8_Q%I(@2WHN\% ,CE7)S8UDB3K&@HL,V6*J3 M%>,%EE3CG(+9%0?F?(>9L M-S M0'Q5DA6[(.5 M@B(KZR]]W[_#44#/_B2 [ -(I;N^J%(YII+Z?,X1?@*4$-BK)0>60G"6.,>Z ZYA ;.*>X;E-UF[%3J3_+[5,(USCN-TXUS(S8TQH&A.D,@?T/#__;% MN;2_GQ'K-6*]M69JHDR9$/ 5+ER3N%W3(1ZT:]/UNB:YLJ'= M>J[Z!A,(WI"K,5"70X#3-:^O7-,C!!QB]CS;[%[W]O@*^U$Z1;0[Q*[9:G4) M[5//;AUU28%\7&PO=V]R:W-H965TF*:(-I$1D!4RH1E,.1)%FA+^? 4)VXT,V]@/ MS.AZ(_6 Z0USLH8YR$4^Y2HR&Y:8II )RC+$834R?/LR<'5^F?"#PDX<])%V MLF3L00??XI%A:4&00"0U U'-%@)($DVD9#S6G$:SI 8>]O?LUZ5WY65)! 0L M^4ECN1D9?0/%L")%(F=L=P.UGZ[FBU@BRB_:5;FN9:"H$)*E-5@I2&E6M>2I MWH<#@-TY < U +\7X-0 IS1:*2MMA402;\C9#G&=K=ATI]R;$JW0:^4$P6=S=SY%_%Z+)_W& M.VZ\XY+/.<'G1Q$K,DFS-9JRA$84!/KM+X7DZG#]:;-7\77:^?2%NQ0YB6!D MJ!LE@&_!\#Y]L%WK:YO9_T3VPKK36'?>8M];%VA*GLDR@3:S%4.W9-#%8.O9 MO<&@,QB:VT,;QVF.:SF#;I/V0F"G$=CYET!>0(S&3ZI>"1!M BL&]V#E@64- M&ULK551;]HP$/XK5C9-19H:$B"D'40* M$"!2"R@)W<.T!Q,.8C6),]M ]^]G)Y"QE3)IVTOBL^_[[CO;=^X=*'OF"8! M+UF:\[Z6"%'8Y)K3 M*^<6S.G1G4A)#@N&^"[+,/L^@)0>^IJAG28"LDV$FM"=7H&W$()8%@LF+;UF M69,,' M(:2I(I(ROATYM3JD IZ/3^SC,G>9RPIS&-+T,UF+I*_9&EK#!N]2$=##%([Y M=!1?3%->?M'AZ-O44+SC@F9'L%20D;SZXY?C/IP!3/,-@'D$F*7N*E"IAP'OR9DL/ MN;-1:;MAZ$4ANGGPW8'_X$>^%S;0>!Z@>33U A3ZDYD_]H?N+$(3;SX)W,74 M'TJ6B3^?2=@(!"8I;_1T(<6JD'I\%#:HA)EO"#-,]$ASD7#DY6M8_TJ@RRSK M5,U3J@/S*N,(XEO4,CXBLVFVT#(YU:7/NJN)FLZP#VD._@DK0* MW"G!JG[WCMTQC9;5T_<7@G;JH)T_!G4Y!\'EQ2%X15(B"%R^!163=::@T[+: MAMV^+,&J)5A7)010[%8IB1'=H&%";EC;+KJ/9_.RO[U6VY:W8-H_6; OVL'67 MF73Y2BF MNUQ4G:F>K?NZ6[6SG^[5H_"(V9;D'*6PD=#F;5<&9U6CK0Q!B[*YK:B0K;(< M)O)M J8#H3J6FC)MG1:+0?7.($5, 9XS2MM#]^S:,0*.,TZ.Z7-H!]N.?8 MU]P#'NZY>(QP,/)XB 1;7[;&Y@6Q<-PA:?&WQ_;1P6\4 M4WG@_#$^F*PN6T8<$?.9(V,(JOX],9OY?HRDXOB5@;;R>\8=#W^_HE\GY!69 M!QHQF_O?O95T+UN#%EJQ-=WY\I[OO[&,4#?&<[@?)7_1/FMKM)"SBR0/LLXJ M@L +T__T.1/BH /&O^F LP[XO1VLK(/UW@Z=K$,G42:EDNA J*2CH>![).+6 M"BW^D8B9]%;TO3 >][D4ZJJG^LG1?#F=CN]_H+MK-)]\O9U<3^SQ[0*-;?MN M>;N8W'Y%L[N;B3WY,DEJ=1G[ZHE 0XSKNGY3T)GU@HN7A!&78=R12BIR%YM 71AM&09#\GV=>2)$R! M.EZZ;K!G54-$M3S[;UB8Y_VN5>%:TZH_,,P*7VU$#?D.:%SXON8J^A?9B35G ME<%BQU(S=Q=NW#U%B_A- M!S^2[D"%;Z8\)!J!0BN/1E&5FSWX= ;\?0 M%0L=-Z#BL4%B_[A;HFG\>NS;\LL$V7=GZ&9!]-D-9 4RH2'1"!1:>4 *GV*> MPV!.NK>8AE MP'8]I>\+FO&]:KM@CAMRGV]>M"N!/JY3IRXH&H%"*X])X8HP!E\),*A+ D4C M4&AE.0N7A+6VH=E*8-6M!-67?K6MK.K;+WUX3>D7K@;K_0!,AI]0P>OC.7DJ M@GHG*+3R6!1^"G?A,QO4$(&B$2BTLIR%(<+Z[Q2-,AO4$&5HE77BS0KP?Q@= M7!@=K# MCV;Z"$_>2P%JJJ#0RJ-3F"K+A-^9 NJ'0-$(%%I9SL(/6?JO1$UR/8,L9W'E MN6R_IQ'1!WZY/HFLZ&T"?F 7#T' 81 MZRH>Y\L+566N!R%FYV0)D9B9$QIB+KITH;(E!3R+06&@&IK65$/L1XK3B<=& MU.F0%0_\"$84L5488OJW!P'9=!5=>1D8^PN/RP'5Z2SQ B; 'Y8C*GIJQC+S M0XB83R)$8=Y5ONL7?;TA ?&*GSYL6*Z-I)0I(4^R$IAOO[!?Q>*%F"EFT"?!+W_&O:YB*V@&<[P*^)ALAI * MB@-T2<#B;[1)UEIBL;MBG(0I6$00^E'RBY_31.0 NO4&P$@!QKX ,P68L= D MLEC6 '/L="C9("I7"S;9B',3HX4:/Y+'..%4S/H"QYU)?W@Y>+BY1'=7:#*\ M&]^?W5^.;]'@LG>/3@; L1^P4W2&'B8#=/+YM*-RL:F$JFZZ02_9P'AC@P&X MY\C4OR)#,\P2>']_N%&$JT)JIM?(]!HQG_DFWUR,S% /(M'B:!3@" U\Y@:$ MK2B@QQLQC:XYA.QWF=B$W2IGE\_*@8T#4HSI=/>E/[5B:])K)" M(LPL$685NS/Q".6( PV%ZZ>\3&M"T(@)Y.M@[9B6W6KI'76=5U&RK&U;6CM; M5HC/RN*S=L2'HX6'?=3#T1-ZO(5P"K3T2"IY#CV2FL@*DAN9Y,91O=FH,Q$U MD142T*[:-:UZXS$361%1+1SA+1_JAUV_]9M]T2GU?6K=SF<.OJVK8@ MT"H5].6+%PTW>+=]JYD./;:ZV(JZI5FKB0[^/QJ8BM*WQ9/NG5< M,]=:5-7%5DS&MJS2*XN5O M$@PTN8(F'4Z6\2UN2KBX$\9-3US;@ \P]02P,$% M @ X(.!6&Q%CN[% P _1$ !D !X;"]W;W)K&ULM5AA;YLX&/XK%I-.F[0+8)*TZ25(2Y,JG9:U:KJ[#],^./ FH(*=V2;I MI/OQ9P.%[$3,'4N_)-CX??SX]#5HN[A\??'^ <^K$N'E>/U3B8@(W48D1E-"G]#7):1KX-^: M5FK$T5_1E=B1 ":6^DP$\#U8_F]OW*'SAX%EOV+9S]&]DZM>2W1+A>29^C0D M^OI)#4"W$E+1R+7_"EP'%=>!,:,YU[CB^E[)5F8\EC]02"0TL6W!RT#!H8^$ M9JI^Z'WO(T)#]#%+BI:!\[#B/.R@ O0W6L8T3K/4* PC=,=D7U3$+\XJC(M7 MX'I9<;TT)OF62E"H$O$3.BC"1WFXMI6][_0<=VSO&R8=59..SJQ&,]X-K'FE M0T-27*>NQ$Y'[9'G5NV9L3MNJ'OD(NY9Y5?"G9DNKNGB7U-@&:^S>JQ!SQDV MJ]"M;<8U^\S_UV$+X&>VSV6AA3@T9:?V&-=H"_XB(^@S2=N=T(S3=1=K?W$' MYQ6=T5^ZTJVMQ35[2[OHALVBZ_=/B*XV!]=8S[N(K@6P\.(E*>I?SY2@VA9< MLR]': M%;"QC'>071M@(;OCDF?4'JX= 9L=X6?SO5.[:9*?&:SK?M8>@KVSR@^_QI$% MUWZ"S7[2+K]^8^'#HQ.%#]<6@<]]!FD!#)4"5["3E?Z\1OW91R?R%/@VOW<0 M*& 9E<7AO.JM[C8^%"?Z>GAQ,;(D?*M6@!+8J%"G=Z$(\N*NH6A(MLO/]VLF M)4OSQPA("%P/4.\WC,F7AIZ@NO'Q_P%02P,$% @ X(.!6'"Q.$^F @ MJ@@ !D !X;"]W;W)K&ULM99O;]HP$,:_RBF; MIE9:FY"$I.L@TB!TK4175-KM1;47)APDJF-GMH'NV\].: 1;H*W$WA#_>W[< M<_BX=%9'W=LI;_3*.UD MS>]5?'<'/\;D%+S61W =UVN0]U\O=[?EMG9:VW5KNV[)\W;R9GIE"CUD>J1@ M1 F#.),)Y7(A$!Z&>ANN%.;R9Y/9BNXWTTW%G_1OBKSC!1ORM3TX8!LWQM^OX MVWOC'Z>$S5.208^P1WBXQGR"HO$6[N6\]18>"+9E.:@M!_^U'(-#)N) L*U$ MA'4BPA?N+F&RR>%>V1NN;/A/R;GMH'7F_W5E[8U.8KKX-1'SC$F@.--"YS34 M!%%UQFJB>%$VEPE7NE65PU2_3* P!_3^C'/U/#']JGX]B?X 4$L#!!0 ( M ."#@5B'-M\*\P( /D) 9 >&PO=V]R:W-H965TO"YF M1A6(6.6_9%7,[>K)0:90)&6P5I P M7CSI<[D0&P'-UAL!7AF0+X1=),I5#BE2OR?%BD@S6]-,(R\UC];B&#?_RA2E M?LMT'/K3LXO1\.%Z1&[/R?7MS??#^]'=F Q'@WNR-P2D+%;[9&]")7", %E MXWUR2*81Y8N(,C*@_(D\CB&9@?S5LU%+,F [*-,/BO3>&^E=CXR%)BLRXB&$ M?P-L74M5D+XS5K>,UJ@9HYK_DF;X;DDBN4F38CDL=K M/8%<(B1J:[T%K;6=9O;8B4II 'U+;R(%<@F6__6+VW&^U6AM55I;=?1"*ZNT M'FBC8"89OI"0(AQHMZI LM1LAVW2WX%GH-GDBO),;U^SO"U">4BNLKCHU130 MK@IHU^88,\Z2+*DU5"WA@PO?WS5=+>&# M?Z3KO'ZCG9W:KL3M6.[&D>+NP'DEY%_K>Z[QWZC5CF/C'V MZVQ;+WOC-$Y +O([AR*!R#@6!W,U6MUK3HO3_'5Z<2D:4[G0A9 8YCK4:73U MQT\6]XRB@R+-S_:90'U3R)N1OIN!-!/T^[D0N.Z8!-5MS_\#4$L#!!0 ( M ."#@5@NA[ZH%P, *@. 9 >&PO=V]R:W-H965TD(TIJT6K5UBY)='J8]..0D6 7,;)-T^_2S M@1)8*0D3S4-BXW/^/C]S3FP[.\KNN \@T'T81'RL^4+$%[K./1]"S,]H#)$< M65,68B&[;*/SF %>I4YAH%N&,=!#3"+-==)G,^8Z-!$!B6#&$$_"$+/?EQ#0 MW5@SM8<'<[+QA7J@NTZ,-[ \36>,=G3"Y45"2'BA$:(P7JLO3,O)F9/.:06 MWPCL>*F-%,J2TCO5N5F--4-%! %X0DE@^;.%"02!4I)Q_,I%M6).Y5AN/ZA? MI_ 29HDY3&CPG:R$/];.-;2"-4X",:>[]Y #]96>1P.>?J-=9ML;:+[?"%*#A*TWL'*':QC'>SJ[KID+8"M M MA*]>PG]"8!YAS1-5H(ZMVA'Q_E.+H1$/*?=6R96*]>3-78!8^Q!V--%A$' MM@7-??7"'!AOZT@[$JMPVP6WW:3NSF1Y &.P0ER!G^3O$^%$^)21/["JP\\T M!ZFF^D?8NJ:1?QQ]6V8[QK(2>*\(O-$.D8L=VB(.FE6# MW1\_S,9=WKW%]R1,PL8B:I9HFTU=J56!]^<.T^ZRD,S&8TQK]H[4JNS[HXO9 M\NQR7"GUGMH='M53X_1M\?32-4+=X6XQVY"(HP#64MXX&\KS!4M.G+JR0P92#'UY2*AXZZK!274_&PO=V]R:W-H965T- "/'@IMO&JAT'VVD+OQ[;2:,4TM*3+@^) MU]X9SSB;3;03:$9EXV^[HTG?YKN$+Q1VJC%&ULE"B(T-;I=C MS[>"@$&B+0,QCRU,@#%+9&3\K#B]>DL+;(X/[.^==^-E011,!/M*ESH=>Z\] MM(05*9B^$[L/4/EQ A/!E+NC79G;\SV4%$H+7H&- DZS\DGVU3DT -W>"4!0 M 8)+ 6$%")W14IFS-26:Q)$4.R1MMF&S WCD%32A3Z".1DMB3?86NT7.$D4J)!!5A;3:S$)Q4Q# I)!X7= M*Q3X0=@"GUP.#X[AV%BL?0:US\#Q]4[P303GIFK,>2:;J\H4(H5.A:2_8=GF MKR0<.$+[,6SCKE]=$=XVK5R2>:0ZK%6'CU"=$XFVA!70IK8D&C8UP+7?_TOI M_[*.5/9JE;VS*F=D3WG!T?<9\ 7('VWRSC+85C52.4E@[)E>I$!NP8M?/.L. M_#=MI?-$9$=F^[79_E,74O^?\@B'_;8Z.KOS8WWA1E.P#7E&Y)IF"C%8&7J_ M,S2[R;+)E8$6N>L3"Z%-UW'#U/P70-H$L[X20A\"VWKJ/TW\!U!+ P04 M" #@@X%8\AGG7O<# V#P &0 'AL+W=O/I[QK^*-8!$SU$8BX&QEG)S:UG"6T-$A39C _[;"O#((891V(;191_ M'T/(]@,#&X<'C\%J+?4#:]C?T!7,07[:S+B:63F*'T00BX#%B,-R8(SP[02[ MVB&Q^!S 7IR,D9:R8.RKGKSS!X:M&4$(GM005/WM8 )AJ)$4CV\9J)&OJ1U/ MQP?TAT2\$K.@ B8L_!+X0"6IK/(^%(OE%^]365<;> M5D@69CB1[/T>]W(&D0BC_0#?H564BL*0?1MZ1BH'$L+UMMG*Y&SJR&"?K M8KD6Z#[VP2\"6(IZSI\<^(])(^(=>"9R\!M$;.+4$)I<[DX:Z#AY.)T$SSD7 M3AV8F[':5SZ:T>]JOTLTXIS&*TC&_XX60G*U=_^K"UZ*W:K'U@E]*S;4@X&A M,E8 WX$Q_.T7[-I_U@G_G\ *86CE86@UH:=A$&_0="N%I+$?Q"M$)1K#*HAC M/6%+] ]07A>$%-E-D/4AM!MB&[=:3K=O[4[U5>VZ/>?4K,"\G3-O-S+_DN0] M^#>C'7!UCJ'[9^!>( #->.#!ZR2E2W9/J+9-%Y?T5(U<\XP8-Q?C7O09_E(; M4);3+:7F5J)(' >3=HGZ8#<0[U3"99MN>8]4C8A)W'K2W9QT M]Z*@'KC6LFN$J$\^5)?$U^,4-/9RC;UK/DRS]D;HG]!^/4Y!.[:/)=&^Z NK M>\(2 A4&Q#B:T-A3EX]:Q1G>:7K<8+M7.;)J[3 YFT?XI(KCZS+I&1WDJ(.\IG"HVT+3^9J!%FJ&8V/;MLNT:PQ+Q:5(_%CW<6,] M_>FZ\9(BIQ+?EEGY"%6C0ETI2CG6;GQA\=[HB[8X**&+$"YA7E._B6L[G0K[ MJF&OW>NT[3/\CQ4<7UO"7R>L6J!;IDO*JEZH]45-QT*.FRMY1=,##3CZ3,,M M:,X'15F]1'=;KO>97"O-P -6G^EN30EU6F5!=58]4A)DG70@$?!5TI@)Y+%M M+-/+?/XT;_Y&2C[636'2V1QATH[R ^7JJB50"$L%:9L=%6F>-FGI1+)- MTN,R<-$+Y"WRL,?4$L#!!0 ( ."#@5A&N_NQ M) , *0( 9 >&PO=V]R:W-H965T&A'CA)M?66A('VVTWB0^/[:2AL*PP>%,_ MQ/>_WYT?KITMXW=BA2CA/DTRT;564N:GMBVB%:9$-%B.F?JR8#PE4@WYTA8Y M1Q(;HS2Q/<<)[)30S H[9F["PPY;RX1F..$@UFE*^$,?$[;M6JZUFYC2Y4KJ M"3OLY&2),Y0W^82KD5VIQ#3%3%"6 <=%U^JYIWW7T09FQ2>*6['7!QW*G+$[ M/;B(NY:CB3#!2&H)HIH-#C!)M)+B^%:*6I5/;;C?WZF?F>!5,',B<,"26QK+ M5==J6Q#C@JP3.67;',Y@O$9S*['@P\PGEQ?C*]@?',]N^Y=#2^NWH-J8/1Y-!UZ?!3:Q_7:^M*=BIQ$V+74K1+(-VB%KUZX@?/N /EQ17Y\2#V< M:D9@"QC=(X^HP".X9%OD4'RXI"F5=#M1[M_W&C6)_BD M0COY*[32.9DG6.W]WMS!O3]YO/=>X/BM)]!*PO-S>5&_/Q*^I H\P84R=1HM=6]Y41*+ M@62Y*4-S)E51,]V5^AN!7"]0WQ>,R=U .ZC^F(0_ %!+ P04 " #@@X%8 MDJB(\,8" "J!P &0 'AL+W=O?/ M9C*.NHYG! &%4!D&K%];& "EADC+^'7@=/*4!G@Z/K+?6>_:RQ)+&'#ZG40J M[CH?'13!"F^HFO/=/1S\- U?R*FT3[3+8IMM!X4;J7AR &L%"6'9&[\8O+I30 M7XG&J6 QN!\-GR8C-+U#_4EO\*6B5Z:3T0)-9U_'T\?*;#X>C!\_HX?I<#1! M[X:@,*'R?<=5.KOA<,-#IGZ6R;^2J>:C!\Y4+-&(11"=$[A:=J[=/VKO^Z6, M0PBKJ%[[@'S/KQ<(&KP>[I?(J>>EK%N^^K52QEA I:_W5(1F>*^WND(](3!; M@QW_Z"VE$GK?_BPJ7L;=*.8V9_E6ICB$KJ,/JP2Q!2=X^Z;6\CX5&?]/9&=E M:.1E:)2Q!Z.75!]170-*5E#DM!S>1'O 0A:Y^@?@F8-F[J!9RC0D6Q(!B]"> M (V*+&3X&XLW]^0V\#KN]E1K6<29J%8NJO6ZLFXYQ8I0HO9%REI_YZW>7&@K MCSE3U\[5M4O5S8E\KMP) $28 KVI%!)8%?[^=D%VKW$AL3"H=J'1/;GV$A!K MVPTD"OF&J>P6R5?SAM.S]^S%>E\WHJQO_*')NM@#%FO")**PTI1>M:W_J\@Z M0S91/+67ZY(K?57;8:R;*0@3H+^O.%?'B4F0M^?@-U!+ P04 " #@@X%8 M/?C(-8P$ I%0 &0 'AL+W=O,_Q!) HNO&D,#")93EF2/W(& WB>W=\-&!K&?@1W'$DUF%(^80A!H),7CWRVHD:ZI)^Y?[]"O M8O%*S(P*F++@F^_)Y=#H&7GSY=(ENK]"W\?W]^/,C>E2?#^/I MX_7MYP?T^P5(Z@?B#W2&?D4F$DO*00Q,J1;7$*:[76B2+$1J%L($W;!(+@6Z MC#SP\@"F8IU2)SOJ$]*(> %N"]GX R(6L2L(30^?3AKHV*F3=HQGUSFIC3F; MJ%?*0U,6JGTF:/RFCCFGT0+4NR_1[ 7MQ]W1E_CV>$.YA[Y_4I#H6D(H_JDR M.%F_7;V^WN_G8D5=&!IJ0PO@3V",?OL%.]:?5>:<""QG53NUJMV$GE@E/J#; MM1221IX?+1"5: (+/XKT@,W1WT!YE0D)LA,CZQSU-'*(;3N.-3"?]O65XWI= M0CK]-"S'O),R[S0R_Q:G!?#.QD_ 59I#E\_ 75\ NN.^"V^3E"S9VZ-*6HY3 MT%,.LEM6NUJ-DZIQ#GH.?ZD75!;W9,+-*=F(,>D4S2Y'=1SL$%+#KYORZ[[/ M[0;BW9)?5JM+"KS+0:35=ZI)]U+2O8-,W7&M9-P36V M]E.&_??9VDB]7_(,M]H%VN48TNI5D\965JFL@XQ5Y7L.ON*/&$=3&KFJ)ZAD MNL7+N4?:'8R+=*L#54ZIR19XK[KB]UE]N!A)YZ59-Q8QHY.UZ\ILJO<+3V#JBBG)JO@K&;B M XOF2G<58B>%S@(XA'JY'M8\C-<+;%Y 5CKQ>VOGVY15E<_R0WFER.8U9044 M-U?0DJ8KZG/TE09KT)QWBK9U"EVLN7[3Y%)I!NZSZIWN5)0N4A+42.R-#1S. M*C-N+LTW?N2'ZQ!]OX%P!KRR7VV&.+9A/15:7G!6U7'O)[?WN+&O.-JN$Z'E M[\;QZ=7(NEPPD6\5'6S,F)0OCRR50#[@.4+_/&9.[@5X@/1T=_0=02P,$% @ MX(.!6+YR!%!B! ]1D !D !X;"]W;W)K&UL MQ5EM;^HV%/XK5C9-FW1+XB2DT %22MH-J;P(VG73U3X88B"Z>>':!LJ_GYVD M(8$T0*^[?DEBYYS'YSRVC\])6MN(?*-+C!EX"?R0MI4E8ZL;5:6S)0X0K44K M'/(W\X@$B/$F6:AT13!R8Z7 5W5-L]0 >:'2:<5](])I16OF>R$>$4#708#( M[A;[T;:M0.6U8^PMEDQTJ)W6"BWP!+.GU8CPEIJAN%Z 0^I%(2!XWE9L>./ MIE"()?[R\);FGH%P91I%WT2CY[8535B$?3QC @+QVP9WL>\+)&[']Q14R<84 MBOGG5_3[V'GNS!11W(W\9\]ER[;24("+YVCMLW&T_1.G#M4%WBSR:7P%VU16 M4\!L35D4I,K<@L +DSMZ28G(*>CU-Q3T5$$_4(#F&PI&JF"]4,S[A!'^UN-ZK#-YZO?M\3]@> ^>[?'8 M'CQ.P/#IX _ ;^#N[[MQMS>Q;Q_N0&]P/QSW[< !^=3!#GD]_ M U?@9Z "ND0$TY;*N%T"79VE-MPF-NAOV.#@60T8\ O0-=TH4>^>KZZ7J#OG MJ\.BNLK)S!C5,T;U&,]XBU'!PM4M7XLNZ$8!WZ 4Q4O<)@2%"\PW#0/3'N%BR]@L ZFF.3[RAA-D*T8 M643*3:>NU8U&TVJIFSQ9QW*6;AB6I17EG&.YQK6NUYN96,%#,_/0?(>'SW%H MP^Z5O<&$AVIP]X+)S*,8C(@WPV7N)L,TN9F_3PW4T?0U,?91.;ZRCRKGSF1QW+E$UEIZ3L7M)7Q8+V#AW=,MW7.=)<) M'4UWI<'OI.,ZH^/Z'#K USX6*Z$T,E8B7!H998(YDL *S#4RYAJ??"(U9/(N M$\R1!%;@O9GQWORP$ZEY7H#J5EIP*5F2P ID06V?B6HRCKZHA+CV I:(YLM"*].V+ M"5C_Y.0'2BH24O)EHCFRT(KD[RL86%W"C 7#()H?[.SR;T0)%(2YO:W5K,;A MWI94@Z3\?$1% _EEK42$5S9*$5Z=O7-?"S"QLHM;*1BN;( M0BN2OR]N8'5U<]'>;AX=V]"HZ8=;6VHQ(PLMH4?-?6(7/T3ZB"R\D (?SSF\ M5KOF@98D_QB2!HM6\5?W:<18%,2/2XQ<3(0 ?S^/(O;:$!_RLS\]G?\ 4$L# M!!0 ( ."#@5@F.C1]V@, -,2 9 >&PO=V]R:W-H965T>6;J&0_3V3+^*)8 $CU%82RZSE+*U9GK MBMD2(B).V IB]67.>$2D6O*%*U8<2&"4HM#U/:_A1H3&3J]C]FYXK\/6,J0Q MW' DUE%$^&X (=MV'>P\;TSH8BGUAMOKK,@"IB#O5C=.]*N/##VJ!<70=?Q-",(828U!%&/#0PA##62XO%O M"NID-K7B_OLS^KEQ7CGS0 0,67A/ [GL.BT'!3 GZU!.V/8+I [5-=Z,A<+\ M1=M$MMEVT&PM)(M29<4@HG'R)$]I(/84<.,5!3]5\-^J4$L5:L;1A)EQ:T0D MZ74XVR*NI16:?C&Q,=K*&QKKGW$JN?I*E9[L38=?QJ.[RS'Z>H[N^Y-)__IV MBK[>W4YO^]>CB^L_D7J@\5_CR?!BVA\HN5]'( D-Q6\=5RK[&L6=I;8&B2W_ M%5O81U$! M^GZI(-&%A$C\4Q;@Q/YIN7V=\F=B16;0=51."^ ;<'J??L$-[X^RX%0$5@C5 M:1:J4QMZ;_RT4HFL_+^D1SL@7)1Y]1.*!0_JF0=U*]*(;F@ <8#^ MIA &92XD^FVCK\OIIN=UW,T^5YM$@50C(]5X6UB_L5 =O9#*71FSQH]V3]HO MN-EE"NR:&;NFE=V$BL?/YQS4"8\EJ$,ET83(TI^_66+=.WU!L50(EW-L91Q; M5H[W1.>J1-^O('H 7IJ%5H1CL[ BL(*S[^ MDG5 'YO2@QHH,I=@F8/O02AZM7?_XW>6L13 5L>L(D5B?D[,KZ*4I2CV6G9 MJ,@PO^VQ]88\IIRE2 ?JF=W>SQ[P_$K&]KOQ9>E#_Z$K&M-H'5FKH1WUV!RO M"JT8@_Q2Q_4/KHC8VE8<':Z*T(KARML-;.\WCDD!*]+1?B=HNF#N9Y2'6Z]D M==ZC8'N34I8%Y.EP%EA1CW:O(K1B#/(>"+<^.@LJ[:&J0BN&*^^BL+7S."H+ M*FV(4K0#';"[-QZ(@"_,U$2@&5O',OE?.]O-)C-],X]XL3_0$QLS=LAADG'/ M%>$+&@L4PEQ!>B=-599X,D%)%I*MS!#B@4G)(O.Z!!( UP+J^YPQ^;S0!K(Y M5N]_4$L#!!0 ( ."#@5@O?D1-!@4 +,L 9 >&PO=V]R:W-H965T MNWJE? F^S/O,.'XY9Y@S@UT8?8_7C''R['M! M/%36G&\N&HUXOF8^C<_##0O$G648^92+TVC5B#<1HXM$Y'N-5K/9;?C4#931 M(+DVBT:#<,L]-V"SB,1;WZ?1RR7SPMU04977"[?N:LWEA<9HL*$K=L?XPV86 MB;-&1EFX/@MB-PQ(Q)9#9:Q>.&I/"I(6?[IL%Q\=$_DHCV'X79Y<+89*4XZ( M>6S.)8**CRM3"H^/7^E6\O#B81YIS":A]]5=\/50T16R M8$NZ]?AMN'-8^D =R9N'7IS\);M]VUY?(?-MS$,_%8L1^&ZP_Z3/Z3_B2*"V MWQ&T4D&KJD!+!5I503L5M*L*.JF@4U70307=JH)>*NA5%>BI0$_>[OYU)._2 MH)R.!E&X(Y%L+6CR(#%$HA:OT VD=^]X).ZZ0L='=_S^ZF9*9E_& M4S*>&N3K^/9V/+V_(Y\,QJGKQ61*HXA*FWTF9^3ASB"??OX\:' Q LEIS-/> M+O>]M=[IS6#SKRHL$[Y?+?:2 &KR?R-X-O",MDOFEEOFDE/.T]WZQIQ,XN1=18D$GHBU : MTR08C85/@A43X8V3QQ=RW&Y&7Y++XQV-%N3;%X$D5YSY\5]%3MKWWR[N7X;T MBWA#YVRHB)@=L^B)*:-??E*[S=^*?(6$&4B8B8192)B-A#D@6,ZK6N95K8P^ MNME(9\9$I.Z8TV#A!JLBP^TAW00B4_[32-7$EZ4IOBY/QUXJ:-=4VVU-S[VDF5DZ]KH&0,)L),P!P7(&:&<&:)<:X"&(V#QX_(@J)E#K_?I9, M>!9D?A2ZBCRQYW:.WF%?T_7>&T>4]EXWNB!A)A)F(6$V$N: 8#ES=3)S=4K- M)1,JN9.F(OM 0V8>#IW5;G9#9KG[;3>J?-G )< MGI:SA)Y90D?,S/73,7;ZHO\WT[#2ONJ^623,1,(L),Q&PAP0+&>E?F:E_@^F M8:WFCV=>I8RZD00),Y P$PFSD# ;"7- L)S?U.9AY;3YP7.O= @NT)I!I1F M0FD6E&9#:0Z*EC?MT7*_BLBX*>4XY?;;JMY[FW++>ZOM*23-A-(L*,V&TAP4 M+>^I0RE +5V]+4B]Y%]R39]=?^N79N-R;NWX!EWDA]),*,V"TFPHS4'1\EX\ M+/6KVD2R^ 1*,Z T$TJSH#0;2G-0M+QI#^4)M;P^\?]71LK!M+-284&[M:$T!T7+^^Q0J5#+2Q7UJA3EL-K>@M8IH#032K.@-!M* M :494)H)I5E0F@VE.2A:WK2'LH5:7K>H^I.Y8(F\ M&PO=V]R:W-H965TNV>^1[>"9 7<,\2W>8[9RQ40 M6HV-@?&Z,,_6&Z$63-\K\1IB$ _E/9,SLV5)LQP*GM$",5B-C6!P.7%5O YX MS*#B>V.DG"PI?5*3:3HV+"4(""1",6#YV,$$"%%$4L;OAM-HMU3 _?$K^[7V M+KTL,8<))=^S5&S&QH6!4ECA+1%S6MU XV>D^!)*N/Y'51WKRN!DRP7-&[!4 MD&=%_<3/31[V (/A$8#= .RW IP&X&BCM3)M*\0"^QZC%6(J6K*I@*:0016!:WWMLON?R [,.ZUYIX_=5Z[O2F!8 M9,4:S2CG:((9>Y$-HL(LU64.NC)0TXXTK>H5.W\PO+#4SS-W^^XZ @=_!1XH M'[;*A[W*[\0&6)>R7EAW.E%76=[/<^!KU/H:]?IZQ&2+=8\+B&RRN$C@>!5J M*GUE^H?2O)^GMFKN M=4YU:WW#;)T5'!%826;K_(O,&JMO@GHB:*F;Z9(*V9KU<",O3V J0+Y?42I> M)ZH_M]>Q_P=02P,$% @ X(.!6#UFY;!)! 2AD !D !X;"]W;W)K M&ULK9EK<^(V%(;_BL;M='9GVMCR#4B!&1(@(0F7 MV*0[F4X_."# L[;%2B*D_[Z^EZP/6!^<#\&RW^>5Y"/)/G+W2-EWOB-$H(\P MB'A/V0FQOU95OMJ1T.-7=$^B^,J&LM 3<9%M5;YGQ%NG4!BHNJ;9:NCYD=+O MIN<6K-^E!Q'X$5DPQ ]AZ+%_;TA CST%*\4)Q]_N1')"[7?WWI:X1+SL%RPN MJ:7+V@])Q'T:(48V/66 KY=6HD\%?_GDR$^.4=*3-TJ_)X7)NJ=H28-(0%8B MY/U)&[BB 4__HV.FM34%K0YA_Y?3@!L'T&T'- M_QDPSP!&#ABR@)D#IBQ@Y8 E"]@Y8,L"K1QHR0+M'&C+ ITBP= M>UP$'TM'7R^BKZ?15[,)GZX60T]X_2ZC1\02?>R7'*1+3LK'BX0?)8NC*UA\ MU8\YT7=?IM.!\XKF8S1?C)S!+ MYM_H%QV'9'6%#/P[TC7= !IT*X_K #Z4QS& C^1Q#<#'TCCN /B=/-X&\'MY MO 7@$WG=P"\$=YW 3P)WD<&G53>1P:=3-Y'!IUAT:=*X]#HVXICUL75B^C7'R-U,\XXS>)5C0D:.E]H*'/5P'E!T;0 MWX,W+EC\VO@/M,)FCB;LF+Q*7_.]MR(])7Y7YH2]$Z7_VR_8UOZ$5LFC1[;-+LJ4FS:9-FLR;-YDV:+9HT>V[2S&G2 MS&W2;-F0V:8E=<.J#D.Z455G=:JR<56FVU79'5 K(+L'9&95-H'< -T#<$],H*^/ M0%]UHZI[ G0VX#<%;DK;JNIF@,[46Q7='.AOJ].IZ!:0#JCW&= 96KNB4LLB[.HE?B,40W:/2Q]Y.I1"-H%EWVT#43 M3"QK*3"?K*7 -+*6 K/'.LH D\9:"LP5:RDP1:REP,RPE@(3PEH*S -K*3#] MJZ7 K*^6 I.]6@K,\>HH'4SM:BDPHZNEP$2NE@+SMUH*3-O4D_VSD+!MNEO/ MT8H>(I'M195GRP\"@W1?]*?S-_AZF>WK_V^3?668>FSK1QP%9!-;:E>MN*4L MV[G/"H+NTUVZ-RH$#=/#'?'6A"6"^/J&4E$4D@K*SR?]_P!02P,$% @ MX(.!6 QT Y$A" KED !D !X;"]W;W)K&UL MM=Q;<]I(&@;@^_R*+N90,U6)0>+HC$V58T[B#%*R6SNU%P+:T!5)S:H;8__[ M[18"F]#6R%5OPB 2MX6-E-O/Q:)8;FCH MBRN^I9%ZYH''H2_5W7A=%-N8^JLD% 9%NU2J%4.?187F3?+8-&[>\)T,6$2G M,1&[,/3CYR\TX/O;@E4X/C!GZXW4#Q2;-UM_35TJOVZGL;I7/"DK%M)(,!Z1 MF#[<%NZLSYY5U8&DXANC>_'J-M&;LN#\N[[CK&X+);U&-*!+J0E?_7BD]S0( MM*36XW\I6C@M4P=?WS[JG63CU<8L?$'O>? OMI*;VT*C0%;TP=\%!Z[P!JW0H6\=AMW*/NW4<>"OW MR%O'H;=RC[UU''PK]^C;Q]&WD]$O'M[PR6S1\J7?O(GYGL2Z7GGZ1C+E)'DU M2;!(SXZNC-6S3.5DTQG?3T9MXMW]N^V2/UI4^BP09.S'L:^GK3_))_+5;9$_ M?OWSIBC5\G2JN$SM+P?;?L.V;#+BD=P(THY6='4.%-6*GM;6/J[M%SM3;-'E M%2E;'XE=LLN&%;K/'[<-\5;^N&6(M_/'2X9X)W?-\2= M_/&:(=[/'Z\:XH/\\8HA/LP?-^UUH_QQTUXWSA\W[763_''37C?-'2^9]KI9 M_KAIKYOGCYOV.C=_W+37>?GCU8S9JWR::\N)5W[#FVRIGE6C-1ER(?;O1^O!/E[J*J)(VDH_FN::@]TQ4SKS]"?Q=9?TMN"^I L:/Q("\W??[%J MI;],TR02:R&Q-A+K(+$N$NLA,0>)]9'8 (D-D=@(B8V1V 2)39'8#(G-D9B+ MQ#P0=M8B*J<647K-F'J# >QFHCZ8,ACLUQ*_MT4'U]/ M^CGK6I=UEJFN?5E7O;XLZUR6V;7+LJYAJ8:RGJ&L%$:US\B2QYON7IC42+] M)Z)OF-Y,V93+ _KI&].'!C]X=+F)>,#7C(J/Q(G49T4FB$_$;B'8BOGQ,^$/ M1&XHN>?AUH^>R7[#EAM=]/(.9Q%)5\_7V6W,'YC\)"C]KI^ED:3Q-F:"7JE/ MAJI@NPW8TE\$]&5K/K!HR<.7C=*^5?]-!92Y6C%]#/)CNI#??VG85OTO\<-K M(9Z%^MA)_"#@>Y&L\9H_TC@*U?*)Y"2@C\]JY:S2;^D*DIA*]9P^NJGSZL78 M12LF9,P6.TE7A/IQI-9?$#5M)9[:!G7K63U^1;R-6D,=V[,@(!&79*$+^"-; MJ2@[O&3+]"5[K>K'3_*"*IL>'M,'%]1K_4'?>6!BZ0?)HDP??#.'][T??)%8 M&XEUD%@7B?60F(/$^DAL@,2&2&R$Q,9(;(+$IDALAL3F2,Q%8AX(.VO2M5.3 MKF5VUKNY\Y_)^,[4DC.#[SWR@<1:2*R-Q#I(K(O$>DC,06)])#9 8D,D-D)B M8R0V06)3)#9#8G,DYB(Q#X2=-8#ZJ0'4?][!\3JR12"Q%A)K([$.$NLBL1X2 M9DWZ+AU1(MB2>_T3N=G+#8R:?R=\C&BYH;/QM(!-\[V\# M2*R%Q-I(K(/$NDBLA\0<)-9'8@,D-D1B(R0V1F(3)#9%8C,D-D=B+A+S0-A9 M8[!*I\Z@3W7X68>,4AO4):!:"ZJUH5H'JG6A6@^J.5"M#]4&4&T(U490;0S5 M)E!M"M5F4&T.U5RHYJ&T\[[QZI0G"WX<*27/OBE8-1Y)RE[XNUL!4FM#M0Y4 MZT*U'E1SH%H?J@V@VA"JC:#:&*I-H-H4JLV@VARJN5#-0VGGKJ]:': *H-H=H(JHVAV@2J3:':#*K-H9H+U3R4=MXK M7L[PU=?N^6E_M:A ^P92:T&U-E3K0+4N5.M!-0>J]:': *H-H=H(JHVAV@2J M3:':#*K-H9H+U3R4=MXW7LYBM[+//?_F!SO_<$5)?:*V'RWU :1E3/4O'<9> M4;WXDX7Q0@[WV0M^=QN GA8-U3I0K0O5>E#-@6I]J#: :D.H-H)J8Z@V@6I3 MJ#:#:G.HYD(U#Z4=VD#QU:4[0QJODPL%ZPMT[")YN(KGZ='3Q8CODDNR%E_* M#U'BP(<[DF^3"X$NN)0\3&YNJ+^BL2Y0SS]P M+H]W] ).EVAN_A]02P,$% @ X(.!6,93(1^L @ YP8 !D !X;"]W M;W)K&ULK55;;]HP&/TK5C9-J[22>TH[B,0E'4@M M0V2LSV[R0:(F,;,-=/]^OD 64$![V NQG>\ < ,XYP+L < \ 5QG5RI2M M,>8X[%&R1U16"S8Y4+U1:.$FK^2_&',JWN8"Q\-X-(G&RZ<(?7]$T6 QF\Z^ MQ6@>+5 \&2PB-!S$TQ$:S,9H/'U:_HC&Z/,8.,X+=H-NT3(6\X\W/9,+)9+/ M3 Z[#O6NSH5=;0<]DXIG#$55"NDI@2DLU#ZS$I5>[]*ZQAS.1,D^$L3:3&NDKI(R277CK.JYO.U[/W#4-M!6Z MGN_<677AB3B_%N=?%?>B3C"D:+ #*@()Q1D6+6C3JHF"A@3;O[]S/?DIG&AM M*72ZGN7?=]NU!K76X*I6_;G(5J(Y4*VT3:AFZ39[977.1;87!6<*S49FE$#7 M*DH92LBVXOK8U:MU6@]42)VM#T6*Z]#]2Z.O@&=,UWG%4 $K06EU[D3[J(Y5 M/>%DHY+IE7"1$\.-$;E#?;>$?4$L#!!0 ( ."#@5A> MIRZV90( +$% 9 >&PO=V]R:W-H965T>>"?DO2H0-3R4C*N15VA=7?J^R@HLB>J)"KG960M9$FVF!?PE>).'8S!.ED)<6\G MU_G("ZP@9)AIRT#,9XM39,P2&1D_6TZO2VF!A^,]^T?GW7A9$853P;[17!2-0/X49P72B8\QSSQP2^4=U)#_?2)^&SC#/,>A#U7T,8 MA-$10=-_AX?/R(FZ2D:.+SI522(YY1L%"Y20%D0B?!^OE);FI/XX5J^&;G"< MSM[>2U61#$>>N9X*Y1:]Y-6+_C#X<,SK?R)[Y'S0.1\\QY[,**OM^0"%62VI MIJ@@$WR+4M,5PV/>&\(+1V@;S39Y'Y@G]K>'IOX6U:CU#TY_B7+CFH)54'/= MG*9NM>L[8W?=GJQ/3#]JVL&UL?51M;]HP$/XK5CI5 MK3218*"M:(C$2[M%*@P5NGZ8]L$D1V+5L3/;X>7?SW8@8U+A2^([WSW/[ MA%LA/U0.H-&N8%P-O%SKLN_[*LFA(*HE2N#F9BUD0;0Q9>:K4@))75+!?!P$ M=WY!*/>BT/GF,@I%I1GE,)=(545!Y'X$3&P'7ML[.EYIEFOK\*.P)!DL0+^5 M8 4!@T1; M!&)>&Q@#8Q;(R/ASP/0:2IMX>CZB/[O:32TKHF LV#M-=3[P'CR4PII43+^* M[7(E@RCW1MH[M!1Y**J5%<4@V"@K*ZS?9'?IPDH#QF01\2,!.=TWD M5$Z()E$HQ19)&VW0[,&5ZK*-.,KM1UEH:6ZIR=/1^,=L&<^^/CN*7 M>!D_+:ZO'G ;/RZ'\?MPAFXFH EE"LV(E,1V\3;TM2&W$'YR(!K51/@,41NC MJ> Z5^B)IY#^#^ ;U8UT?)0^PA<1)Y"T4*?]%>$ =]#;8H)NOMQ>P.TT+>DX MW.X9W"ED1.T5^C6%8@7R]V>U7D2PB]17)4E@X)E-42 WX$775^V[X/&"OFZC MKWM1WS/EA">4, 2[4JA* DI,9RG/@&NTKK3UE&1O5D>KS\37\#T';Y=V$W5L M"^]#?W,JRS^9J@)DYG9'&:Z*ZWK &F^SGL-Z*O^%U[L])3*C7"$&:Y,:M.X- MN:SWI3:T*-V,KH0V$^^.N?G%@+0!YGXMA#X:EJ#Y:45_ 5!+ P04 " #@ M@X%8PH^^$3 # #R$@ #0 'AL+W-T>6QEUY-B9X[*67X^OG:8?^"+&PU:6JL2^)^?< M8_L&6QW49B78S9PQ$RU+(>LAF1M3?8KC>CIG):W/5,6D10JE2VIL5\_BNM*, MYC602A'W.ITT+BF79#20B_*J-'4T50MIAN2\#47^]C4?DF[ZD41>;JQR-B1W M)^]_+92Y?!?Y^]&'HZ/.W>GE?OS$ :OT#TK ,7*NUA+$'ZL@3/J6/2 M%[O2[O%C*^2)QQBM'Z#9+!LF=!PY;A9F-"B4W*Q/0GS JM.21?=4#,F8"C[1 M'%@%+;E8^7 / E,EE(Z,+0R;K@N1^L'#7=^#FFET2BZ5=KE]!O]WTCR^!ZQ[ M8) +T1KL$1\8#2IJ#-/RRG;Z M3=,EZ]!H(%@!=C2?S>%N5!4#:(PJ;2/G=*8D=1[6C*9A9:=,B!MXH7X6.]K+ M8FO=.K!JLFU:0TW3R_@.Z&^K>>UMV=ZK=*.*WROS96&'(UT?"I1=:U;PI>LO MB]8 IM[%U6E5B=5GP6>R9'[P+TXX&M U+YHKS1]L-BB5J0TP3:)[I@V?;D=^ M:UK=LJ59E].RP#WWWJ#GOSO/,R:9IF+;M*W]0Y[E5SMN=J!_X=G]6]EW'#29 M7!R^QV;7/723Z5LP^2:6NW_X)I/L(#W&S?Z]=4C8.2*TT0B.8D/R PYV8I,T MFBRX,%PVO3G/Z#?T;?/YZR@"V%N6W!(-NWO+.>+,FN?NH:) M:)[:M+_!\+II>PZTN;C,V9+EXZ:K9Q/7C&S#9FTN(.PC5^X*(QC'8V$$,"P/ MY@#C>!:6YW\:3Q\=C\AX M''0PQN8M3>$;5L.\ 0/+ YG^;*[QU<8KY/DZP-;TN0K!1HI7(C92?*X!"<\; M,+(LO-I8'F!@JX#5#N0/YX&:"G.2!%85\X:]P3B291@"M1BNT31%9B>%3WA] ML+*NQS $P( L !?3T\$MP>:4#M.*2VBZD8 M_1!2:5K5N %(MB6/:( M7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1 MH2)8%II%R=.B':5_'IR=]?)3J^YV4W\F_FZK6L]&Z:;;GX[$NUGS#]%]R MRVMS9"75AC6FJ>['>JLX*_6:\V93C9W)Y&R\8:(>??JX/]="C6%#-KQHA*Q- M9]MQ*_BC?CG>-LF#T.).5*+Y,1MUWRL^(AM1BXWXRBT?KZ42/V7= ML(H62E;5;#3M#]QRU8CBEV[:0N;L3G<]#;O+F &9CR MV&UXW?1Q5+QJ 6N]%EL](C7;\-DHD ]$_.8 R#,$\NQHD '3:P#Y#H%\9Q=RP7Z0!TT6 M7'5_;X=-*'112;U3'""^1Q#?VT6,:RU*KDBN6&ER,?&58O5]'TQ ^ $A_&"7 MD"YO;OSL*TDO"8VODO@R#OPD)WX0I,LDCV$.GV!)?&(7,XOF?AZ%9.%G>1Q1 MB(6ZQ;)9I<]:TPNL@A).:7J67!+++H,LHR$SV:I\%G MB(4996I9*='?RSC_"FDP=4PMNZ,+#4D7>9PF9#'WD^Z!?O&SS R'P?N&N6-J M61YQ$J0W$126OSV+^(YW&;0K[E?OS%3R D)HJI95/0Y04U(Z*%C&ZC5Z\F0G)@Z MN.+Z#83#C.)8-LIO\V)/"C$QI3B6E4*#ZRAACR(B=G&L6T;$$V0DOHD%,+BR<'< MX]AV#X8Y<(^+N<>U[1Z ^3JCA[R!F)A[7-ONP3"'T<3.!00"XF(-=V20-'#Q1Z;BQ.?8B)"<@]H( &F.DRI_D M$Q.0>T !7YB O ,**-PG>3-Y M)SZET:#B]3 !>;:+GY=W,S63=K]=/"#M')X$)J)PQ7]GOBG_P!02P,$ M% @ X(.!6+DCVC>R 0 5!P !H !X;"]?28*[#X("CA6 MBC1H3F7-6+[^JT_6^.TS[NJ\;0YILVW3X+C?'=*TVN3]CD&'PW'H[F=4[V_W,P?S4QO_,[%9K;:+^-$LOO?Q MD/\8''Z:[BMM8LS58%YWZYBG53CN;MLI7"[R=)Y<#6;+:=7-EE*%TD$*05H^ MR"#(R@RP>]0-!+^: )!$W*!\D091P2)/6P M)M!:D&LA\%H0;"$06Y!L(3!;$&TA4%N0;2%P6Q!N(9!;D&XAL%L0;R'06U%O M)=!;46\ET%M[']L$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJ MK01Z&^IM!'H;ZFT$>AOJ;01Z6^^PA$!O0[V-0&]#O8U ;T.]C4!O0[V-0&]# MO8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&_O'783Z.VHMQ/H[:BW$^CM MJ+<_4N^43[N8;CW7-;[_D53G\[/Q]OK+\KK98^>"5:'WO(FO?6F:2>*H\DGO<3>QS9HDVMJJS'2(XVS= MY-]2!ON$-*[LYOBBM+X?)R3L9$([\G/ ?MWKFIPK<^K-M LONHZSV*9B/FPK M\NGY$B=Z-/-YF5%NLE4=EZ3>.M*Y+XA"7:6[HOWSR2'N,.VN_.K\KLRYP#AS MYHSU\<0<71YW.))V]<#&0N1">?X3CXFQ]-7?1^UIYY3_,CMN[X=QR^X\/.MN MU^_QUS,^UK^P#P'2AP3I0X'T<0/2QPBDCUN0/NY ^K@'Z8,/41I!$96CD,I1 M3.4HJ'(453D*JQS%58X"*T>15:#(*E!D%2BR"A19!8JL D56@2*K0)%5H,@J M4&25*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4616*K I%5H4BJT*15:'( MJE!D52BRJO^4]=V8Y5__^&KO::W+YI#/NK^+TT]02P$"% ,4 " #@@X%8 M!T%-8H$ "Q $ @ $ 9&]C4')O<',O87!P+GAM M;%!+ 0(4 Q0 ( ."#@5@>_A6([P "L" 1 " :\ M !D;V-0&UL4$L! A0# M% @ X(.!6.B'4G9*!P D"\ !@ ("!#@@ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ X(.!6+97W4[( M!0 S1H !@ ("!(QD 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X(.!6-(I30.-!P .Q\ !@ M ("!%2H 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ X(.!6%GSLL=8(P 9EP !D ("!WS8 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ X(.!6&)G M^Q [ @ ]@0 !D ("!86 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X(.!6.58V2C&!@ M X !D M ("!^FT 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ X(.!6*-0]H\- @ I@0 !D ("! M"GT 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ X(.!6 *>2PB) P WP@ !D ("!:*@ 'AL+W=O&PO=V]R:W-H965T[ !X;"]W;W)K&UL4$L! A0#% @ X(.!6 %W ]#G!0 BRD !D M ("!^;X 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ X(.!6'"Q.$^F @ J@@ !D ("!ALP M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MX(.!6#%^BNY) @ =08 !D ("!V]4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X(.!6"8Z-'W: P TQ( !D M ("!/>P 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ X(.!6#UFY;!)! 2AD !D ("!:?@ 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ X(.! M6%ZG+K9E @ L04 !D ("!) @! 'AL+W=O4H" # ! &0 M @(' "@$ >&PO=V]R:W-H965T7!E&UL4$L%!@ W - #< ^ X .09 0 $! end XML 62 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 65 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 128 245 1 false 35 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://iveda.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://iveda.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://iveda.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://iveda.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://iveda.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) Sheet http://iveda.com/role/StatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statements of Cash Flows Sheet http://iveda.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://iveda.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 995514 - Disclosure - RELATED PARTIES Sheet http://iveda.com/role/RelatedParties RELATED PARTIES Notes 11 false false R12.htm 995515 - Disclosure - SHORT-TERM AND LONG-TERM DEBT Sheet http://iveda.com/role/Short-termAndLong-termDebt SHORT-TERM AND LONG-TERM DEBT Notes 12 false false R13.htm 995516 - Disclosure - PREFERRED STOCK Sheet http://iveda.com/role/PreferredStock PREFERRED STOCK Notes 13 false false R14.htm 995517 - Disclosure - EQUITY Sheet http://iveda.com/role/Equity EQUITY Notes 14 false false R15.htm 995518 - Disclosure - STOCK OPTION PLAN AND WARRANTS Sheet http://iveda.com/role/StockOptionPlanAndWarrants STOCK OPTION PLAN AND WARRANTS Notes 15 false false R16.htm 995519 - Disclosure - INCOME TAXES Sheet http://iveda.com/role/IncomeTaxes INCOME TAXES Notes 16 false false R17.htm 995520 - Disclosure - EARNINGS (LOSS) PER SHARE Sheet http://iveda.com/role/EarningsLossPerShare EARNINGS (LOSS) PER SHARE Notes 17 false false R18.htm 995521 - Disclosure - CONTINGENT LIABILITIES???TAIWAN Sheet http://iveda.com/role/ContingentLiabilitiestaiwan CONTINGENT LIABILITIES???TAIWAN Notes 18 false false R19.htm 995522 - Disclosure - SUBSEQUENT EVENTS Sheet http://iveda.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 19 false false R20.htm 995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://iveda.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 995525 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables) Sheet http://iveda.com/role/Short-termAndLong-termDebtTables SHORT-TERM AND LONG-TERM DEBT (Tables) Tables http://iveda.com/role/Short-termAndLong-termDebt 22 false false R23.htm 995526 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables) Sheet http://iveda.com/role/StockOptionPlanAndWarrantsTables STOCK OPTION PLAN AND WARRANTS (Tables) Tables http://iveda.com/role/StockOptionPlanAndWarrants 23 false false R24.htm 995527 - Disclosure - INCOME TAXES (Tables) Sheet http://iveda.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://iveda.com/role/IncomeTaxes 24 false false R25.htm 995528 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables) Sheet http://iveda.com/role/EarningsLossPerShareTables EARNINGS (LOSS) PER SHARE (Tables) Tables http://iveda.com/role/EarningsLossPerShare 25 false false R26.htm 995529 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Sheet http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details) Details 26 false false R27.htm 995530 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) Sheet http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details) Details 27 false false R28.htm 995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables 28 false false R29.htm 995532 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) Sheet http://iveda.com/role/ScheduleOfShort-termDebtDetails SCHEDULE OF SHORT-TERM DEBT (Details) Details 29 false false R30.htm 995533 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) Sheet http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical) Details 30 false false R31.htm 995534 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) Sheet http://iveda.com/role/ScheduleOfLong-termDebtDetails SCHEDULE OF LONG-TERM DEBT (Details) Details 31 false false R32.htm 995535 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) Sheet http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical) Details 32 false false R33.htm 995536 - Disclosure - PREFERRED STOCK (Details Narrative) Sheet http://iveda.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details Narrative) Details http://iveda.com/role/PreferredStock 33 false false R34.htm 995537 - Disclosure - EQUITY (Details Narrative) Sheet http://iveda.com/role/EquityDetailsNarrative EQUITY (Details Narrative) Details http://iveda.com/role/Equity 34 false false R35.htm 995538 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Sheet http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Details 35 false false R36.htm 995539 - Disclosure - SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details) Sheet http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details) Details 36 false false R37.htm 995540 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) Sheet http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details) Details 37 false false R38.htm 995541 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details) Sheet http://iveda.com/role/ScheduleOfWarrantTransactionsDetails SCHEDULE OF WARRANT TRANSACTIONS (Details) Details 38 false false R39.htm 995542 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) Sheet http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details) Details 39 false false R40.htm 995543 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Sheet http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Details 40 false false R41.htm 995544 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative) Sheet http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative STOCK OPTION PLAN AND WARRANTS (Details Narrative) Details http://iveda.com/role/StockOptionPlanAndWarrantsTables 41 false false R42.htm 995545 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 42 false false R43.htm 995546 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) Sheet http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details) Details 43 false false R44.htm 995547 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://iveda.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://iveda.com/role/IncomeTaxesTables 44 false false R45.htm 995548 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Sheet http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details) Details 45 false false R46.htm 995549 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative) Sheet http://iveda.com/role/EarningsLossPerShareDetailsNarrative EARNINGS (LOSS) PER SHARE (Details Narrative) Details http://iveda.com/role/EarningsLossPerShareTables 46 false false R47.htm 995550 - Disclosure - CONTINGENT LIABILITIES???TAIWAN (Details Narrative) Sheet http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative CONTINGENT LIABILITIES???TAIWAN (Details Narrative) Details http://iveda.com/role/ContingentLiabilitiestaiwan 47 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:PropertyPlantAndEquipmentUsefulLife - form10-k.htm 61 form10-k.htm ivda-20231231.xsd ivda-20231231_cal.xml ivda-20231231_def.xml ivda-20231231_lab.xml ivda-20231231_pre.xml form10-k001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 68 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "IVDA", "nsuri": "http://iveda.com/20231231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "ivda-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "ivda-20231231_cal.xml" ] }, "definitionLink": { "local": [ "ivda-20231231_def.xml" ] }, "labelLink": { "local": [ "ivda-20231231_lab.xml" ] }, "presentationLink": { "local": [ "ivda-20231231_pre.xml" ] } }, "keyStandard": 220, "keyCustom": 25, "axisStandard": 14, "axisCustom": 0, "memberStandard": 16, "memberCustom": 18, "hidden": { "total": 56, "http://fasb.org/us-gaap/2023": 51, "http://iveda.com/20231231": 2, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 128, "entityCount": 1, "segmentCount": 35, "elementCount": 458, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 465, "http://xbrl.sec.gov/dei/2023": 35, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://iveda.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://iveda.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R3": { "role": "http://iveda.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R4": { "role": "http://iveda.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R5": { "role": "http://iveda.com/role/StatementsOfStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://iveda.com/role/StatementsOfStockholdersEquityParenthetical", "longName": "00000006 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)", "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2022-01-012022-03-31", "name": "us-gaap:StockholdersEquityReverseStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "i", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-03-31", "name": "us-gaap:StockholdersEquityReverseStockSplit", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "i", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R7": { "role": "http://iveda.com/role/StatementsOfCashFlows", "longName": "00000007 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://iveda.com/role/SummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://iveda.com/role/RelatedParties", "longName": "995514 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://iveda.com/role/Short-termAndLong-termDebt", "longName": "995515 - Disclosure - SHORT-TERM AND LONG-TERM DEBT", "shortName": "SHORT-TERM AND LONG-TERM DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://iveda.com/role/PreferredStock", "longName": "995516 - Disclosure - PREFERRED STOCK", "shortName": "PREFERRED STOCK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://iveda.com/role/Equity", "longName": "995517 - Disclosure - EQUITY", "shortName": "EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://iveda.com/role/StockOptionPlanAndWarrants", "longName": "995518 - Disclosure - STOCK OPTION PLAN AND WARRANTS", "shortName": "STOCK OPTION PLAN AND WARRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://iveda.com/role/IncomeTaxes", "longName": "995519 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://iveda.com/role/EarningsLossPerShare", "longName": "995520 - Disclosure - EARNINGS (LOSS) PER SHARE", "shortName": "EARNINGS (LOSS) PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://iveda.com/role/ContingentLiabilitiestaiwan", "longName": "995521 - Disclosure - CONTINGENT LIABILITIES\u2014TAIWAN", "shortName": "CONTINGENT LIABILITIES\u2014TAIWAN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://iveda.com/role/SubsequentEvents", "longName": "995522 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "IVDA:NatureOfOperationsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "IVDA:NatureOfOperationsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://iveda.com/role/Short-termAndLong-termDebtTables", "longName": "995525 - Disclosure - SHORT-TERM AND LONG-TERM DEBT (Tables)", "shortName": "SHORT-TERM AND LONG-TERM DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://iveda.com/role/StockOptionPlanAndWarrantsTables", "longName": "995526 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Tables)", "shortName": "STOCK OPTION PLAN AND WARRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://iveda.com/role/IncomeTaxesTables", "longName": "995527 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://iveda.com/role/EarningsLossPerShareTables", "longName": "995528 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)", "shortName": "EARNINGS (LOSS) PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails", "longName": "995529 - Disclosure - SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "shortName": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "IVDA:AccountsAndOtherPayablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "longName": "995530 - Disclosure - SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details)", "shortName": "SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_country_US", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_country_US", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "NTD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "NTD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "longName": "995532 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details)", "shortName": "SCHEDULE OF SHORT-TERM DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShortTermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ShanghaiBankMember", "name": "us-gaap:ShortTermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R30": { "role": "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "longName": "995533 - Disclosure - SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical)", "shortName": "SCHEDULE OF SHORT-TERM DEBT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ShanghaiBankMember", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ShanghaiBankMember_srt_MinimumMember", "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R31": { "role": "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "longName": "995534 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details)", "shortName": "SCHEDULE OF LONG-TERM DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_ShanghaiBankMember", "name": "us-gaap:LoansPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R32": { "role": "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "longName": "995535 - Disclosure - SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical)", "shortName": "SCHEDULE OF LONG-TERM DEBT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_ShanghaiBankMember", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShortTermDebtTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ShanghaiBankMember_srt_MinimumMember", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R33": { "role": "http://iveda.com/role/PreferredStockDetailsNarrative", "longName": "995536 - Disclosure - PREFERRED STOCK (Details Narrative)", "shortName": "PREFERRED STOCK (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_SeriesAPreferredStockMember", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R34": { "role": "http://iveda.com/role/EquityDetailsNarrative", "longName": "995537 - Disclosure - EQUITY (Details Narrative)", "shortName": "EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_srt_MaximumMember", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R35": { "role": "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "longName": "995538 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "shortName": "SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R36": { "role": "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails", "longName": "995539 - Disclosure - SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details)", "shortName": "SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "longName": "995540 - Disclosure - SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)", "shortName": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R38": { "role": "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "longName": "995541 - Disclosure - SCHEDULE OF WARRANT TRANSACTIONS (Details)", "shortName": "SCHEDULE OF WARRANT TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R39": { "role": "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails", "longName": "995542 - Disclosure - SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details)", "shortName": "SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_WarrantMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "IVDA:SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R40": { "role": "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "longName": "995543 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)", "shortName": "SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_WarrantMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "IVDA:ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R41": { "role": "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "longName": "995544 - Disclosure - STOCK OPTION PLAN AND WARRANTS (Details Narrative)", "shortName": "STOCK OPTION PLAN AND WARRANTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R42": { "role": "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "995545 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R43": { "role": "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails", "longName": "995546 - Disclosure - SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details)", "shortName": "SUMMARY OF OPERATING LOSS CARRYFORWARDS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "IVDA:YearOfExpiration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R44": { "role": "http://iveda.com/role/IncomeTaxesDetailsNarrative", "longName": "995547 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "IVDA:TaiwanCorporateTaxRate", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R45": { "role": "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "longName": "995548 - Disclosure - SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "shortName": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "IVDA:WeightedAverageSharesOutstandingBasic", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R46": { "role": "http://iveda.com/role/EarningsLossPerShareDetailsNarrative", "longName": "995549 - Disclosure - EARNINGS (LOSS) PER SHARE (Details Narrative)", "shortName": "EARNINGS (LOSS) PER SHARE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R47": { "role": "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "longName": "995550 - Disclosure - CONTINGENT LIABILITIES\u2014TAIWAN (Details Narrative)", "shortName": "CONTINGENT LIABILITIES\u2014TAIWAN (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_MegasysMember", "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_MegasysMember", "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } } }, "tag": { "stpr_AZ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "AZ", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ARIZONA" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "IVDA_AccountsAndOtherPayablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://iveda.com/20231231", "localname": "AccountsAndOtherPayablesPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts and Other Payables", "documentation": "Accounts And Other Payables [Policy Text Block]", "label": "Accounts And Other Payables [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts and Other Payables", "totalLabel": "Accounts and Other Payables", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r25", "r627" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r590" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r251", "r252" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r27" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Comprehensive Loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r33", "r34", "r95", "r160", "r455", "r487", "r488" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r14", "r34", "r404", "r407", "r423", "r483", "r484", "r743", "r744", "r745", "r753", "r754", "r755" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r689" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid-In Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r90", "r627", "r815" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r378", "r379", "r380", "r501", "r753", "r754", "r755", "r796", "r817" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r695" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r695" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r695" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r695" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Based Compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r70", "r71", "r345" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Costs of Capital", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing." } } }, "auth_ref": [ "r51" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Warrants for Services", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r15", "r50", "r117" ] }, "IVDA_AdjustmentsToAdditionalPaidInCapitalWarrantsSoldInOverAllotment": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantsSoldInOverAllotment", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Warrants sold in Over allotment", "documentation": "Adjustments to additional paid-in capital warrants sold in over allotment." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r659", "r671", "r681", "r707" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r662", "r674", "r684", "r710" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r695" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r702" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r666", "r675", "r685", "r702", "r711", "r715", "r723" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for uncollectible accounts", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r161", "r255", "r260", "r261", "r262", "r811" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r667" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r123", "r155", "r185", "r219", "r239", "r245", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r399", "r401", "r413", "r452", "r536", "r627", "r640", "r763", "r764", "r801" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r150", "r165", "r185", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r399", "r401", "r413", "r627", "r763", "r764", "r801" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNet", "crdr": "debit", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "lang": { "en-us": { "role": { "label": "Net Assets (Liabilities)", "documentation": "Amount of net assets (liabilities)." } } }, "auth_ref": [ "r12" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "OTHER ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Assets", "label": "Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets, excluding property, plant, and equipment and other property and investments, that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Charges and Other Assets." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r667" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r652", "r654", "r667" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r652", "r654", "r667" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r652", "r654", "r667" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r718" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r719" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r714" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r714" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r714" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r714" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r714" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r714" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r717" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r716" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r715" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r715" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r35", "r153", "r606" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r36" ] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted Cash", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r36", "r122" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and Cash Equivalents- Beginning of Period", "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r35", "r106", "r182" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r106" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash, FDIC Insured Amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "IVDA_ChangHwaBankMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ChangHwaBankMember", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Chang Hwa Bank [Member]", "documentation": "Chang Hwa Bank [Member]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r693" ] }, "IVDA_ChiconyPowerTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ChiconyPowerTechnologyMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chicony Power Technology [Member]", "documentation": "Chicony Power Technology [Member]" } } }, "auth_ref": [] }, "IVDA_ChunghwaTelecomMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ChunghwaTelecomMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chunghwa Telecom [Member]", "documentation": "Chunghwa Telecom [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r146", "r157", "r158", "r159", "r185", "r204", "r205", "r208", "r210", "r216", "r217", "r257", "r284", "r286", "r287", "r288", "r291", "r292", "r313", "r314", "r317", "r320", "r327", "r413", "r492", "r493", "r494", "r495", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r524", "r545", "r566", "r583", "r584", "r585", "r586", "r587", "r732", "r749", "r756" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r157", "r158", "r159", "r216", "r313", "r314", "r315", "r317", "r320", "r325", "r327", "r492", "r493", "r494", "r495", "r620", "r732", "r749" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Range of Exercise Prices", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r328" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r694" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r694" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwan" ], "lang": { "en-us": { "role": { "label": "CONTINGENT LIABILITIES\u2014TAIWAN", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r112", "r278", "r279", "r591", "r760" ] }, "IVDA_CommonStockAndPrefundedWarrantOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "CommonStockAndPrefundedWarrantOffering", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock and Pre-Funded Warrant Offering for Cash \u2013 August 2022", "documentation": "Common stock and prefunded warrant offering" } } }, "auth_ref": [] }, "IVDA_CommonStockAndPrefundedWarrantOfferingShares": { "xbrltype": "sharesItemType", "nsuri": "http://iveda.com/20231231", "localname": "CommonStockAndPrefundedWarrantOfferingShares", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock and Pre-Funded Warrant Offering for Cash - August 2022, shares", "documentation": "Common stock and prefunded warrant offering shares" } } }, "auth_ref": [] }, "IVDA_CommonStockIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "CommonStockIssuedForServices", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common Stock issued for Services", "documentation": "Common stock issued for services." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r630", "r631", "r632", "r634", "r635", "r636", "r637", "r753", "r754", "r796", "r814", "r817" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r89" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/EquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r89", "r524" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r89" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r15", "r89", "r524", "r542", "r817", "r818" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value; 100,000,000 shares authorized; 16,169,891 and 15,066,739 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r89", "r454", "r627" ] }, "IVDA_CommonStockWarrantsIssuedForInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "CommonStockWarrantsIssuedForInterest", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common Stock Warrants Issued for Interest", "documentation": "Common stock warrants issued for interest." } } }, "auth_ref": [] }, "IVDA_CommonStockWarrantsIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "CommonStockWarrantsIssuedForServices", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common Stock Warrants Issued for Services", "documentation": "Common stock warrants issued for services." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r699" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r698" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r700" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r697" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Comprehensive Loss", "label": "Comprehensive Income, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r38", "r40", "r77", "r78", "r250", "r590" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r38", "r40", "r77", "r78", "r250", "r489", "r590" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r38", "r40", "r77", "r78", "r250", "r590", "r735" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r85", "r139" ] }, "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure", "crdr": "debit", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Financial exposure contingent future payments", "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity." } } }, "auth_ref": [ "r79" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of concentration risk", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r38", "r40", "r77", "r78", "r250" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r38", "r40", "r77", "r78", "r250", "r590" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r76", "r608" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "COST OF REVENUE", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r100", "r185", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r413", "r763" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r39", "r250" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Interest rate", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r29", "r81", "r305" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt interest rate", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r29", "r81", "r311", "r422" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r187", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r422", "r615", "r616", "r617", "r618", "r619", "r750" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt instrument, maturity date", "verboseLabel": "Debt instrument, maturity date, description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r30" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r31", "r55", "r58", "r80", "r81", "r83", "r84", "r115", "r116", "r187", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r422", "r615", "r616", "r617", "r618", "r619", "r750" ] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfAccountsAndOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue and Customer Deposits", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r739" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Tax Assets, Net", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r794" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "crdr": "debit", "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Operating Loss Carryforward - USA", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards." } } }, "auth_ref": [ "r75", "r795" ] }, "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOtherLossCarryforwards", "crdr": "debit", "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other." } } }, "auth_ref": [ "r75", "r795" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation Allowance - USA", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r388" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DepositContractsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositContractsPolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deposits \u2013 Current", "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer." } } }, "auth_ref": [ "r0" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r7", "r49" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r7", "r224" ] }, "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther", "crdr": "credit", "presentation": [ "http://iveda.com/role/EarningsLossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dilutive securities convertible", "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrants" ], "lang": { "en-us": { "role": { "label": "STOCK OPTION PLAN AND WARRANTS", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r343", "r347", "r374", "r375", "r377", "r625" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTION TRANSACTIONS", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r9", "r64" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r654" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r652", "r654", "r667" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r652", "r654", "r667", "r703" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r653" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r641" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r654" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r654" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r688" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r644" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "BASIC LOSS PER SHARE", "verboseLabel": "Basic Loss Per Share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r193", "r194", "r195", "r196", "r197", "r202", "r204", "r208", "r209", "r210", "r214", "r411", "r412", "r449", "r463", "r610" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Basic EPS" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "DILUTED LOSS PER SHARE", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r177", "r193", "r194", "r195", "r196", "r197", "r204", "r208", "r209", "r210", "r214", "r411", "r412", "r449", "r463", "r610" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://iveda.com/role/EarningsLossPerShare" ], "lang": { "en-us": { "role": { "label": "EARNINGS (LOSS) PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r201", "r211", "r212", "r213" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "EFFECT OF EXCHANGE RATE CHANGES ON CASH", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r799" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock- based compensation", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r376" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r647" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r643" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r643" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r731" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r643" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r728" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r667" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r643" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r643" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r643" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r643" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r729" ] }, "IVDA_EquipmentSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "EquipmentSalesMember", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Equipment Sales [Member]", "documentation": "Equipment Sales [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r15", "r147", "r171", "r172", "r173", "r188", "r189", "r190", "r192", "r198", "r200", "r215", "r258", "r259", "r329", "r378", "r379", "r380", "r392", "r393", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r414", "r416", "r417", "r418", "r419", "r420", "r423", "r483", "r484", "r485", "r501", "r566" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r696" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r659", "r671", "r681", "r707" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r656", "r668", "r678", "r704" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r702" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r10", "r23" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r663", "r675", "r685", "r711" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r663", "r675", "r685", "r711" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r663", "r675", "r685", "r711" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r663", "r675", "r685", "r711" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r663", "r675", "r685", "r711" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "GROSS PROFIT", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r98", "r185", "r219", "r238", "r244", "r246", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r413", "r611", "r763" ] }, "IVDA_HuaNamBankMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "HuaNamBankMember", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Hua Nam Bank [Member]", "documentation": "Hua Nam Bank [Member]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r1", "r111" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS BEFORE INCOME TAXES", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r2", "r96", "r127", "r219", "r238", "r244", "r246", "r450", "r460", "r611" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://iveda.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r186", "r381", "r385", "r386", "r390", "r394", "r396", "r397", "r398", "r497" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "BENEFIT (PROVISION) FOR INCOME TAXES", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r133", "r144", "r199", "r200", "r227", "r384", "r395", "r464" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r170", "r382", "r383", "r386", "r387", "r389", "r391", "r491" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Tax Paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r37" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts Receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "(Increase) Decrease in Operating Assets" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayable", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts and Other Payables", "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other Current Assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r747" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other Assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r747" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r666", "r675", "r685", "r702", "r711", "r715", "r723" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r721" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r655", "r727" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r655", "r727" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r655", "r727" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest Expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r82", "r129", "r174", "r223", "r421", "r551", "r638", "r816" ] }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestOnConvertibleDebtNetOfTax", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest Value of Convertible Debt Issued", "label": "Interest on Convertible Debt, Net of Tax", "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash." } } }, "auth_ref": [ "r203", "r206", "r210" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest Paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r178", "r180", "r181" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r163", "r607", "r627" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r134", "r152", "r162", "r263", "r264", "r265", "r434", "r609" ] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory reserve", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r47", "r742" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r102", "r222" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Stockholders\u2019 Equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r94", "r126", "r457", "r627", "r751", "r758", "r798" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r28", "r151", "r185", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r400", "r401", "r402", "r413", "r627", "r763", "r801", "r802" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableCurrent", "crdr": "credit", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "Loans", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r27" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongDurationContractsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongDurationContractsPolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deposits\u2014Long-Term", "documentation": "Disclosure of accounting policy for long-duration insurance products (whole life, universal life, variable annuities, guaranteed renewable term, and title insurance contracts), including the basis for recognizing and determining amounts of revenues and policyholder funds pertaining to long-duration contracts, the general nature of and basis of presentation for separate accounts of contract holders, the practices and methods of allocating fees to policyholders' and contract holders' accounts, the nature, terms, valuation methods and assumptions used to determine fair value of minimum guarantees provided to policy and contract holders, and the methods used for capitalizing and amortizing sales inducements and policy acquisition costs. Disclosure may also include the classification of cash receipts and cash disbursements in statement of cash flows." } } }, "auth_ref": [ "r136", "r137" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfLong-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "LONG-TERM DEBT", "verboseLabel": "Long term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r24", "r125", "r300", "r310", "r616", "r617", "r810" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfLong-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "Current Portion of Long-Term Debt", "negatedLabel": "Current portion of long term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r156" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r250", "r623", "r767", "r812", "r813" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://iveda.com/role/EquityDetailsNarrative", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r342", "r433", "r482", "r516", "r517", "r574", "r576", "r578", "r579", "r581", "r601", "r602", "r613", "r620", "r624", "r629", "r765", "r803", "r804", "r805", "r806", "r807", "r808" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r694" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r694" ] }, "IVDA_MegasysMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "MegasysMember", "presentation": [ "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Megasys [Member]", "documentation": "Megasys [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r342", "r433", "r482", "r516", "r517", "r574", "r576", "r578", "r579", "r581", "r601", "r602", "r613", "r620", "r624", "r629", "r765", "r803", "r804", "r805", "r806", "r807", "r808" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r714" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r722" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r250", "r623", "r767", "r812", "r813" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r695" ] }, "IVDA_NatureOfOperationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://iveda.com/20231231", "localname": "NatureOfOperationsPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Nature of Operations", "documentation": "Nature Of Operations [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Provided by Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r179" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Provided by (Used in) Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r179" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Used in Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r106", "r107", "r108" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://iveda.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://iveda.com/role/StatementsOfCashFlows", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "NET LOSS", "label": "Net Loss", "verboseLabel": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r97", "r108", "r128", "r149", "r166", "r168", "r173", "r185", "r191", "r193", "r194", "r195", "r196", "r199", "r200", "r207", "r219", "r238", "r244", "r246", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r412", "r413", "r461", "r544", "r564", "r565", "r611", "r638", "r763" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Standards", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "IVDA_NonControlledInterestInJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "NonControlledInterestInJointVentures", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Joint Venture Non-Controlled Equity Portion", "documentation": "Non controlled interest in joint ventures." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r694" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r692" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r691" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r722" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r722" ] }, "us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Joint Venture Non-Controlled Interest", "label": "Noncontrolling Interest in Net Income (Loss) Joint Venture Partners, Nonredeemable", "documentation": "Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture." } } }, "auth_ref": [ "r99" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Income (Expense)", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r103" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OTHER INCOME (EXPENSE)" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Operating Expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "LOSS FROM OPERATIONS", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r219", "r238", "r244", "r246", "r611" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Net operating loss", "verboseLabel": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r74" ] }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLimitationsOnUse", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforwards, limitations on use", "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r73" ] }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsValuationAllowance", "crdr": "credit", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Valuation allowance increased", "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r72" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Current Assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r164", "r627" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r154" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Comprehensive Loss", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r15", "r22", "r167", "r169", "r176", "r414", "r415", "r420", "r448", "r462", "r743", "r744" ] }, "IVDA_OtherCurrentAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://iveda.com/20231231", "localname": "OtherCurrentAssetsPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Other Current Assets", "documentation": "Other Current Assets [Policy Text Block]", "label": "Other Current Assets [Policy Text Block]" } } }, "auth_ref": [] }, "IVDA_OtherCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "OtherCustomersMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Customers [Member]", "documentation": "Other Customers [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Miscellaneous Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r104" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r694" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r654" ] }, "IVDA_OtherRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "OtherRevenueMember", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Revenue [Member]", "documentation": "Other Revenue [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r661", "r673", "r683", "r709" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r664", "r676", "r686", "r712" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r664", "r676", "r686", "r712" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r690" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of Property and Equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r105" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r693" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r693" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r692" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r695" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r691" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r648" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r649" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r630", "r631", "r634", "r635", "r636", "r637", "r814", "r817" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, par value", "verboseLabel": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r88", "r313" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r88", "r524" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r88", "r313" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://iveda.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r88", "r524", "r542", "r817", "r818" ] }, "us-gaap_PreferredStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockTextBlock", "presentation": [ "http://iveda.com/role/PreferredStock" ], "lang": { "en-us": { "role": { "label": "PREFERRED STOCK", "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock." } } }, "auth_ref": [ "r114" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, value", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r88", "r453", "r627" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassification", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r737" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common Stock Issued, Net of (Cost of Capital)", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Joint Venture Non-Controlled Equity Portion", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r733", "r746" ] }, "IVDA_ProceedsFromRepaymentsOfChangesInRestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "ProceedsFromRepaymentsOfChangesInRestrictedCash", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in Restricted Cash", "documentation": "Proceeds from repayments of changes in restricted cash." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfNotesPayable", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Payments to) Long-Term Debt", "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Payments to) Due to Related Parties", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfShortTermDebt", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Payments on) Short-Term Notes Payable/Debt", "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r247", "r435", "r476", "r477", "r478", "r479", "r480", "r481", "r604", "r621", "r628", "r736", "r761", "r762", "r767", "r812" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "auth_ref": [ "r247", "r435", "r476", "r477", "r478", "r479", "r480", "r481", "r604", "r621", "r628", "r736", "r761", "r762", "r767", "r812" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT, NET", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r451", "r459", "r627" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r8", "r140", "r143", "r458" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r690" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r690" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://iveda.com/role/EquityDetailsNarrative", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r280", "r281", "r282", "r283", "r340", "r342", "r370", "r371", "r372", "r432", "r433", "r482", "r516", "r517", "r574", "r576", "r578", "r579", "r581", "r601", "r602", "r613", "r620", "r624", "r629", "r632", "r759", "r765", "r804", "r805", "r806", "r807", "r808" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://iveda.com/role/EquityDetailsNarrative", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "auth_ref": [ "r280", "r281", "r282", "r283", "r340", "r342", "r370", "r371", "r372", "r432", "r433", "r482", "r516", "r517", "r574", "r576", "r578", "r579", "r581", "r601", "r602", "r613", "r620", "r624", "r629", "r632", "r759", "r765", "r804", "r805", "r806", "r807", "r808" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r656", "r668", "r678", "r704" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r341", "r427", "r428", "r519", "r520", "r521", "r522", "r523", "r541", "r543", "r573" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r341", "r427", "r428", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r519", "r520", "r521", "r522", "r523", "r541", "r543", "r573", "r800" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://iveda.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r424", "r425", "r426", "r428", "r429", "r498", "r499", "r500", "r548", "r549", "r550", "r570", "r572" ] }, "IVDA_RepublicOfChinaTaiwanMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "RepublicOfChinaTaiwanMember", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "lang": { "en-us": { "role": { "label": "Republic of China (Taiwan) [Member]", "documentation": "Republic of China (Taiwan) [Member]." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r657", "r669", "r679", "r705" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r658", "r670", "r680", "r706" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r665", "r677", "r687", "r713" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Restricted Cash", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r738", "r748" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r91", "r117", "r456", "r486", "r488", "r496", "r525", "r627" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r147", "r188", "r189", "r190", "r192", "r198", "r200", "r258", "r259", "r378", "r379", "r380", "r392", "r393", "r403", "r405", "r406", "r408", "r410", "r483", "r485", "r501", "r817" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "TOTAL REVENUE", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r220", "r221", "r237", "r242", "r243", "r247", "r248", "r250", "r338", "r339", "r435" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r145", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r603" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "lang": { "en-us": { "role": { "label": "Net Revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r175", "r185", "r220", "r221", "r237", "r242", "r243", "r247", "r248", "r250", "r257", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r413", "r450", "r763" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "REVENUE" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r722" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r722" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r250", "r734" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCOUNTS AND OTHER PAYABLES", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LONG-TERM DEBT", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r31", "r55", "r58", "r80", "r81", "r83", "r84", "r115", "r116", "r616", "r618", "r752" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://iveda.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r11", "r59", "r60", "r61", "r62" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://iveda.com/role/EarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r757" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r44", "r45", "r46", "r48" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r344", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r120" ] }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTextBlock", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHORT-TERM DEBT", "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r52", "r53", "r54", "r55", "r56", "r57", "r58", "r115", "r116", "r117", "r157", "r158", "r159", "r216", "r313", "r314", "r315", "r317", "r320", "r325", "r327", "r492", "r493", "r494", "r495", "r620", "r732", "r749" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT TRANSACTIONS", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r63" ] }, "IVDA_ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://iveda.com/20231231", "localname": "ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE", "documentation": "Schedule of Warrants Outstanding And Exercisable [Table Text Block]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r642" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r646" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r645" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r650" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r250", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r614", "r736", "r812" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "auth_ref": [ "r248", "r249", "r513", "r514", "r515", "r575", "r577", "r580", "r582", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r605", "r622", "r632", "r767", "r812" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Information", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r231", "r232", "r233", "r234", "r235", "r236", "r248", "r612" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General & Administrative", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r101" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://iveda.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r740", "r741", "r766" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r740", "r741", "r766" ] }, "IVDA_ServiceRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ServiceRevenueMember", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Service Revenue [Member]", "documentation": "Service Revenue [Member]" } } }, "auth_ref": [] }, "IVDA_ShanghaiBankMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShanghaiBankMember", "presentation": [ "http://iveda.com/role/ScheduleOfLong-termDebtDetails", "http://iveda.com/role/ScheduleOfLong-termDebtDetailsParenthetical", "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shanghai Bank [Member]", "documentation": "Shanghai Bank [Member]" } } }, "auth_ref": [] }, "IVDA_ShanghaiBankOneMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShanghaiBankOneMember", "presentation": [ "http://iveda.com/role/ScheduleOfShort-termDebtDetails", "http://iveda.com/role/ScheduleOfShort-termDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shanghai Bank One [Member]", "documentation": "Shanghai Bank One [Member]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://iveda.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://iveda.com/role/StatementsOfCashFlows", "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Option Compensation", "verboseLabel": "Stock option compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-Average Fair Value of Options Granted During the Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r362" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Dividend yield", "verboseLabel": "Dividend Yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r371" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "verboseLabel": "Expected Volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r370" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Risk-Free interest rate", "verboseLabel": "Risk-Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r372" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r344", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373" ] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Shares, Options Exercisable at End of Year", "label": "Warrants Exercisable, Number Exercisable", "documentation": "Non option equity instruments exercisable number." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, Exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, Forfeited or Canceled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r20" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Outstanding at Beginning of Year", "periodEndLabel": "Shares, Outstanding at End of Year", "label": "Warrants Outstanding, Number Outstanding", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r16", "r17" ] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-Average Exercise Price, Options Exercisable at End of Year", "label": "Warrants Exercisable, Weighted-Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average ExercisePrice." } } }, "auth_ref": [] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Exercised", "documentation": "Share based compensation arrangement by share based payment award non options exercised weighted average exercise price." } } }, "auth_ref": [] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-Average Exercise Price, Forfeited or Canceled", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, forfeited.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-Average Exercise Price, Granted", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding, Granted.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "IVDA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://iveda.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantTransactionsDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at Beginning of Year", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at End of Year", "label": "Warrants Outstanding, Weighted-Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average ExercisePrice." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized under plan", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r626" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Shares, Options Exercisable at End of Year", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r353" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-Average Exercise Price, Options Exercisable at End of Year", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r353" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, Forfeited or Canceled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r357" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Granted", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r775" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Fair Value of Options Granted During the Period", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r365" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares, Outstanding at Beginning of Year", "periodEndLabel": "Shares, Outstanding at End of Year", "label": "Options outstanding", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r351", "r352" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at Beginning of Year", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at End of Year", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r351", "r352" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE", "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r356" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Forfeited or Canceled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r357" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r355" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Range of Exercise, Lower Range Limit", "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Options Exercisable, Number Exercisable", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding, Number Outstanding", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Range of Exercise, Upper Range Limit", "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r69" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://iveda.com/role/ScheduleOfBlack-scholesOption-pricingModelDetails", "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Expected life", "verboseLabel": "Expected Life", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r369" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Options Exercisable, Weighted-Average Exercise Price", "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding." } } }, "auth_ref": [ "r67" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding, Weighted-Average Exercise Price", "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices." } } }, "auth_ref": [ "r66" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionOutstandingAndExercisableDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding, Weighted- Average Remaining Contractual Life", "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r119" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/ScheduleOfShort-termDebtDetails" ], "lang": { "en-us": { "role": { "label": "Short Term Debt", "verboseLabel": "Short term debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r87", "r124", "r627", "r809" ] }, "us-gaap_ShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTextBlock", "presentation": [ "http://iveda.com/role/Short-termAndLong-termDebt" ], "lang": { "en-us": { "role": { "label": "SHORT-TERM AND LONG-TERM DEBT", "documentation": "The entire disclosure for short-term debt." } } }, "auth_ref": [ "r113" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r109", "r183" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r651" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r148", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r250", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r614", "r736", "r812" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/PreferredStockDetailsNarrative", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r146", "r157", "r158", "r159", "r185", "r204", "r205", "r208", "r210", "r216", "r217", "r257", "r284", "r286", "r287", "r288", "r291", "r292", "r313", "r314", "r317", "r320", "r327", "r413", "r492", "r493", "r494", "r495", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r524", "r545", "r566", "r583", "r584", "r585", "r586", "r587", "r732", "r749", "r756" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r15", "r32", "r147", "r171", "r172", "r173", "r188", "r189", "r190", "r192", "r198", "r200", "r215", "r258", "r259", "r329", "r378", "r379", "r380", "r392", "r393", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r414", "r416", "r417", "r418", "r419", "r420", "r423", "r483", "r484", "r485", "r501", "r566" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r248", "r249", "r513", "r514", "r515", "r575", "r577", "r580", "r582", "r589", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r605", "r622", "r632", "r767", "r812" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/EquityDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r188", "r189", "r190", "r215", "r435", "r490", "r512", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r537", "r538", "r539", "r540", "r541", "r543", "r546", "r547", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r566", "r633" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/BalanceSheetsParenthetical", "http://iveda.com/role/ContingentLiabilitiestaiwanDetailsNarrative", "http://iveda.com/role/EquityDetailsNarrative", "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails", "http://iveda.com/role/StatementsOfOperations", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r188", "r189", "r190", "r215", "r435", "r490", "r512", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r537", "r538", "r539", "r540", "r541", "r543", "r546", "r547", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r566", "r633" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r660", "r672", "r682", "r708" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock issued for conversion error, shares", "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r15", "r55", "r88", "r89", "r117" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock issued for services, shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock Offering for Cash, shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r15", "r88", "r89", "r117", "r492", "r566", "r584" ] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "8 for 1 conversion adjustment, shares", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r15" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://iveda.com/role/ScheduleOfStockOptionTransactionsDetails", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of options and warrants, shares", "negatedLabel": "Shares, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r15", "r88", "r89", "r117", "r356" ] }, "IVDA_StockIssuedDuringPeriodSharesStockWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://iveda.com/20231231", "localname": "StockIssuedDuringPeriodSharesStockWarrantsExercised", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants issued August 2022, shares", "documentation": "Stock Issued During Period Shares Stock Warrants Exercised." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock issued for conversion error", "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)." } } }, "auth_ref": [ "r15", "r32", "r117" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock issued for services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock Offering for Cash", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r15", "r88", "r89", "r117", "r501", "r566", "r584", "r639" ] }, "IVDA_StockIssuedDuringPeriodValueReverseStockSplits": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "StockIssuedDuringPeriodValueReverseStockSplits", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "8 for 1 conversion adjustment", "documentation": "Stock issued during period value reverse stock splits." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of options and warrants", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r15", "r32", "r117" ] }, "IVDA_StockIssuedDuringPeriodValueStockWarrantsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "StockIssuedDuringPeriodValueStockWarrantsExercised", "crdr": "credit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants issued August 2022", "documentation": "Stock issued during period value stock warrants exercised." } } }, "auth_ref": [] }, "IVDA_StockIssuedValueJointVenturePartnersNonControlledEquityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://iveda.com/20231231", "localname": "StockIssuedValueJointVenturePartnersNonControlledEquityInterest", "crdr": "debit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Joint Venture Non-Controlled Equity Interest", "label": "StockIssuedValueJointVenturePartnersNonControlledEquityInterest" } } }, "auth_ref": [] }, "IVDA_StockOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "StockOptionPlanMember", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Option Plan [Member]", "documentation": "Stock Option Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://iveda.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://iveda.com/role/BalanceSheets", "http://iveda.com/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Stockholders\u2019 Equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r89", "r92", "r93", "r110", "r526", "r542", "r567", "r568", "r627", "r640", "r751", "r758", "r798", "r817" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://iveda.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://iveda.com/role/Equity" ], "lang": { "en-us": { "role": { "label": "EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r114", "r184", "r312", "r314", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r326", "r329", "r409", "r569", "r571", "r588" ] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://iveda.com/role/StatementsOfStockholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r118" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://iveda.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r430", "r431" ] }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "presentation": [ "http://iveda.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF OPERATING LOSS CARRYFORWARDS", "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r73" ] }, "IVDA_SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://iveda.com/20231231", "localname": "SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION", "documentation": "Summary Of Warrants Outstanding And Exercisable Information [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://iveda.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r701" ] }, "IVDA_TaiwanCoMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "TaiwanCoMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Taiwan Co [Member]", "documentation": "Taiwan Co [Member]" } } }, "auth_ref": [] }, "IVDA_TaiwanCorporateTaxRate": { "xbrltype": "stringItemType", "nsuri": "http://iveda.com/20231231", "localname": "TaiwanCorporateTaxRate", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Taiwan corporate tax rate", "documentation": "Taiwan corporate tax rate." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r693" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r700" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r130", "r131", "r132", "r253", "r254", "r256" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r724" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r725" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r723" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r723" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r726" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r724" ] }, "IVDA_TwoThousandTenStockOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "TwoThousandTenStockOptionPlanMember", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2010 Stock Option Plan [Member]", "documentation": "2010 Stock Option Plan [Member]" } } }, "auth_ref": [] }, "IVDA_TwoThousandTwentyPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "TwoThousandTwentyPlanMember", "presentation": [ "http://iveda.com/role/StockOptionPlanAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2020 Plan [Member]", "documentation": "2020 Plan [Member]" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://iveda.com/role/ScheduleOfNetRevenueAndNetAssetsLiabilitiesForOtherSignificantGeographicRegionsDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r720" ] }, "IVDA_UsBasedSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "UsBasedSegmentMember", "presentation": [ "http://iveda.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "U.S. - Based Segment [Member]", "documentation": "U.S. - Based Segment [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r41", "r42", "r43", "r135", "r138", "r141", "r142" ] }, "us-gaap_UtilityRevenueAndExpenseRecognitionPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UtilityRevenueAndExpenseRecognitionPolicy", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue and Expense Recognition", "documentation": "Disclosure of accounting policies and anticipated effects of regulatory rulings and on rate-setting regarding revenues and expenses incurred and recovered, including billed and unbilled revenues, revenues collected subject to refund, taxes collected from customers and remitted to governmental authorities, and postretirement benefits." } } }, "auth_ref": [ "r86" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://iveda.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails", "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r630", "r631", "r634", "r635", "r636", "r637" ] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://iveda.com/role/SummaryOfWarrantsOutstandingAndExercisableInformationDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding, Weighted-Average Remaining Contractual Life", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r797" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "DILUTED WEIGHTED AVERAGE SHARES", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r203", "r210" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://iveda.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "BASIC WEIGHTED AVERAGE SHARES", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r202", "r210" ] }, "IVDA_WeightedAverageSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://iveda.com/20231231", "localname": "WeightedAverageSharesOutstandingBasic", "presentation": [ "http://iveda.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Shares", "documentation": "Weighted average shares outstanding basic." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://iveda.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r730" ] }, "IVDA_YearOfExpiration": { "xbrltype": "gYearItemType", "nsuri": "http://iveda.com/20231231", "localname": "YearOfExpiration", "presentation": [ "http://iveda.com/role/SummaryOfOperatingLossCarryforwardsDetails" ], "lang": { "en-us": { "role": { "label": "Year of Expiration", "documentation": "Year of Expiration." } } }, "auth_ref": [] }, "IVDA_YouMingHueiCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://iveda.com/20231231", "localname": "YouMingHueiCoLtdMember", "presentation": [ "http://iveda.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "YOU MING HUEI CO. LTD [Member]", "documentation": "YOU MING HUEI CO. LTD [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479524/944-825-05-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "20A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-20A" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)-(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "980", "SubTopic": "10", "Section": "05", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482115/980-10-05-3" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "SubTopic": "80", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "80", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r604": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r605": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r606": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r609": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r610": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r611": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r612": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r613": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r614": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r615": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r616": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r617": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r618": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r619": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r620": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r621": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r622": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r623": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r624": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r625": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r626": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r627": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r628": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r630": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r632": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r638": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r639": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r640": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r641": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r642": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r643": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r644": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r645": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r647": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r648": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r661": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r662": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r663": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r664": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r665": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r666": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r667": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r668": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r669": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r670": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r671": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r672": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r673": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r674": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r675": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r676": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r677": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r678": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r679": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r680": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r681": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r682": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r683": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r684": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r685": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r686": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r687": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r688": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r690": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r691": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r692": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r693": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r694": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r695": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r696": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r697": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r698": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r699": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r700": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r701": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r702": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r703": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r704": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r705": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r706": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r707": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r708": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r709": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r710": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r711": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r712": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r713": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r714": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r715": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r716": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r717": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r718": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r719": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r720": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r721": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r722": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r723": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r724": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r725": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r726": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r727": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r728": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r729": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r730": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r731": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r732": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r782": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r783": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r784": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r785": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r786": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r787": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r788": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r789": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r790": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r791": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r792": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r793": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r794": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r795": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r796": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r797": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r798": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r799": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r800": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r801": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r802": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r803": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r804": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r805": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r806": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r807": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r808": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r809": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r810": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r811": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r812": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r813": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r814": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r815": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r816": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r817": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r818": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 69 0001493152-24-012417-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-012417-xbrl.zip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end XML 71 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001397183 2023-01-01 2023-12-31 0001397183 2023-09-30 0001397183 2024-03-15 0001397183 2023-10-01 2023-12-31 0001397183 2023-12-31 0001397183 2022-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001397183 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001397183 2022-01-01 2022-12-31 0001397183 IVDA:EquipmentSalesMember 2023-01-01 2023-12-31 0001397183 IVDA:EquipmentSalesMember 2022-01-01 2022-12-31 0001397183 IVDA:ServiceRevenueMember 2023-01-01 2023-12-31 0001397183 IVDA:ServiceRevenueMember 2022-01-01 2022-12-31 0001397183 IVDA:OtherRevenueMember 2023-01-01 2023-12-31 0001397183 IVDA:OtherRevenueMember 2022-01-01 2022-12-31 0001397183 us-gaap:CommonStockMember 2021-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001397183 us-gaap:RetainedEarningsMember 2021-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001397183 2021-12-31 0001397183 us-gaap:CommonStockMember 2022-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001397183 us-gaap:RetainedEarningsMember 2022-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001397183 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001397183 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001397183 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001397183 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001397183 us-gaap:CommonStockMember 2023-12-31 0001397183 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001397183 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001397183 us-gaap:RetainedEarningsMember 2023-12-31 0001397183 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001397183 2022-01-01 2022-03-31 0001397183 IVDA:ChunghwaTelecomMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001397183 IVDA:ChunghwaTelecomMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001397183 IVDA:TaiwanCoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:YouMingHueiCoLtdMember 2023-01-01 2023-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChiconyPowerTechnologyMember 2023-01-01 2023-12-31 0001397183 IVDA:TaiwanCoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChunghwaTelecomMember 2022-01-01 2022-12-31 0001397183 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember IVDA:ChiconyPowerTechnologyMember 2022-01-01 2022-12-31 0001397183 IVDA:OtherCustomersMember srt:MinimumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001397183 IVDA:OtherCustomersMember srt:MinimumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001397183 srt:MinimumMember 2023-12-31 0001397183 srt:MaximumMember 2023-12-31 0001397183 country:US 2023-01-01 2023-12-31 0001397183 country:US 2023-12-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2023-01-01 2023-12-31 0001397183 IVDA:RepublicOfChinaTaiwanMember 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2022-12-31 0001397183 IVDA:HuaNamBankMember 2023-12-31 0001397183 IVDA:HuaNamBankMember 2022-12-31 0001397183 IVDA:ChangHwaBankMember 2023-12-31 0001397183 IVDA:ChangHwaBankMember 2022-12-31 0001397183 IVDA:ShanghaiBankOneMember 2023-12-31 0001397183 IVDA:ShanghaiBankOneMember 2022-12-31 0001397183 srt:MinimumMember IVDA:ShanghaiBankMember 2023-01-01 2023-12-31 0001397183 srt:MaximumMember IVDA:ShanghaiBankMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankMember 2023-01-01 2023-12-31 0001397183 IVDA:HuaNamBankMember 2023-01-01 2023-12-31 0001397183 IVDA:ChangHwaBankMember 2023-01-01 2023-12-31 0001397183 IVDA:ShanghaiBankOneMember 2023-01-01 2023-12-31 0001397183 srt:MinimumMember IVDA:ShanghaiBankMember 2023-12-31 0001397183 srt:MaximumMember IVDA:ShanghaiBankMember 2023-12-31 0001397183 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2010-01-18 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2011-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2012-12-31 0001397183 IVDA:TwoThousandTenStockOptionPlanMember 2023-12-31 0001397183 srt:MaximumMember IVDA:TwoThousandTwentyPlanMember 2020-12-15 0001397183 IVDA:TwoThousandTwentyPlanMember 2023-12-31 0001397183 IVDA:StockOptionPlanMember 2023-12-31 0001397183 IVDA:StockOptionPlanMember 2022-12-31 0001397183 srt:MinimumMember 2022-01-01 2022-12-31 0001397183 srt:MaximumMember 2022-01-01 2022-12-31 0001397183 us-gaap:WarrantMember 2023-12-31 0001397183 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001397183 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001397183 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001397183 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001397183 IVDA:UsBasedSegmentMember 2023-12-31 0001397183 us-gaap:DomesticCountryMember 2023-12-31 0001397183 us-gaap:DomesticCountryMember 2023-01-01 2023-12-31 0001397183 stpr:AZ 2023-12-31 0001397183 2021-01-01 2021-12-31 0001397183 2020-12-31 0001397183 2020-01-01 2020-12-31 0001397183 2019-12-31 0001397183 2019-01-01 2019-12-31 0001397183 2018-12-31 0001397183 2018-01-01 2018-12-31 0001397183 2017-12-31 0001397183 2017-01-01 2017-12-31 0001397183 2016-12-31 0001397183 2016-01-01 2016-12-31 0001397183 2015-12-31 0001397183 2015-01-01 2015-12-31 0001397183 2014-12-31 0001397183 2014-01-01 2014-12-31 0001397183 2013-12-31 0001397183 2013-01-01 2013-12-31 0001397183 2012-12-31 0001397183 2012-01-01 2012-12-31 0001397183 2011-12-31 0001397183 2011-01-01 2011-12-31 0001397183 2010-12-31 0001397183 2010-01-01 2010-12-31 0001397183 2009-12-31 0001397183 2009-01-01 2009-12-31 0001397183 2008-12-31 0001397183 2008-01-01 2008-12-31 0001397183 2007-12-31 0001397183 2007-01-01 2007-12-31 0001397183 2006-12-31 0001397183 2006-01-01 2006-12-31 0001397183 2005-12-31 0001397183 2005-01-01 2005-12-31 0001397183 IVDA:MegasysMember 2023-01-01 2023-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:TWD false FY 0001397183 P3Y 10-K true 2023-12-31 --12-31 2023 false 001-41345 IVEDA SOLUTIONS, INC. NV 20-2222203 1744 S Val Vista Suite 213 Mesa AZ 85204 (480) 307-8700 Common Stock, par value $0.00001 per share No No Yes Yes Non-accelerated Filer true false false false 9500000 16169891 false false false false BF Borgers CPA PC 5041 Lakewood, CO 4754597 7312095 129778 129527 281049 1222690 324515 526470 435580 371990 5925520 9562772 891187 32911 444723 267387 444723 267387 7261430 9863070 1110087 1638727 348771 398409 65408 1458858 2102544 190776 0.00001 0.00001 100000000 100000000 0.00001 0.00001 500 500 0 0 0 0 0.00001 0.00001 100000000 100000000 16169891 16169891 15066739 15066739 162 150 54065633 52496914 -99048 -222380 -220643 -47941796 -44706671 5802572 7569750 7261430 9863070 6052298 4159398 443567 308881 6495865 4468279 5428261 3504778 1067604 963501 4478553 4292820 4478553 4292820 -3410949 -3329320 -28099 -17078 131881 57397 7254 53323 96527 -13004 -97605 -3216817 -3342324 18308 2947 -3235124 -3345270 -0.20 -0.20 -0.26 -0.26 15973422 15973422 12846848 12846848 9668369 97 40727518 -41361401 -143493 -777279 -1613470 -1163918 120581 120581 65 215000 1 219899 219900 5555 5555 8215 23000 23000 1885000 19 8011231 8011250 3289474 33 4999803 4999836 2797 2797 -3345270 -3345270 -77150 -77150 616 15066739 150 52496914 -44706671 -220643 7569750 15066739 150 52496914 -44706671 -220643 7569750 945900 10 1322875 1322885 157252 2 138544 138546 99048 -3235124 -3235124 -1737 -1737 16169891 162 54065633 -47941796 -222380 5802572 16169891 162 54065633 -47941796 -222380 5802572 1-for-8 -3235124 -3345270 19753 17801 104600 120581 2700 5555 138546 219900 -930803 785969 -199124 214898 66995 168122 175592 19919 -522460 -1238379 -2604645 -5408720 878205 14165 -878205 -14165 -685 -214 -47554 358888 -300000 -251498 -164093 -99048 1322885 11511741 924100 11406322 1252 -56617 -2557499 5926820 7312095 1385275 4754596 7312095 9793 53323 28779 <p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zkTyRQEOtR13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 <span id="xdx_82E_z4URz0kgHQ1b">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--NatureOfOperationsPolicyTextBlock_zLjt06vj4Bsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zDrnLsreuL5h">Nature of Operations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provides true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Iveda also offers smart utility, smart sensors, gateways and trackers. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our <b>IvedaAI® </b>intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI Functions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Object Search</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Search (No Database Required)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Recognition (from a Database)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Plate Recognition (100+ Countries), includes make and model</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrusion Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weapon Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fire Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">People Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temperature Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Health Analytics (Facemask Detection)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QR and Barcode Detection</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Camera View</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Tracking</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abnormality Detection – Vehicle/Person wrong direction detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle/Person Loitering Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>●</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fall Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illegal Parking Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heatmap Generation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaAI </b>consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaAI </b>works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda’s Cerebro</b> is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaSPS </b>is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Utilus </b>is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government or large-scale city deployments</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supporting and Improving City Services </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing Emergency Response Times </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crime&amp; Hazard Protection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring and Improving Air Quality </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sound Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traffic Monitoring and Mobility as a Service </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data Analytics and Monetization Opportunities</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>vumastAR </b>is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quality and Maintenance Exams: </b>vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Factory and Line Work: </b>Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pharma: </b>Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supply Chain:</b> Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing: </b>Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transportation: </b>Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retail: </b>Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaXpress </b>is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda Smart UVC</b> is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda’s Smart Drones</b> are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features of Iveda’s Smart Drone:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fully Autonomous</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Easy operation and 24-7 flight mission</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent Computing</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live video streaming - real-time object recognition and tracking</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Onboard (edged) AI and data analysis</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safety Design</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiply redundant and fail-safe systems</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weather resistant industrial grade systems (IP54)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed and made in Taiwan (MIT)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Skywatch</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planning and editing real-time/timed missions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">User/Group permission control &amp; flight data management</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failsafe alarm and FPV gimbal control</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insight</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automated orthorectified service of imagery (2D/3D)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI technology for inspecting natural disaster, vehicle &amp; pedestrian tracking, and energy facilities inspection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Visualizing geographic data and analysis report</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propellers: 8 (multiply redundant)</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diagonal Footprint: 29.76″ / 756 mm</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weight: 14.1lbs / 6.4 Kg</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hover time: 30 mins</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wind tolerance: Beaufort scale – 6</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP rating: IP54</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Camera sensor: Dual RGB, IR/thermal</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Network: 5G/4G LTE and 2.4G Wi-Fi</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Smart Utility Cabinet</b> gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vemo Body Camera</b> streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaCare</b>, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we previously only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras, which are a global standard for the interface of IP-based physical security products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEGAsys, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. MEGAsys combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_zZZ94VcK7db2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zXx05k4a6Vb2">Consolidation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQUJ4NUv0Nec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_z0hGEeuuotY7">Impairment of Long-Lived Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z8KkRPBwcM48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zOicDw5tpVk2">Basis of Accounting</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_z6JeXWjVJqq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_zLrBWMuVsyf9">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--UtilityRevenueAndExpenseRecognitionPolicy_z1x1xiINvkTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zP0nkPkWeHcj">Revenue and Expense Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, <i>Revenue from Contracts with Customers</i>, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (<i>i.e.</i>, when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sells its products and services primarily to municipalities and commercial customers in the following manner:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable and the amount can be reliably estimated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zjZ2uWFivcKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zHgGMk1oC9A3">Comprehensive Loss</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z419dsc3nVVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zo6LjJ42foo7">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central </span>Deposit Insurance Corporation) with maximum coverage of NTD <span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_pn6n6_uNTD_c20231231_zaMFHgg7Yki6">3 </span>million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ChunghwaTelecomMember_zn2ZrtWL9zld" title="Concentration risk, percentage">50</span>% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ChunghwaTelecomMember_zf4tVNS29Ei4" title="Concentration risk, percentage">52</span>% of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from two customers out of 65 total customers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TaiwanCoMember_zOcSYNL7Tmol" title="Concentration risk, percentage">48</span>% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--YouMingHueiCoLtdMember_z4UL8TSfOzLg" title="Concentration risk, percentage">25</span>%, 2) Chicony Power Technology Co Ltd with <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyMember_z5KGjSFdBu53" title="Concentration risk, percentage">23</span>%, (both Taiwan companies).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from two customers out of 42 total customers represented approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TaiwanCoMember_zAanQJuQVfdj" title="Concentration risk, percentage">52</span>% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_z8szwlSPGsgg" title="Concentration risk, percentage">21</span>%, 2) Chicony Power Technology Co Ltd with <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyMember_zZtv5PhpuD7l" title="Concentration risk, percentage">31</span>%, (both Taiwan companies).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No other customers represented greater than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_zCjI8isz6rmj" title="Percentage of concentration risk"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_zrtgeh3hHIU1" title="Percentage of concentration risk">10</span></span>% of total revenues in years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zC25XVeJkCM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zixTc71MvdUl">Cash and Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zZmL7Cf2LnRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zot26om6gh42">Accounts Receivable</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of December 31, 2023 and 2022, respectively, an allowance for uncollectible accounts of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zjUSOIC5fx09" title="Allowance for uncollectible accounts">0</span> and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zkwrVmlZdCQc" title="Allowance for uncollectible accounts">0</span> was deemed necessary for our U.S.-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--DepositContractsPolicy_zGG3TtOisSVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zRHSw2gXhaK8">Deposits – Current</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--OtherCurrentAssetsPolicyTextBlock_zYZmKIV1WTW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zPnewNdpewp5">Other Current Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets represent cash paid in advance to vendors for service coverage extending into subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zjKPNWrs33F9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_z4IRy5Z1hItd">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_c20231231_zFGgROIdbBm9" title="Inventory reserve">0</span> and $<span id="xdx_903_eus-gaap--InventoryValuationReserves_iI_c20221231_zreQnnzrQglh" title="Inventory reserve">0</span>, as of December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zMTWhJJK0ms8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zeRUYabrirlh">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231__srt--RangeAxis__srt--MinimumMember_z7TTtPq80Nyh" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0613">three</span></span> to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__srt--RangeAxis__srt--MaximumMember_zLyW41BUw7k5" title="Useful life">seven years</span>. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_901_eus-gaap--Depreciation_pp0p0_c20230101__20231231_zpDIEhobuw1i" title="Depreciation expense">19,753</span> and $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zzuph8Ggvfn6" title="Depreciation expense">17,801</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--LongDurationContractsPolicy_z6Et29cKgvO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zADr7YDA2Cb3">Deposits—Long-Term</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zUhi1HOtxTSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zhPWrIsRsnf6">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2023, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to U.S. federal income tax as well as state income tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2019 to 2022 are open to examination by federal, local, and state authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2019 to 2022 are open to examination by the Taiwan Ministry of Finance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zuMUI58zs6kk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_z9n4GGdaRET3">Restricted Cash</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--AccountsAndOtherPayablesPolicyTextBlock_zELFodqNacmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_znHSGptGiyNf">Accounts and Other Payables</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span> </span></span></b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjZ2bmh6J1M5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_zWcKJr9grvY2">SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20231231_zdcKISaRvXl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zAiK9f0v3DB1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_iI_maCzllP_ziGUhJBh9Wx7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accounts Payable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">179,949</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">360,395</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iI_maCzllP_zjRgfTsze9ma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued Expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">900,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,243,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredRevenueCurrent_iI_maCzllP_zvtYHuRgyev5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29,211</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">35,305</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtCzllP_zDrwNQAMrY99" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,110,087</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,638,727</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z5tqZKCsZT97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zxpbmVVjUV39" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zodYCVcIM9G8">Deferred Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments received from customers on future installation projects are recorded as deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z1AXK88Z1nVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zBMlcx2skJFe">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pp0p0_c20230101__20231231_zRHWZXdHJUKi" title="Stock option compensation">104,600</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231_zSOMFyRM7Glc" title="Stock option compensation">120,581</span> of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zrVlBEeRNMm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_z9eCaJ2n9h99">Fair Value of Financial Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2023 and December 31, 2022. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zK5Cajk8dRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_zGZFbd13GPZ4">Segment Information</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYD4qwpPUVQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGcSGCDThK7h" style="display: none">SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Assets (Liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__country--US_zridXGNz360k" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Revenue">852,136</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--US_zN8n6TTl2bA6" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Assets (Liabilities)">5,364,184</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Republic of China (Taiwan)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zGoAV4wTF3Ta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Revenue">5,648,982</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zITDaCw1nkMg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Assets (Liabilities)">907,113</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zvPA6ixE8vG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zfv6TTF2KRDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z03scp2cDnN5">Reclassification</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztB8C47hypy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zrXkvPzvZOsi">New Accounting Standards</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No new relevant accounting standards</span></p> <p id="xdx_850_zjEuWjniydu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--NatureOfOperationsPolicyTextBlock_zLjt06vj4Bsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_zDrnLsreuL5h">Nature of Operations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda has been offering real-time IP video surveillance technologies to our customers since 2005. While we still offer video surveillance technologies, our core product line has evolved to include AI intelligent video search technology that provides true intelligence to any video surveillance system and IoT (Internet of Things) devices and platforms. Iveda also offers smart utility, smart sensors, gateways and trackers. Our evolution is in response to digital transformation demands from many cities and organizations across the globe. Our <b>IvedaAI® </b>intelligent video search technology adds critical intelligence to normally passive video surveillance systems. IvedaAI provides AI functions to any IP camera and most popular network video recorders (NVR) and video management systems (VMS). IvedaAI comes with an appliance or server, preconfigured with multiple AI functions based on the end user requirements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI Functions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Object Search</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Search (No Database Required)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Face Recognition (from a Database)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Plate Recognition (100+ Countries), includes make and model</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrusion Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weapon Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fire Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">People Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle Counting</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temperature Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Health Analytics (Facemask Detection)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QR and Barcode Detection</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Camera View</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live Tracking</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abnormality Detection – Vehicle/Person wrong direction detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle/Person Loitering Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>●</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fall Detection</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Illegal Parking Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heatmap Generation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaAI </b>consists of deep-learning video analytics software running in a computer/server environment that can either be deployed at an edge level or data center for centralized cloud model. We combined hardware and artificial intelligence software for fast and efficient video search for objects stored in an external (NVR) or storage device and live streaming video data from any IP camera.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaAI </b>works with any ONVIF-compliant IP cameras and most popular NVR/VMS (Video Management System) platforms, enabling accurate search across dozens to thousands of cameras in less than 1 second. IvedaAI products are designed to maximize efficiency, save time, and cut cost. Instead of watching hours of video recording after-the-fact, users can set up alerts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda offers many IoT sensors and devices for various applications, such as energy management, smart home, smart building, smart community and patient/elder care. Our gateway and station serve as the main hub for sensors and devices in any given area. They are equipped with high-level communication protocols such as Zigbee, WiFi, Bluetooth, and USB. They connect to the Internet via Ethernet or cellular data network. We provide IoT platforms that enable centralized device management and push digital services on a massive scale. Our smart devices include water sensor, environment sensor, entry sensor, smart plug, siren, body temperature pad, a care wrist watch and tracking devices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. Our smart power hardware is equipped with an RS485 communication interface allowing the meters to be connected to various third-party SCADA software for monitoring and control purposes. This line of product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda’s Cerebro</b> is a software technology platform that integrates a multitude of disparate systems for central access and management of applications, subsystems, and devices throughout an entire environment. It is system agnostic and will support cross-platform interoperability. Cerebro’s roadmap includes a dashboard for all of Iveda’s platforms for central management of all devices. It provides remote access to a Dashboard for a single user interface, providing convenient anywhere, anytime access and analysis of relevant information in a timely manner for managing an entire organization or city. Cerebro links city systems and subsystems inseparably to each other. This integration and unification of all subsystems enable acquisition and analysis of all information on one central entity allowing comprehensive, effective and overall management and protection of a city.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaSPS </b>is our smart power solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. We offer smart power technology for office buildings, schools, shopping centers, hotels, hospitals, and smart city projects. This product includes smart power, water meter, smart lighting controls systems, and smart payment system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the last few years, smart city has been a hot topic among cities across the globe. With little to no human interaction, technology increases efficiency, expedites decision making, and reduces response time. Dwindling public safety budgets and resources have necessitated this transformation. More and more municipalities are using next-generation technologies to improve the safety and security of its citizens. Our response is our complete suite of IoT technologies, including AI intelligent video search technology, smart sensors, tracking devices, video surveillance systems, and smart power.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Utilus </b>is our smart pole solution, utilizing our Cerebro IoT platform. This completes our digital transformation solution crucial in smart city deployments as well as in large organizations. Iveda leverages infrastructure already available in most modern cities – Light poles with power We equip existing poles with Utilus. Utilus consists of power and Internet, establishing a communication network for access and management of sensors and devices that the city requires to keep its citizens safe and secure and to effectively manage utility consumption. Our smart pole offering is also ideal for:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government or large-scale city deployments</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supporting and Improving City Services </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing Emergency Response Times </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crime&amp; Hazard Protection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitoring and Improving Air Quality </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sound Detection </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traffic Monitoring and Mobility as a Service </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data Analytics and Monetization Opportunities</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>vumastAR </b>is an AI vision software that uses video taken on IP cameras, AR glasses, Androids, and tablets to analyze and process data in real-time. vumastAR is fully customizable to the user’s needs, with one short video the AI can be trained in as little as two hours. Deployable in multiple industries for uses such as:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quality and Maintenance Exams: </b>vumastAR has the power to assist with critical measuring of carcinogenic chemical compound levels, electrical wiring, and welding inspections.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Factory and Line Work: </b>Fast and accurate machine recognition enables itemized counting, inventory audits, and assembly kitting. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pharma: </b>Accurately identify and quantify medication, greatly reducing the manual labor of counting pills while eliminating human error. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supply Chain:</b> Detect defects and anomalies for improved accuracy, increasing the bottom line by actively reducing lost revenue incurred from manual mistakes. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing: </b>Digitalize meter and gauge reading and monitoring, as well as part number identification, with the ability to turn analog information into digital data </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transportation: </b>Enhance safety and security for operations including loading and unloading tanker trucks, protecting both personnel and products/equipment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retail: </b>Ensure correct item identification and organization, providing increased accuracy for retail checkout and product categorization, ultimately impacting revenue streams.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vumastAR is sold as a license per device with a monthly subscription requirement for cloud access to trained AI models.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaXpress </b>is a system that enables users to use pre-existing IP cameras and apply AI analytics without the need for large servers or a dedicated IT department. Designed to be plug-and-play IvedaXpress provides a hassle free set up process with no maintenance required for hardware. Each IP camera is hosted from a local computer or smartphone for live viewing and playback. Video may be stored on that local computer or stored remotely using free storage from Amazon or Dropbox.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda Smart UVC</b> is a Commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI). Iveda Smart UVC adds UV lights to standard HVAC vents for quick, easy, and inexpensive deployment to homes and commercial buildings. Leveraging the existing air circulation system, Iveda Smart UVC vents disinfect the air by irradiating UV light on the passing air. Eliminating the need to manually disinfect offices, meeting rooms, and other workspaces. Iveda Smart UVC can be Integrated with Iveda SPS (smart power management) and sensors to efficiently and effectively operate the light source upon detected movement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Iveda’s Smart Drones</b> are flown to perform certain functions from an aerial view without the need for a pilot onboard. Smart Drones utilize AI-based software for autonomous operation and navigation from taking off, returning to base, carrying out mission-critical tasks or simply doing an aerial patrol, without the need of human intervention. Unlike typical drones, Iveda Smart Drones are cloud-based and can be part of a network of drones for central management. They are equipped with Iveda’s Sentir Video Surveillance System and IvedaAI Intelligent Video Search Technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda Smart Drone product offering is robust and expansive for a multitude of industrial, commercial, and military applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Features of Iveda’s Smart Drone:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fully Autonomous</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheduled autonomous take-off, flight mission execution, monitoring, landing and recharging</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Easy operation and 24-7 flight mission</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intelligent Computing</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live video streaming - real-time object recognition and tracking</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Onboard (edged) AI and data analysis</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safety Design</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiply redundant and fail-safe systems</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weather resistant industrial grade systems (IP54)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed and made in Taiwan (MIT)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Skywatch</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planning and editing real-time/timed missions</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">User/Group permission control &amp; flight data management</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failsafe alarm and FPV gimbal control</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insight</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Automated orthorectified service of imagery (2D/3D)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI technology for inspecting natural disaster, vehicle &amp; pedestrian tracking, and energy facilities inspection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Visualizing geographic data and analysis report</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Propellers: 8 (multiply redundant)</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diagonal Footprint: 29.76″ / 756 mm</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weight: 14.1lbs / 6.4 Kg</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hover time: 30 mins</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wind tolerance: Beaufort scale – 6</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP rating: IP54</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Camera sensor: Dual RGB, IR/thermal</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Network: 5G/4G LTE and 2.4G Wi-Fi</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Smart Utility Cabinet</b> gives end users a convenient tool to monitor their daily energy consumption, to pinpoint electrical leaks, and to prevent power line overload and potential fire. It utilizes IoT sensors to detect abnormalities in consumption, temperature and tampering. Iveda Smart Utility Cabinet has an internal environment control design, housed in a durable industrial-grade cabinet. It includes a smart edge computing gateway with multi-RF communication protocols such as 4G, Z-Wave and WiFi and tampering sensor for unauthorized access. Smart water meter and gas meter may be added to the Cabinet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vemo Body Camera</b> streams live video, using 4G, to headquarters and doubles as a walkie talkie with a push-to-talk feature. With its multi-mode audio, it can also be used for broadcasting and hands-free audio conferencing for group talk. Vemo has WiFi capability which is ideal for city-wide deployments. Vemo transmits live streaming video instantaneously to the cloud without additional software or hardware. Vemo’s cloud management platform can centrally manage an unlimited number of devices and video can be accessed on a PC, Android and iOS client. Moreover, Vemo can stream directly into the IvedaAI platform for real-time video analytics to search for faces, objects or license plates in real time.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IvedaCare</b>, launched in November 2022, is a simple, easy to use suite of wireless health and wellness devices intended to help you monitor the health and activities of your loved ones, even when you can’t be there yourself. Our mission is to help ensure your loved one’s safety and independence. Stay connected to your elderly loved ones with our advanced IoT devices for real-time monitoring, fall detection, medication reminders and more. With IvedaCare, you not only can monitor your home and loved ones from afar but can potentially make life-saving decisions using the app. Cloud-based, wireless sensors collect real-time data shared with the entire family circle within the app. Customers may add a subscription service for Pro Monitoring. If the Trusted Circle is unavailable, our emergency call center will dispatch emergency services quickly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we sold and installed video surveillance equipment, primarily for security purposes and secondarily for operational efficiencies and marketing. We also provided video hosting, in-vehicle streaming video, archiving, and real-time remote surveillance services to a variety of businesses and organizations. While we previously only used off-the shelf camera systems from well-known camera brands, we now source our own cameras using manufacturers in Taiwan in order for us to be more flexible in fulfilling our customer needs. We now have the capability to provide IP cameras and NVRs based on customer specifications. We still utilize ONVIF (Open Network Video Interface Forum) cameras, which are a global standard for the interface of IP-based physical security products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2014, we changed our revenue model from direct project-based sales to licensing our platform and selling IoT hardware to service providers such as telecommunications companies, integrators and other technology resellers already providing services to an existing customer base. Partnering with service providers that have an existing loyal subscriber base allows us to focus on servicing just a handful of our partners and concentrating on our technology offering. Service providers leverage their end-user infrastructure to sell, bill, and provide customer service for Iveda’s product offering. This business model provides dual revenue streams – one from hardware sales and the other from monthly licensing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MEGAsys, our subsidiary in Taiwan, specializes in deploying new, and integrating existing, video surveillance systems for airports, commercial buildings, government customers, data centers, shopping centers, hotels, banks, and Safe City. MEGAsys combines security surveillance products, software, and services to provide integrated security solutions to the end user. Through Iveda Taiwan, we have access not only to Asian markets but also to Asian manufacturers and engineering expertise. Iveda Taiwan is our research and development arm, working with a team of developers in Taiwan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ConsolidationPolicyTextBlock_zZZ94VcK7db2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zXx05k4a6Vb2">Consolidation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zQUJ4NUv0Nec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86C_z0hGEeuuotY7">Impairment of Long-Lived Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a significant amount of property and equipment, consisting primarily of leased equipment. We review the recoverability of the carrying value of long-lived assets using the methodology prescribed in ASC 360 “Property, Plant and Equipment.” We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the undiscounted future net operating cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. We did not make any impairment for the years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z8KkRPBwcM48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zOicDw5tpVk2">Basis of Accounting</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_z6JeXWjVJqq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_zLrBWMuVsyf9">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--UtilityRevenueAndExpenseRecognitionPolicy_z1x1xiINvkTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zP0nkPkWeHcj">Revenue and Expense Recognition</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, <i>Revenue from Contracts with Customers</i>, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (<i>i.e.</i>, when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company sells its products and services primarily to municipalities and commercial customers in the following manner:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer and charged for service when installation or maintenance work is performed.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues from fixed-price equipment installation contracts (project sales) are recognized on the percentage-of-completion method. The percentage completed is measured by the percentage of costs incurred to date to estimated total costs for each contract. This method is used because management considers expended costs to be the best available measure of progress on these contracts. Because of inherent uncertainties in estimating costs and revenues, it is at least reasonably possible that the estimates used will change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract costs include all direct material, subcontractors, labor costs, and equipment costs and those indirect costs related to contract performance. General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenues when their realization is reasonably assured. Claims are included in revenues when realization is probable and the amount can be reliably estimated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of Iveda US hardware sales are to international customers and are made through independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The distributor retains the margin as its compensation for its role in the transaction. The distributor or integrator generally maintains product inventory or product is drop shipped from the manufacturer, customer receivables and all related risks and rewards of ownership. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Iveda US also sells software that include licensing fees that are paid either monthly or yearly. The revenues are recorded monthly, if the license is paid yearly the revenue will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zjZ2uWFivcKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zHgGMk1oC9A3">Comprehensive Loss</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive loss is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. Our current component of other comprehensive income is the foreign currency translation adjustment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z419dsc3nVVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zo6LjJ42foo7">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central </span>Deposit Insurance Corporation) with maximum coverage of NTD <span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_pn6n6_uNTD_c20231231_zaMFHgg7Yki6">3 </span>million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ChunghwaTelecomMember_zn2ZrtWL9zld" title="Concentration risk, percentage">50</span>% of the total accounts receivable at December 31, 2023 was from one customer out of a total of 24 customer accounts receivable accounts. This specific customer was Chunghwa Telecom. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ChunghwaTelecomMember_zf4tVNS29Ei4" title="Concentration risk, percentage">52</span>% of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from two customers out of 65 total customers represented approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TaiwanCoMember_zOcSYNL7Tmol" title="Concentration risk, percentage">48</span>% of total revenue for the year ended December 31, 2023. These specific customers were 1) YOU MING HUEI CO. LTD with <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--YouMingHueiCoLtdMember_z4UL8TSfOzLg" title="Concentration risk, percentage">25</span>%, 2) Chicony Power Technology Co Ltd with <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyMember_z5KGjSFdBu53" title="Concentration risk, percentage">23</span>%, (both Taiwan companies).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from two customers out of 42 total customers represented approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TaiwanCoMember_zAanQJuQVfdj" title="Concentration risk, percentage">52</span>% of total revenue for the year ended December 31, 2022. These specific customers were 1) Chunghwa Telecom with <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_z8szwlSPGsgg" title="Concentration risk, percentage">21</span>%, 2) Chicony Power Technology Co Ltd with <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyMember_zZtv5PhpuD7l" title="Concentration risk, percentage">31</span>%, (both Taiwan companies).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No other customers represented greater than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_zCjI8isz6rmj" title="Percentage of concentration risk"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_zrtgeh3hHIU1" title="Percentage of concentration risk">10</span></span>% of total revenues in years ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3000000 0.50 0.52 0.48 0.25 0.23 0.52 0.21 0.31 0.10 0.10 <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zC25XVeJkCM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zixTc71MvdUl">Cash and Cash Equivalents</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zZmL7Cf2LnRh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zot26om6gh42">Accounts Receivable</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days are considered delinquent. For our Taiwan-based segment, receivables over one year are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. As of December 31, 2023 and 2022, respectively, an allowance for uncollectible accounts of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zjUSOIC5fx09" title="Allowance for uncollectible accounts">0</span> and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zkwrVmlZdCQc" title="Allowance for uncollectible accounts">0</span> was deemed necessary for our U.S.-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_846_eus-gaap--DepositContractsPolicy_zGG3TtOisSVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zRHSw2gXhaK8">Deposits – Current</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our current deposits represent tender deposits placed with local governments and major customers in Taiwan during the bidding process for new proposed projects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--OtherCurrentAssetsPolicyTextBlock_zYZmKIV1WTW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zPnewNdpewp5">Other Current Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other current assets represent cash paid in advance to vendors for service coverage extending into subsequent periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--InventoryPolicyTextBlock_zjKPNWrs33F9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_z4IRy5Z1hItd">Inventories</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We review our inventories for excess or obsolete products or components based on an analysis of historical usage and an evaluation of estimated future demand, market conditions, and alternative uses for possible excess or obsolete parts. The allowance for slow-moving and obsolete inventory is $<span id="xdx_90A_eus-gaap--InventoryValuationReserves_iI_c20231231_zFGgROIdbBm9" title="Inventory reserve">0</span> and $<span id="xdx_903_eus-gaap--InventoryValuationReserves_iI_c20221231_zreQnnzrQglh" title="Inventory reserve">0</span>, as of December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zMTWhJJK0ms8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zeRUYabrirlh">Property and Equipment</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost. Depreciation is computed primarily using the straight-line method over estimated useful lives of <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dxL_c20231231__srt--RangeAxis__srt--MinimumMember_z7TTtPq80Nyh" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl0613">three</span></span> to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__srt--RangeAxis__srt--MaximumMember_zLyW41BUw7k5" title="Useful life">seven years</span>. Expenditures for routine maintenance and repairs are charged to expense as incurred. Depreciation expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_901_eus-gaap--Depreciation_pp0p0_c20230101__20231231_zpDIEhobuw1i" title="Depreciation expense">19,753</span> and $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zzuph8Ggvfn6" title="Depreciation expense">17,801</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P7Y 19753 17801 <p id="xdx_84C_eus-gaap--LongDurationContractsPolicy_z6Et29cKgvO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zADr7YDA2Cb3">Deposits—Long-Term</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term deposits consist of a deposit related to the leases of Iveda Taiwan’ office space, and tender deposits placed with local governments and major customers in Taiwan as part of the bidding process, which are anticipated to be held more than one year if the bid is accepted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zUhi1HOtxTSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zhPWrIsRsnf6">Income Taxes</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes are recognized in the consolidated financial statements for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts based on enacted tax laws and statutory tax rates. Temporary differences arise from sales cut-off, depreciation, deferred rent expense, and net operating losses. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that represents our best estimate of such deferred tax assets that, more likely than not, will be realized. Income tax expense is the tax payable for the year and the change during the year in deferred tax assets and liabilities. During 2023, we reevaluated the valuation allowance for deferred tax assets and determined that no current benefits should be recognized for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to U.S. federal income tax as well as state income tax.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our U.S. income tax returns are subject to review and examination by federal, state, and local authorities. Our U.S. tax returns for the years 2019 to 2022 are open to examination by federal, local, and state authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Taiwan tax returns are subject to review and examination by the Taiwan Ministry of Finance. Our Taiwan tax return for the years 2019 to 2022 are open to examination by the Taiwan Ministry of Finance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zuMUI58zs6kk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86E_z9n4GGdaRET3">Restricted Cash</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--AccountsAndOtherPayablesPolicyTextBlock_zELFodqNacmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_znHSGptGiyNf">Accounts and Other Payables</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span> </span></span></b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjZ2bmh6J1M5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_zWcKJr9grvY2">SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20231231_zdcKISaRvXl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zAiK9f0v3DB1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_iI_maCzllP_ziGUhJBh9Wx7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accounts Payable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">179,949</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">360,395</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iI_maCzllP_zjRgfTsze9ma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued Expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">900,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,243,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredRevenueCurrent_iI_maCzllP_zvtYHuRgyev5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29,211</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">35,305</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtCzllP_zDrwNQAMrY99" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,110,087</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,638,727</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_z5tqZKCsZT97" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjZ2bmh6J1M5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none"><span id="xdx_8BA_zWcKJr9grvY2">SCHEDULE OF ACCOUNTS AND OTHER PAYABLES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20231231_zdcKISaRvXl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zAiK9f0v3DB1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_iI_maCzllP_ziGUhJBh9Wx7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Accounts Payable</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">179,949</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">360,395</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccruedLiabilitiesCurrent_iI_maCzllP_zjRgfTsze9ma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued Expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">900,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,243,027</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredRevenueCurrent_iI_maCzllP_zvtYHuRgyev5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Deferred Revenue and Customer Deposits</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29,211</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">35,305</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_mtCzllP_zDrwNQAMrY99" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accounts and Other Payables</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,110,087</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,638,727</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 179949 360395 900928 1243027 29211 35305 1110087 1638727 <p id="xdx_840_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zxpbmVVjUV39" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_866_zodYCVcIM9G8">Deferred Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance payments received from customers on future installation projects are recorded as deferred revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z1AXK88Z1nVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zBMlcx2skJFe">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2006, we adopted the fair value recognition provisions of ASC 718, “Share-Based Payment,” which requires the recognition of an expense related to the fair value of stock-based compensation awards. We elected the modified prospective transition method as permitted by ASC 718. Under this transition method, stock-based compensation expense includes compensation expense for stock-based compensation granted on or after the date ASC 718 was adopted based on the grant-date fair value estimated in accordance with the provisions of ASC 718. We recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. The fair value of stock-based compensation awards granted prior to, but not yet vested as of December 31, 2023 and 2022, were estimated using the “minimum value method” as prescribed by original provisions of ASC 718, “Accounting for Stock-Based Compensation.” Therefore, no compensation expense is recognized for these awards in accordance with ASC 718. We recognized $<span id="xdx_906_eus-gaap--ShareBasedCompensation_pp0p0_c20230101__20231231_zRHWZXdHJUKi" title="Stock option compensation">104,600</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231_zSOMFyRM7Glc" title="Stock option compensation">120,581</span> of stock-based compensation expense for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 104600 120581 <p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zrVlBEeRNMm9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_z9eCaJ2n9h99">Fair Value of Financial Instruments</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of December 31, 2023 and December 31, 2022. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, 0 payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zK5Cajk8dRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_862_zGZFbd13GPZ4">Segment Information</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We conduct operations in various geographic regions. The operations conducted and the customer bases located in the foreign countries are similar to the business conducted and the customer bases located in the United States. The net revenues and net assets (liabilities) for other significant geographic regions are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYD4qwpPUVQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGcSGCDThK7h" style="display: none">SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Assets (Liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__country--US_zridXGNz360k" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Revenue">852,136</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--US_zN8n6TTl2bA6" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Assets (Liabilities)">5,364,184</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Republic of China (Taiwan)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zGoAV4wTF3Ta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Revenue">5,648,982</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zITDaCw1nkMg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Assets (Liabilities)">907,113</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zvPA6ixE8vG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYD4qwpPUVQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zGcSGCDThK7h" style="display: none">SCHEDULE OF NET REVENUE AND NET ASSETS (LIABILITIES) FOR OTHER SIGNIFICANT GEOGRAPHIC REGIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Assets (Liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">United States</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__country--US_zridXGNz360k" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Revenue">852,136</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--US_zN8n6TTl2bA6" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net Assets (Liabilities)">5,364,184</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Republic of China (Taiwan)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zGoAV4wTF3Ta" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Revenue">5,648,982</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsNet_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--RepublicOfChinaTaiwanMember_zITDaCw1nkMg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Assets (Liabilities)">907,113</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 852136 5364184 5648982 907113 <p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zfv6TTF2KRDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z03scp2cDnN5">Reclassification</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztB8C47hypy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zrXkvPzvZOsi">New Accounting Standards</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No new relevant accounting standards</span></p> <p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zcBj0oWWNQDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 <span id="xdx_82A_z3AAHsEdkiL5">RELATED PARTIES </span>- None</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--ShortTermDebtTextBlock_zy3a4tKVG49i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 <span id="xdx_823_zovYULy7wGL3">SHORT-TERM AND LONG-TERM DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfShortTermDebtTextBlock_zivaouRcztl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The short-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zCfLQZlabl57" style="display: none">SCHEDULE OF SHORT-TERM DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_ztl21Y9hKZWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">88,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zJZmprsMjxvk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loan from Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zq7Ji2Ovfx1k" title="Interest rate">1</span>%-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_z3pPv0XDhqT5" title="Interest rate">3.06</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zuKZZjmyzYyf" title="Debt instrument, maturity date">Due in January 2024 and July 2024</span>.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zmzNWTLf0N9j" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Short term debt">88,032</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zleZm4y8yYna" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0687">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from HuaNam Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zAQY4riCcN0h" title="Interest rate">3.44</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zdahQHlQ2Ae9" title="Debt instrument, maturity date">Due in May 2024.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zcGWeEgNPIV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">97,777</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_z8NVBBsazFV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from ChangHwa Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zpHdotW6Th77" title="Interest rate">3</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zTFMjUckYlwd" title="Debt instrument, maturity date">Due in November 2024.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zs1yBSQ3NOh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">162,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zjLlX7yKyuWj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan Agreement with Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zaVD9JEBW57j" title="Interest rate">2.94</span>% interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zc4g31Qgpnpe" title="Debt instrument, maturity date">due September 2023.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zSldOO1CzUWi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_z70N6VpmcpT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">398,409</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20231231_zqTvY8VveNcb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">348,771</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20221231_zGRUIMpIkdF2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">398,409</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_ziWneRanKxaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_z1zPzigWEkJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>The Long-term debt balances were as follows</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B5_zkbp8f9Cp7Na">SCHEDULE OF LONG-TERM DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--LoansPayableCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zupCDOJ89Ibd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loans"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LoansPayableCurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zcN5sfEEU1V" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loans">256,184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loans from Shanghai Bank with interest rates <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zk0vOEMzsVie" title="Debt interest rate">1.50</span>% - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zrdpCllMltQf" title="Debt interest rate">2.97</span>% per annum due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zXcnpuzGSarg" title="Debt instrument, maturity date description">February 2024</span> – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zCGzjqtkS4ii" title="Debt instrument, maturity date, description">November 2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--LoansPayableCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zZ9namfWGXy" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Loans"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--LoansPayableCurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zNCKixawmiRe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Loans">256,184</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Current Portion of Long-term debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebtCurrent_iNI_di_c20231231_zBaoz1KlaKBk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current portion of long term debt"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--LongTermDebtCurrent_iNI_di_c20221231_zzuQP5XzYwSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current portion of long term debt">(65,408</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20231231_zD4s8QCkWqg1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long term debt"><span style="-sec-ix-hidden: xdx2ixbrl0739">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20221231_zr61JR39VDF3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long term debt">190,776</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zQZOz05ZW5ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfShortTermDebtTextBlock_zivaouRcztl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The short-term debt balances were as follows:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zCfLQZlabl57" style="display: none">SCHEDULE OF SHORT-TERM DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from Shanghai Bank at 1%-3.06% interest rate per annum. Due in January 2024 and July 2024.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_ztl21Y9hKZWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">88,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zJZmprsMjxvk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0677">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loan from Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zq7Ji2Ovfx1k" title="Interest rate">1</span>%-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_z3pPv0XDhqT5" title="Interest rate">3.06</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zuKZZjmyzYyf" title="Debt instrument, maturity date">Due in January 2024 and July 2024</span>.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zmzNWTLf0N9j" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Short term debt">88,032</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zleZm4y8yYna" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0687">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from HuaNam Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zAQY4riCcN0h" title="Interest rate">3.44</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zdahQHlQ2Ae9" title="Debt instrument, maturity date">Due in May 2024.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_zcGWeEgNPIV5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">97,777</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HuaNamBankMember_z8NVBBsazFV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0695">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan from ChangHwa Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zpHdotW6Th77" title="Interest rate">3</span>% interest rate per annum. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zTFMjUckYlwd" title="Debt instrument, maturity date">Due in November 2024.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zs1yBSQ3NOh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">162,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChangHwaBankMember_zjLlX7yKyuWj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0703">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loan Agreement with Shanghai Bank at <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zaVD9JEBW57j" title="Interest rate">2.94</span>% interest rate per annum <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIT1JULVRFUk0gREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zc4g31Qgpnpe" title="Debt instrument, maturity date">due September 2023.</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_zSldOO1CzUWi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt"><span style="-sec-ix-hidden: xdx2ixbrl0709">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankOneMember_z70N6VpmcpT7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">398,409</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShortTermBorrowings_iI_c20231231_zqTvY8VveNcb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">348,771</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShortTermBorrowings_iI_c20221231_zGRUIMpIkdF2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term debt">398,409</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 88032 0.01 0.0306 Due in January 2024 and July 2024 88032 0.0344 Due in May 2024. 97777 0.03 Due in November 2024. 162962 0.0294 due September 2023. 398409 348771 398409 <p id="xdx_891_eus-gaap--ScheduleOfDebtInstrumentsTextBlock_z1zPzigWEkJl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>The Long-term debt balances were as follows</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B5_zkbp8f9Cp7Na">SCHEDULE OF LONG-TERM DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loans from Shanghai Bank with interest rates 1.50% - 2.97% per annum due February 2024 – November 2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--LoansPayableCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zupCDOJ89Ibd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loans"><span style="-sec-ix-hidden: xdx2ixbrl0719">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LoansPayableCurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zcN5sfEEU1V" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loans">256,184</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Loans from Shanghai Bank with interest rates <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zk0vOEMzsVie" title="Debt interest rate">1.50</span>% - <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zrdpCllMltQf" title="Debt interest rate">2.97</span>% per annum due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_905_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MinimumMember_zXcnpuzGSarg" title="Debt instrument, maturity date description">February 2024</span> – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPTkctVEVSTSBERUJUIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90B_eus-gaap--DebtInstrumentMaturityDateDescription_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember__srt--RangeAxis__srt--MaximumMember_zCGzjqtkS4ii" title="Debt instrument, maturity date, description">November 2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--LoansPayableCurrent_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zZ9namfWGXy" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Loans"><span style="-sec-ix-hidden: xdx2ixbrl0731">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--LoansPayableCurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShanghaiBankMember_zNCKixawmiRe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Loans">256,184</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Current Portion of Long-term debt</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--LongTermDebtCurrent_iNI_di_c20231231_zBaoz1KlaKBk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current portion of long term debt"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--LongTermDebtCurrent_iNI_di_c20221231_zzuQP5XzYwSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current portion of long term debt">(65,408</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance at end of period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--LongTermDebt_iI_c20231231_zD4s8QCkWqg1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long term debt"><span style="-sec-ix-hidden: xdx2ixbrl0739">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LongTermDebt_iI_c20221231_zr61JR39VDF3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long term debt">190,776</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 256184 0.0150 0.0297 February 2024 November 2026 256184 65408 190776 <p id="xdx_802_eus-gaap--PreferredStockTextBlock_ztsuTHzPNwc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 <span id="xdx_823_znYxWOLe5wX2">PREFERRED STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are currently authorized to issue up to <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__srt--RangeAxis__srt--MaximumMember_ze5OmHhuF0oe" title="Preferred stock, shares authorized">12,500,000</span> shares of preferred stock, par value $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_z3WhNEl147Oa" title="Preferred stock, par value">0.00001</span> per share, <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zofUJKI0gRPk" title="Preferred stock, shares authorized">1,250,000</span> shares of which are designated as Series A Preferred Stock and <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z4J3jL146lWk" title="Preferred stock, shares authorized">500</span> shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 12500000 0.00001 1250000 500 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zHmZoF7asMoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 <span id="xdx_825_zCOI1AbAJzPf">EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Common Stock</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue up to <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231__srt--RangeAxis__srt--MaximumMember_z9j2QN6n8C4a" title="Common stock, shares authorized">37,500,000</span> shares of common stock, par value $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231_zStIxjyuh7o" title="Common stock, par value">0.00001</span> per share. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 37500000 0.00001 <p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zFVMNDrpi4e2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 <span id="xdx_829_zJZB2efnND66">STOCK OPTION PLAN AND WARRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Stock Options</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20100118__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_zFWPZ9CNjcx3" title="Number of shares authorized under plan">125,000</span> shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20111231__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_z45TyXf94F18" title="Number of shares authorized under plan">375,000</span> shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20121231__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_zsccuQ4w4AEk" title="Number of shares authorized under plan">1,625,000</span> shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of December 31, 2023 there were <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTenStockOptionPlanMember_zsSbK4BBGLBc" title="Options outstanding">359,125</span> options outstanding under the 2010 Option Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan has a maximum of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20201215__us-gaap--PlanNameAxis__custom--TwoThousandTwentyStockOptionPlanMember__srt--RangeAxis__srt--MaximumMember__us-gaap--PlanNameAxis__custom--TwoThousandTwentyPlanMember_zKnXBDHD5bka" title="Number of shares authorized under plan">1,250,000</span> shares authorized with similar terms and conditions to the 2010 Option Plan. As of December 31, 2023 there were <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyPlanMember_zIPa31Qi1pE8" title="Options outstanding">941,875</span> options outstanding under the 2020 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and December 31, 2022, there were <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--StockOptionPlanMember_zGftK7Jch9al" title="Options outstanding">1,301,000</span> and <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20221231__us-gaap--PlanNameAxis__custom--StockOptionPlanMember_zJ4Lr9twBM9g" title="Options outstanding">1,014,438</span> options outstanding, respectively, under all the option plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods. At December 31, 2023, we had approximately $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20231231_zBFLgqDDEJ4g" title="Unrecognized stock- based compensation">93,887</span> unrecognized stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zbdXbmK2EzF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions during 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zfm67wEfVete" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Outstanding at Beginning of Year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zdePPGoE1A27" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">1,014,438</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zChwyuuUTSJ" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zopkyPbENmy7" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">893,438</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zqwyKW5KFNC5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">6.80</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231_zB5uMmp0hRa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">233,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zuoDl2bYYVC" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">0.68</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_zMnjF6aRUm3i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">233,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zZMmeO0cjUz6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">2.26</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zfTKw0kVzB29" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zWFkWTFV6K01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zhLPpjuMYGq5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0801">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_z1ymKsr1MGxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_zBfEpMQhDWIj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(10,938</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zPRDrAFE0cz4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">1.35</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zmatxCvbCy51" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(112,125</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231_z5TF5NTNtykc" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">16.19</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_z84ESKRj5Qld" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">1,301,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zfEeV6eQCFi" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">4.50</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zDz84gKkfaW1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">1,014,438</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zF0SOWoZ5Uv8" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options Exercisable at Year-End</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zCkjekDJFwz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">1,260,375</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zLAbRACiwke" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">4.62</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zvrVeoSyzEW" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">959,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_zZNs6r2F5EZ1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Options Granted During the Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zgJWBI1MGbk" title="Weighted-Average Fair Value of Options Granted During the Period">0.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_zVI5KNWAIEMd" title="Weighted-Average Fair Value of Options Granted During the Period">0.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"> </td></tr> </table> <p id="xdx_8AB_zTPHIXuf1Fdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_zaXT7ck19hl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to stock options outstanding and exercisable at December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zDJf67Uh7Wpa" style="display: none">SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Options Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Options Exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Range of <br/> Exercise<br/> Prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number<br/> Outstanding at<br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average<br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number <br/> Exercisable at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20230101__20231231_z6slWAmx4Pth" title="Range of Exercise, Lower Range Limit">0.32</span> - $<span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231_zd9pfvopNXbd" title="Range of Exercise, Upper Range Limit">17.76</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231_zdEYc2lxQP0h" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Outstanding, Number Outstanding">1,301,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_z9gbFgGTT8u9" title="Options Outstanding, Weighted- Average Remaining Contractual Life">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20231231_z2wvlPSW59lk" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Outstanding, Weighted-Average Exercise Price">4.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231_z4ELPYogxgTh" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Exercisable, Number Exercisable">1,260,375</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20231231_z0JhOdobgqQg" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Exercisable, Weighted-Average Exercise Price">4.62</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zCBiTtX3t495" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeNwcsKMPh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zzUZKu66JaH5" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zoFEb8D2kj1k" title="Expected life">5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zeAGqlQz1Ks8" title="Expected life">5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Dividend Yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231_zOok89zDF7ea" title="Dividend yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_z4RIMfyIUTo3" title="Dividend yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231_zpew7nMEXp98" title="Expected volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_zABqBm7jHQeh" title="Expected volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-Free Interest Rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231_zpsY7d3nN4al" title="Risk-Free interest rate">4.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_z7tx7Y8ODcpl" title="Risk-Free interest rate">1.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> <p id="xdx_8AD_z63vOxiDGEN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zL22TDANdh24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant transactions during 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zEyVEiU6n2M8" style="display: none">SCHEDULE OF WARRANT TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Outstanding at Beginning of Year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_zJZF0PBob9Bd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zl2tmN0Fgy0i" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zNy9IjJX2EF9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">872,259</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zkPHUpHqap21" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231_zeKHodlMUg2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">11,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20230101__20231231_zGKn8Nj62Rfa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">0.72</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zE2IUFLsQiuf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">5,616,224</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20220101__20221231_zTDzP1XV042d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231_ztTUv3eaA8D9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised">(945,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20230101__20231231_z8KCEslq03x9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231_zenkPYESLqUk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised">(8,214</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20220101__20221231_zAG7RkMbdXyb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20230101__20231231_zv1nsdX53r9b" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(245,114</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20230101__20231231_zVVn2naLRcta" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">3.34</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20220101__20221231_zpYoxDpos4L4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(246,609</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20220101__20221231_zLTpj3U3GyCj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20231231_zu3b7uqqQ4ol" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">5,053,896</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zg2w2ZbgKWe5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_zfEYJz9Wq8vl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zoJueKAksBtg" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Warrant Exercisable at Year-End</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20231231_zfAGc4thUWbf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">5,053,896</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zTDiLEyHvT61" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20220101__20221231_zzE8J2ZZH427" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_zCKUByP6fyfb" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Warrants Granted During the Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_z0z9wBbHJCuj" title="Weighted-Average Fair Value of Options Granted During the Period">0.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zHbd2VIy8zSg" title="Weighted-Average Fair Value of Options Granted During the Period">0.72</span> - $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z8NZkPzt5Cw3" title="Weighted-Average Fair Value of Options Granted During the Period">2.53</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_znilgwzyUDZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock_zLdcdQg8zpM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to warrants outstanding and exercisable at December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zEBRtB1YZyI8" style="display: none">SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Warrants Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Warrants Exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Range of <br/> Exercise <br/> Prices</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Number <br/> Outstanding <br/> at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average Remaining Contractual <br/> Life</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zA4TqEbp2SNb" title="Range of Exercise Prices">0.68</span> - $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MaximumMember_zHpi7pgSLrH7" title="Range of Exercise Prices">13.20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8isFYROEml9" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Outstanding, Number Outstanding">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNkSHvxb0Df3" title="Warrants Outstanding, Weighted-Average Remaining Contractual Life">3.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zaX7hmjNlPZ6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Outstanding, Weighted-Average Exercise Price">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJ0Xh923dek6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Exercisable, Number Exercisable">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0Bymy5tI5Cf" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Exercisable, Weighted-Average Exercise Price">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zIu28JOnYfdk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock_zXv6CFuPptT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zJoO9CKXzTub" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zRcIvbKZvj9c" title="Expected Life">1.5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcCcdBpqSy4f" title="Expected Life">1.5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Dividend Yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zRGXmWSlfzP4" title="Dividend Yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zptoh3RVf8Za" title="Dividend Yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z2AJ5dft5smf" title="Expected Volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0bVWZzWEhqb" title="Expected Volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-Free Interest Rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zvo600iaapV" title="Risk-Free Interest Rate">4.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zDtTPjzGYLxb" title="Risk-Free Interest Rate">0.18</span> - <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zynlVeHkyTZa" title="Risk-Free Interest Rate">1.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> <p id="xdx_8AF_zaoaJvuMvrnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 125000 375000 1625000 359125 1250000 941875 1301000 1014438 93887 <p id="xdx_89E_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zbdXbmK2EzF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions during 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zfm67wEfVete" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Outstanding at Beginning of Year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zdePPGoE1A27" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">1,014,438</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zChwyuuUTSJ" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zopkyPbENmy7" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">893,438</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zqwyKW5KFNC5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">6.80</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231_zB5uMmp0hRa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">233,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zuoDl2bYYVC" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">0.68</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_zMnjF6aRUm3i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">233,125</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zZMmeO0cjUz6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">2.26</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zfTKw0kVzB29" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0797">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zWFkWTFV6K01" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zhLPpjuMYGq5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0801">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_z1ymKsr1MGxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0803">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_zBfEpMQhDWIj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(10,938</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zPRDrAFE0cz4" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">1.35</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zmatxCvbCy51" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(112,125</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20220101__20221231_z5TF5NTNtykc" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">16.19</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_z84ESKRj5Qld" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">1,301,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zfEeV6eQCFi" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">4.50</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zDz84gKkfaW1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">1,014,438</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zF0SOWoZ5Uv8" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options Exercisable at Year-End</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zCkjekDJFwz7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">1,260,375</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zLAbRACiwke" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">4.62</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zvrVeoSyzEW" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">959,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_zZNs6r2F5EZ1" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">5.61</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Options Granted During the Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_zgJWBI1MGbk" title="Weighted-Average Fair Value of Options Granted During the Period">0.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_zVI5KNWAIEMd" title="Weighted-Average Fair Value of Options Granted During the Period">0.92</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"> </td></tr> </table> 1014438 5.61 893438 6.80 233125 0.68 233125 2.26 10938 1.35 112125 16.19 1301000 4.50 1014438 5.61 1260375 4.62 959750 5.61 0.34 0.92 <p id="xdx_899_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_zaXT7ck19hl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to stock options outstanding and exercisable at December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zDJf67Uh7Wpa" style="display: none">SCHEDULE OF STOCK OPTION OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Options Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Options Exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Range of <br/> Exercise<br/> Prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number<br/> Outstanding at<br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average<br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number <br/> Exercisable at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20230101__20231231_z6slWAmx4Pth" title="Range of Exercise, Lower Range Limit">0.32</span> - $<span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231_zd9pfvopNXbd" title="Range of Exercise, Upper Range Limit">17.76</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231_zdEYc2lxQP0h" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Outstanding, Number Outstanding">1,301,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_z9gbFgGTT8u9" title="Options Outstanding, Weighted- Average Remaining Contractual Life">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20231231_z2wvlPSW59lk" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Outstanding, Weighted-Average Exercise Price">4.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231_z4ELPYogxgTh" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Exercisable, Number Exercisable">1,260,375</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20231231_z0JhOdobgqQg" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Options Exercisable, Weighted-Average Exercise Price">4.62</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> </table> 0.32 17.76 1301000 P6Y6M 4.50 1260375 4.62 <p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeNwcsKMPh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zzUZKu66JaH5" style="display: none">SCHEDULE OF BLACK-SCHOLES OPTION-PRICING MODEL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zoFEb8D2kj1k" title="Expected life">5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_zeAGqlQz1Ks8" title="Expected life">5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Dividend Yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231_zOok89zDF7ea" title="Dividend yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_z4RIMfyIUTo3" title="Dividend yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231_zpew7nMEXp98" title="Expected volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_zABqBm7jHQeh" title="Expected volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-Free Interest Rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231_zpsY7d3nN4al" title="Risk-Free interest rate">4.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_z7tx7Y8ODcpl" title="Risk-Free interest rate">1.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> P5Y P5Y 0 0 0.90 0.90 0.0400 0.0100 <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zL22TDANdh24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant transactions during 2023 and 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zEyVEiU6n2M8" style="display: none">SCHEDULE OF WARRANT TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Outstanding at Beginning of Year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20230101__20231231_zJZF0PBob9Bd" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zl2tmN0Fgy0i" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20221231_zNy9IjJX2EF9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares, Outstanding at Beginning of Year">872,259</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zkPHUpHqap21" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted-Average Exercise Price, Outstanding at Beginning of Year">3.04</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20230101__20231231_zeKHodlMUg2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">11,250</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20230101__20231231_zGKn8Nj62Rfa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">0.72</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zE2IUFLsQiuf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted">5,616,224</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedWeightedAverageExercisePrice_c20220101__20221231_zTDzP1XV042d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted">2.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231_ztTUv3eaA8D9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised">(945,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20230101__20231231_z8KCEslq03x9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised">1.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231_zenkPYESLqUk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised">(8,214</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedWeightedAverageExercisePrice_c20220101__20221231_zAG7RkMbdXyb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Forfeited or Cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20230101__20231231_zv1nsdX53r9b" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(245,114</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20230101__20231231_zVVn2naLRcta" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">3.34</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20220101__20221231_zpYoxDpos4L4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Forfeited or Canceled">(246,609</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedCancelledWeightedAverageExercisePrice_c20220101__20221231_zLTpj3U3GyCj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted-Average Exercise Price, Forfeited or Canceled">2.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Outstanding at End of Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20230101__20231231_zu3b7uqqQ4ol" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">5,053,896</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zg2w2ZbgKWe5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20221231_zfEYJz9Wq8vl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Outstanding at End of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zoJueKAksBtg" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Outstanding at End of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Warrant Exercisable at Year-End</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20230101__20231231_zfAGc4thUWbf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">5,053,896</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zTDiLEyHvT61" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20220101__20221231_zzE8J2ZZH427" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Options Exercisable at End of Year">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_zCKUByP6fyfb" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted-Average Exercise Price, Options Exercisable at End of Year">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted-Average Fair Value of Warrants Granted During the Year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_z0z9wBbHJCuj" title="Weighted-Average Fair Value of Options Granted During the Period">0.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zHbd2VIy8zSg" title="Weighted-Average Fair Value of Options Granted During the Period">0.72</span> - $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z8NZkPzt5Cw3" title="Weighted-Average Fair Value of Options Granted During the Period">2.53</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6233660 2.66 872259 3.04 11250 0.72 5616224 2.96 945900 1.40 8214 2.80 245114 3.34 246609 2.80 5053896 2.84 6233660 2.66 5053896 2.84 6233660 2.66 0.24 0.72 2.53 <p id="xdx_895_ecustom--SummaryOfWarrantsOutstandingAndExercisableInformationTableTextBlock_zLdcdQg8zpM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information with respect to warrants outstanding and exercisable at December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zEBRtB1YZyI8" style="display: none">SUMMARY OF WARRANTS OUTSTANDING AND EXERCISABLE INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Warrants Outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Warrants Exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Range of <br/> Exercise <br/> Prices</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Number <br/> Outstanding <br/> at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average Remaining Contractual <br/> Life</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Number <br/> Exercisable <br/> at <br/> December 31,<br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">Weighted- <br/> Average <br/> Exercise <br/> Price</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zA4TqEbp2SNb" title="Range of Exercise Prices">0.68</span> - $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231231__srt--RangeAxis__srt--MaximumMember_zHpi7pgSLrH7" title="Range of Exercise Prices">13.20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z8isFYROEml9" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Outstanding, Number Outstanding">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNkSHvxb0Df3" title="Warrants Outstanding, Weighted-Average Remaining Contractual Life">3.4</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zaX7hmjNlPZ6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Outstanding, Weighted-Average Exercise Price">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJ0Xh923dek6" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Exercisable, Number Exercisable">6,233,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0Bymy5tI5Cf" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Warrants Exercisable, Weighted-Average Exercise Price">2.84</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> </table> 0.68 13.20 6233660 P3Y4M24D 2.84 6233660 2.84 <p id="xdx_890_ecustom--ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock_zXv6CFuPptT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for options granted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zJoO9CKXzTub" style="display: none">SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Life</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zRcIvbKZvj9c" title="Expected Life">1.5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcCcdBpqSy4f" title="Expected Life">1.5</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Dividend Yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zRGXmWSlfzP4" title="Dividend Yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zptoh3RVf8Za" title="Dividend Yield">0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z2AJ5dft5smf" title="Expected Volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0bVWZzWEhqb" title="Expected Volatility">90</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-Free Interest Rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zvo600iaapV" title="Risk-Free Interest Rate">4.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zDtTPjzGYLxb" title="Risk-Free Interest Rate">0.18</span> - <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zynlVeHkyTZa" title="Risk-Free Interest Rate">1.00</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> P1Y6M P1Y6M 0 0 0.90 0.90 0.0400 0.0018 0.0100 <p id="xdx_80F_eus-gaap--IncomeTaxDisclosureTextBlock_zlvG3caHvTOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 <span id="xdx_825_zCvjPjimfjq3">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">U.S. Federal Corporate Income Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zb5zKM9JNLp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zLbjfcq8BPy5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_zFLws2LT6Xle" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_zZVtMbkKMOLi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTALNz6nP_za9Ft4Mj8E07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Tax Operating Loss Carryforward - USA</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">14,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">11,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_maDTALNz6nP_z4IT7RVAZi1e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz6nP_ziY6t8sMqZVg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation Allowance - USA</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz6nP_zV853NGZcntj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Deferred Tax Assets, Net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zE4bGY1yGPSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation allowance increased approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwardsValuationAllowance_iI_pn5n6_c20231231__us-gaap--StatementBusinessSegmentsAxis__custom--UsBasedSegmentMember_zvVPhE9tgugd" title="Valuation allowance increased">1.0</span> million, primarily as a result of the increased net operating losses of our U.S.- based segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, we had federal net operating loss carryforwards for income tax purposes of approximately $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zJD6b5EDY1zg" title="Net operating loss carryforwards">35</span> million <span id="xdx_90D_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_c20230101__20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zdQK2MDm4Lk2" title="Operating loss carryforwards, limitations on use">which will begin to expire in 2025.</span> We also have Arizona net operating loss carryforwards for income tax purposes of approximately $ <span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__srt--StatementGeographicalAxis__stpr--AZ_z7aTds6L2836" title="Net operating loss carryforwards">2.0</span> million which expire after five years. These carryforwards have been utilized in the determination of the deferred income taxes for financial statement purposes. The following table accounts for federal net operating loss carryforwards only.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zzzz2iLDr2t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zSiWMOQ0mVY5" style="display: none">SUMMARY OF OPERATING LOSS CARRYFORWARDS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ending</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Net Operating</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Year of</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%">2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20231231_z1B7GVmSc1na" style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: right" title="Net operating loss">3,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_906_ecustom--YearOfExpiration_c20230101__20231231_zM2iprIFZlvb" title="Year of Expiration">2043</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231_zVcKmsxpDfEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">3,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20220101__20221231_zSWnATMX9Qmf" title="Year of Expiration">2042</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231_zTtIX2YKjD24" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--YearOfExpiration_c20210101__20211231_zlyuwQxks9Nd" title="Year of Expiration">2041</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231_zcqXhihxq9Ec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">590,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--YearOfExpiration_c20200101__20201231_zpQHcBUGFUGa" title="Year of Expiration">2040</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2019</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231_zTbFfAKyqwb3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">260,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--YearOfExpiration_c20190101__20191231_zi7qvEBFwxUe" title="Year of Expiration">2039</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2018</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20181231_zgKVq5SFgy87" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">160,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--YearOfExpiration_c20180101__20181231_zJosH9shobYb" title="Year of Expiration">2038</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2017</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20171231_z8RKWAljaDD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">140,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--YearOfExpiration_c20170101__20171231_z6Legnxr2MT8" title="Year of Expiration">2037</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2016</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20161231_ziPugWsEl9Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,640,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20160101__20161231_zK6HkpMZfxGc" title="Year of Expiration">2036</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2015</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20151231_zx8gXjZF0YWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">3,400,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20150101__20151231_zGvRCoywwUZk" title="Year of Expiration">2035</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2014</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20141231_zsZ7RwcwLQkb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">5,230,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20140101__20141231_zCd8yNkizllk" title="Year of Expiration">2034</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2013</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20131231_zcAdmMJzSKa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">5,600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--YearOfExpiration_c20130101__20131231_zYmcJHNd7tc5" title="Year of Expiration">2033</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2012</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20121231_zmFZhmyQBvwe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">2,850,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--YearOfExpiration_c20120101__20121231_zWdhfo5C2Egf" title="Year of Expiration">2032</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2011</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20111231_zludhzgK6xve" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">2,427,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20110101__20111231_zaPyyZgEMhDg" title="Year of Expiration">2031</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2010</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20101231_zInQc3IwyAd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,799,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--YearOfExpiration_c20100101__20101231_zOZKYbKGIaa6" title="Year of Expiration">2030</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2009</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20091231_zCABAVh7cXma" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,750,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--YearOfExpiration_c20090101__20091231_zX7hfldmGEpj" title="Year of Expiration">2029</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2008</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20081231_zyUl1RkHq927" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,308,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--YearOfExpiration_c20080101__20081231_zrUF3rmgeek2" title="Year of Expiration">2028</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2007</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20071231_zXyRyuszSeDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">429,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--YearOfExpiration_c20070101__20071231_zlJwrgCXNbU2" title="Year of Expiration">2027</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2006</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20061231_zKxPTtiUgDdl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">476,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--YearOfExpiration_c20060101__20061231_zV48c7k3p4lg" title="Year of Expiration">2026</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2005</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20051231_zzLDsqajAgc4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--YearOfExpiration_c20050101__20051231_zFGtDcVYa4Al" title="Year of Expiration">2025</span></td></tr> </table> <p id="xdx_8A9_zkliuOpKiDxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Taiwan (Republic of China) Corporate Tax</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--TaiwanCorporateTaxRate_c20230101__20231231_zsmb92JR4F4" title="Taiwan corporate tax rate">Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According to the Taiwan corporate income tax (“TCIT”) reporting system, the TCIT sales cut-off base is concurrent with the business tax classified as value-added type (“VAT”) which will be reported to the Ministry of Finance (“MOF”) on a bi-monthly basis. Since the VAT and TCIT are accounted for on a VAT tax basis that recorded all sales on business tax on a VAT tax reporting system, the Company is bound to report the TCIT according to the MOF prescribed tax reporting rules. Under the VAT tax reporting system, sales cut-off did not take the accrual base but rather on a VAT taxable reporting basis. Therefore, when the company adopted US GAAP on accrual basis, the sales cut-off TCIT timing difference which derived from the VAT reporting system will create a temporary sales cut-off timing difference and this difference is reflected in the deferred tax assets or liabilities calculations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zb5zKM9JNLp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities and tax credit and operating loss carryforward that create deferred tax assets and liabilities are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zLbjfcq8BPy5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_zFLws2LT6Xle" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_zZVtMbkKMOLi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_maDTALNz6nP_za9Ft4Mj8E07" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Tax Operating Loss Carryforward - USA</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">14,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">11,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_maDTALNz6nP_z4IT7RVAZi1e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNz6nP_ziY6t8sMqZVg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation Allowance - USA</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,800,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNz6nP_zV853NGZcntj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Deferred Tax Assets, Net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0973">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 14800000 11800000 14800000 11800000 1000000.0 35000000 which will begin to expire in 2025. 2000000.0 <p id="xdx_89C_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zzzz2iLDr2t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zSiWMOQ0mVY5" style="display: none">SUMMARY OF OPERATING LOSS CARRYFORWARDS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ending</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">Net Operating</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Year of</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss:</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Expiration</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%">2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20231231_z1B7GVmSc1na" style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: right" title="Net operating loss">3,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_906_ecustom--YearOfExpiration_c20230101__20231231_zM2iprIFZlvb" title="Year of Expiration">2043</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231_zVcKmsxpDfEf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">3,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20220101__20221231_zSWnATMX9Qmf" title="Year of Expiration">2042</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20211231_zTtIX2YKjD24" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--YearOfExpiration_c20210101__20211231_zlyuwQxks9Nd" title="Year of Expiration">2041</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20201231_zcqXhihxq9Ec" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">590,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--YearOfExpiration_c20200101__20201231_zpQHcBUGFUGa" title="Year of Expiration">2040</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2019</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20191231_zTbFfAKyqwb3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">260,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--YearOfExpiration_c20190101__20191231_zi7qvEBFwxUe" title="Year of Expiration">2039</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2018</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20181231_zgKVq5SFgy87" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">160,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--YearOfExpiration_c20180101__20181231_zJosH9shobYb" title="Year of Expiration">2038</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2017</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20171231_z8RKWAljaDD9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">140,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--YearOfExpiration_c20170101__20171231_z6Legnxr2MT8" title="Year of Expiration">2037</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2016</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20161231_ziPugWsEl9Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,640,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20160101__20161231_zK6HkpMZfxGc" title="Year of Expiration">2036</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2015</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20151231_zx8gXjZF0YWh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">3,400,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20150101__20151231_zGvRCoywwUZk" title="Year of Expiration">2035</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2014</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20141231_zsZ7RwcwLQkb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">5,230,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20140101__20141231_zCd8yNkizllk" title="Year of Expiration">2034</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2013</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20131231_zcAdmMJzSKa3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">5,600,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--YearOfExpiration_c20130101__20131231_zYmcJHNd7tc5" title="Year of Expiration">2033</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2012</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20121231_zmFZhmyQBvwe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">2,850,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--YearOfExpiration_c20120101__20121231_zWdhfo5C2Egf" title="Year of Expiration">2032</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2011</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20111231_zludhzgK6xve" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">2,427,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--YearOfExpiration_c20110101__20111231_zaPyyZgEMhDg" title="Year of Expiration">2031</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2010</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20101231_zInQc3IwyAd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,799,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--YearOfExpiration_c20100101__20101231_zOZKYbKGIaa6" title="Year of Expiration">2030</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2009</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20091231_zCABAVh7cXma" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,750,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--YearOfExpiration_c20090101__20091231_zX7hfldmGEpj" title="Year of Expiration">2029</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2008</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20081231_zyUl1RkHq927" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">1,308,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--YearOfExpiration_c20080101__20081231_zrUF3rmgeek2" title="Year of Expiration">2028</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2007</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20071231_zXyRyuszSeDb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">429,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--YearOfExpiration_c20070101__20071231_zlJwrgCXNbU2" title="Year of Expiration">2027</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2006</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20061231_zKxPTtiUgDdl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">476,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--YearOfExpiration_c20060101__20061231_zV48c7k3p4lg" title="Year of Expiration">2026</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2005</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20051231_zzLDsqajAgc4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net operating loss">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--YearOfExpiration_c20050101__20051231_zFGtDcVYa4Al" title="Year of Expiration">2025</span></td></tr> </table> 3000000 2043 3000000 2042 1000000 2041 590000 2040 260000 2039 160000 2038 140000 2037 1640000 2036 3400000 2035 5230000 2034 5600000 2033 2850000 2032 2427000 2031 1799000 2030 1750000 2029 1308000 2028 429000 2027 476000 2026 414000 2025 Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year <p id="xdx_80E_eus-gaap--EarningsPerShareTextBlock_zxXGYHaj1uZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 <span id="xdx_82E_zbGTCTK5m7ib">EARNINGS (LOSS) PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required by ASC No. 260, “Earnings per Share.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the years ended December 31, 2023 and 2022 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we did not have net losses in 2023 and 2022 we would have had an additional amount of dilutive securities convertible at less than the then fair market value of the common stock. These amounts would have been <span id="xdx_904_eus-gaap--DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_c20230101__20231231_zQCbuapfWrJk" title="Dilutive securities convertible">90,000</span> and <span id="xdx_903_eus-gaap--DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_c20220101__20221231_z9CsdXpCqTQc" title="Dilutive securities convertible">90,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXkc5sishBkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zKyvw2Lhgyl3" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20231231_zI6DrCt5b5ji" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zriS6GUE6SQ9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB_zCRzxEhI6wl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zHJBPE5OCFx3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(3,235,124</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(3,345,270</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--WeightedAverageSharesOutstandingBasic_z9xFvNrDJ8ee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Weighted Average Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,973,422</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,840,598</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_pid_zakWaWv7EOkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Basic Loss Per Share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.26</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AC_zKUr4ZmhOuWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 90000 90000 <p id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXkc5sishBkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zKyvw2Lhgyl3" style="display: none">SCHEDULE OF EARNINGS PER SHARE BASIC AND DILUTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20230101__20231231_zI6DrCt5b5ji" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zriS6GUE6SQ9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, <br/> 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB_zCRzxEhI6wl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic EPS</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zHJBPE5OCFx3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(3,235,124</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(3,345,270</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--WeightedAverageSharesOutstandingBasic_z9xFvNrDJ8ee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Weighted Average Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,973,422</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,840,598</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_pid_zakWaWv7EOkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Basic Loss Per Share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.26</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -3235124 -3345270 15973422 12840598 -0.20 -0.26 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjfqQdspkWF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 <span id="xdx_82E_zkkZqelQNbb8">CONTINGENT LIABILITIES—TAIWAN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Siemens, Shihlin Electric &amp; Engineering Corporation, and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of December 31, 2023 is $<span id="xdx_90A_eus-gaap--ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_pp0p0_c20230101__20231231__dei--LegalEntityAxis__custom--MegasysMember_zmE7sguozgPj" title="Financial exposure contingent future payments">320,237</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 320237 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zVSVavf0jeig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 <span id="xdx_828_zd2OzjS6Opkj">SUBSEQUENT EVENTS</span></b></span></p>